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published in: Eur. J. Chem. 138, 9-37 (1984). Additionally, the symbol Cyt""m is used in 
this thesis to designate a cystine residue bridging the positions η and m in a peptide. 
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CHAPTER 1 
Introduction 
DNA-PROTEIN INTERACTIONS 
Interactions between nucleic acids and proteins play a fundamental role in genetic 
processes occurring in living systems. Such processes are for example DNA replication, 
recombination, DNA repair, gene expression and regulation. The participation of DNA 
binding proteins in these processes is often quite well understood on the biochemical level. 
However, the interactions between proteins and nucleic acids on the molecular level have 
still to be elucidated in many instances. 
The DNA binding proteins may be divided into double-stranded (ds) DNA binding 
proteins and single-stranded (ss) DNA binding proteins. With respect to the former, 
considerable progress has been made in recent years in structural studies of their com-
plexes with dsDNA. Several structural motifs for recognition and binding of dsDNA have 
been described: the helix-turn-helix motif, the zinc finger, the leucine zipper and the ß-
ribbon (for a review: see Freemont et al., 1991). 
Generally, much less is known about the structure of ssDNA binding proteins and their 
interaction with ssDNA. Most of this knowledge concerns the non-specific interactions. 
Prokaryotic ssDNA binding proteins that have been extensively studied are: the gene 32 
protein (g32P) encoded by bacteriophage T4 (Chase and Williams, 1986), the ssDNA 
binding protein (SSB) of Escherichia coli (Meyer and Laine, 1990) and the gene-V 
proteins (GVPs) encoded by different filamentous bacteriophages. These proteins function 
by stabilizing the single stranded DNA strands formed by unwinding of the DNA double 
helix. 
The gene-V proteins encoded by certain filamentous phages serve as relatively simple 
model systems for studying protein-ssDNA interactions. The coiiphages M13, IKe and Pf3 
code for gene-V proteins that are relatively small in size (87, 88 and 78 residues respecti-
vely) and can be isolated in large quantities. For these reasons, these three GVPs (often 
referred to as M13 GVP, Ike GVP and Pf3 GVP) are appropriate objects for high 
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resolution structural studies. These studies can be performed by crystallography (on the 
crystalline protein) and/or by high resolution NMR spectroscopy (on the protein in 
solution). 
Before we discuss the structure and function of the M13 GVP, some attention will be 
given to the filamentous phages and their life cycle. 
THE FILAMENTOUS BACTERIOPHAGES 
General aspects 
The filamentous bacteriophages form a class of non-lytic ssDNA viruses {lnoviridae) that 
share morphological and structural features (for a review: see Model and Rüssel, 1988). 
The phages contain a circular ssDNA genome (5000-7000 nucleotides) encapsulated in a 
tube-like protein coat. They have been divided into two subclasses (I and II). The phages 
comprising class I contain a genome that is packed in the protein tube as a right-handed 
helix with the bases pointing towards the helix axis (Day, 1988). In the phages of class II, 
the bases point away from the helix axis towards the protein coat. 
The phages M13, fd, fl, IKe, 12-2 and Ifl are members of class I and all have Escherichia 
coli as a host. The phages of M13, fd and fl are often collectively referred to as Ff. They 
have genomes with a high degree of homology (>98%) and their gene-V encoded ssDNA 
binding proteins have identical amino acid sequences. The IKe phage is distantly related to 
Ff. Their genomic organization are almost identical, but their DNA is only for 55% 
homologous and their GVP amino acid sequence only for 40% (Peeters et al., 1983), 
The phages of class II include Pf3 and Pfl, which have Pseudomonas aeruginosa, and Xf, 
which has Xanthomonas oryzae as a host, respectively. Although the genomes of PO and 
Pfl show no sequence homology to that of the Ff and IKe phages (Hill et al., 1991), some 
similarities in the genomic organization of the Pf3 and the Ff and IKe have been recogni-
zed (Luiten et al., 1985). The GVPs encoded by PO and Pfl both contain a segment with 
a limited homology to the so-called DNA binding loop of the GVPs encoded by M13 and 
IKe (Folmer et al., 1994; Plyte and Kneale, 1991). 
In the next section, some information will be given about the life cycle of coliphage M13, 
which is related to the subject of this thesis. 
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The M13 life cycle 
The filamentous bacteriophage M(unich)13 was discovered in 1963 in waste water samples 
of Munich incubated with several types of Escherichia coli (Hofschneider and Preuss, 
1963). Since then, M13 has been extensively studied by means of genetical, biochemical 
and physical techniques and its DNA is nowadays used as a vector in DNA recombinant 
experiments. The genome is 6407 nucleotides long and contains 10 genes, after which the 
protein products are named (for example, the 'gene-V protein' to be discussed here). 
The M13 life cycle has been studied thoroughly (for a review: see Model and Rüssel, 
1988) and will be only very briefly summarized below. It is expected that its general cha-
racterization will also pertain to the life cycles of the other phages of subclass I. An 
important characteristic of the Ff life cycle is the fact that infection does not lead to lysis 
or death of the host cell, but that a state of permanent infection is established in which 
new phage particles are continuously produced. 
Infection of the host bacterium occurs via adsorption of the phage to the tip of a conjuga-
tive pilus of the host bacterium. Subsequently, a penetration process follows during which 
the viral DNA strand (vsDNA) is released into the cytoplasm and the major coat protein is 
stripped off and deposited in the cell membrane for later use. The ensuing process of viral 
DNA replication can be subdivided in three stages: (1) conversion of vsDNA into a 
circular double-stranded replicative form (RF), (2) multiplication of the replicative form 
via the so-called "rolling circle" mechanism (Gilbert and Dressier, 1968), (3) synthesis of 
progeny viral strands. 
Transcription of the RF dsDNA and subsequent translation results in the synthesis of the 
ten phage specific proteins. The accumulation of phage ssDNA continues until the ssDNA 
binding protein encoded by gene-V of the phage reaches a critical threshold level. At this 
concentration, the GVP molecules start binding cooperatively to the displaced viral strands 
produced in the "rolling circle" process, thereby preventing their conversion into RF. The 
consequence is that the number of RF molecules is maintained at a constant level, so that 
a toxic accumulation of phage DNA and proteins is avoided. Finally, the viral DNA-GVP 
complex migrates into the cell membrane. Upon passage through the membrane and 
extrusion of the new phage, the gene-V protein is exchanged for the phage coat protein 
(which has accumulated in the membrane) and recycled into the cell, where it associates 
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with new ssDNA molecules (Pratt et al., 1974). 
In addition to its indispensable role in viral DNA replication and assembly, GVP also 
functions as a translational repressor in the regulation of the proteins encoded by genes I, 
II, HI, V and X (Zaman, 1991). In this process, the GVP binds specifically to unique 
mRNA target sequences. Thus, the nucleic acid binding properties of GVP play a central 
role in the fine-tuned process of the regulation of phage replication. 
In the next section, the present knowledge about the structure and the ssDNA binding 
properties of this protein will be briefly summarized. 
THE N113 GENE-V PROTEIN 
General aspects 
The gene-V protein encoded by bacteriophage M13 consists of 87 residues, and occurs in 
solution predominantly as a dimer with a molecular mass of 19.4 kDa. At millimolar 
concentrations, higher order aggregates are formed (Bulsink et al., 1986). Also the GVP 
encoded by phage IKe (van Duynhoven, 1992) and the ssDNA binding protein encoded by 
phage Pf3 (Folmer et al., 1994) occur as dimers in solution and have a tendency to 
aggregate at higher concentrations. The amino acid sequences of M13 and IKe GVP are 
compared in Fig.l. The high degree of sequence identity (40 %) is obvious (Peeters et al., 
1983). 
The specific aggregation effect of the wild-type M13 GVP hinders the recording of good 
quality NMR spectra. This is believed to be associated with specific protein-protein inter-
actions between dimeric gene-V protein molecules in which the tyrosine residue at 
position 41 and possibly the one at position 34 is involved (Folkers et al., 1991). This 
hypothesis was strengthened by the observation that the solubility of tyrosine 41 mutants 
of gene-V protein is significantly higher than that of the wild-type protein. The discovery 
of these so-called "solubility" mutants of M13 GVP enabled the study of the solution 
structure of gene-V protein and its interaction with ssDNA by means of two-dimensional 
NMR. These studies culminated in the eludication of the solution structure of M13 GVP 
mutant Tyr41 —» His (Folkers et al., 1994). Below, this structure will be discussed briefly. 
The results with the mutant are also valid for the wild-type M13 GVP as the two proteins 
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adopt virtually the same conformation in solution (Folkers et al,, 1991). 
ι io 
M13 Met Ile Lys Val Glu Ile Lys Pro Ser Gin Ala Gin Phe Thr Thr 
IKe Met Leu Thr Val Glu Ile His Asp Ser Gin Val Ser Val Lys Glu 
ι io 
20 
Arg Ser Gly Val Ser Arg Gin Glv Lys Pro Туг Ser Leu Asn 
Arg Ser Gly Val Ser Gin Lys Ser Gly Lys Pro Туг Thr Ile Arg 
20 30 
30 40 
Glu Gin Leu Cys Tyr Val Asp Leu Gly Asn Glu Туг Pro Val Leu 
Glu Gin Glu Ala Tyr Ile Asp Leu Glv Gly Val Tyr Pro Ala Leu 
40 
50 
Val Lys Ile Thr Leu Asp Glu Gly Gin Pro Ala Tyr Ala Pro Gly 
Phe Asn Phe Asn Leu Glu Asp Gly Gin Gin Pro Tyr Pro Ala Gly 
50 60 
60 70 
Leu Tyr Thr Val His Leu Ser Ser Phe Lys Val Gly Gin Phe Gly 
Lys Tyr Arg Leu His Pro Ala Ser Phe Lys Ile Asn Asn Phe Gly 
70 
80 87 
Ser Leu Met Ile Asp Arg Leu Arg Leu Val Pro Ala Lys M13 
Gin Val Ala Val Gly Arg Val Leu Leu Glu Ser Val Lys IKe 
80 88 
F/g. /. Comparison of the amino acid sequences of M13 GVP (Cuypers et ai, 1974) and 
IKe GVP (Peelers et al., J983). Optimum alignment of the sequences is achieved when 
Glnll in IKe GVP is considered as an insertion. Identical residues are underlined. 
General DNA binding properties. 
The binding of M13 and IKe GVP to ssDNA has been monitored by a variety of techni­
ques, such as UV (van Amerongen et al., 1990), fluorescence (Alma et al., 1983; Bulsink 
et al., 1988a; Bulsink et al., 1988b; Pretorius et al., 1975), circular dichroism (Kansy et 
al., 1986), NMR (de Jong et al., 1987), electron microscopy (Gray, 1989) and neutron 
scattering (Gray et al., 1982). The binding has been shown to be largely non-specific with 
respect to the ssDNA (Stassen et al., 1992). Electrostatic interactions play an important 
role as judged from the salt dependence of the binding (Bulsink et al., 1988). They exist 
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between electropositive patches on the protein surface and the negatively charged sugar-
phosphate backbone. Non-electrostatic intermolecular interactions, e.g. stacking between 
aromatic rings of GVP and the nucleotide bases, are of a highly dynamic nature and play a 
minor role in oligonucieotide-GVP complex stabilization. The resulting, rather loose 
oligonucleotide-GVP interaction allows a rapid sliding (translocation) of GVP along the 
ssDNA lattice. This may be relevant for rapid rearrangements of the distribution of the 
GVP molecules (Bulsink et al., 1988a). These redistributions probably play a role in the 
fast formation of the large rod-like nucleoprotein assemblies, in which the viral DNA 
adopts a left-handed helical structure (Gray, 1989). 
With regard to GVP binding to ssDNA, two binding modes have been distinguished, 
which are referred to as the oligonucleotide and the polynucleotide binding modes (Alma 
et al., 1983; Bulsink et al., 1988b). The oligonucleotide binding mode (for chain length < 
30 nucleotides) is characterized by a stoichiometry of 3 nucleotides per protein monomer 
(n=3), and low binding cooperativity. In the polynucleotide binding mode, 4 nucleotides 
are bound per protein monomer (iv=4) and the cooperativity of binding is high. Here, 
cooperativity means that when one protein dimer has associated with a long strand, 
subsequent binding of other GVP molecules side by side is facilitated through dimer-dimer 
interactions. This property is probably reflected in the tendency of GVP to form aggrega-
tes (de Jong et al., 1987). 
Much effort has been invested in the identification of the amino acid residues of GVP that 
are involved in the binding of ssDNA. Special attention has been paid to the positively 
charged amino acid residues, which may interact electrostatically with the negatively 
charged phosphate backbone of the DNA. These basic residues are the six lysines, the four 
arginines and the single histidine residue of the protein monomer. The residues with 
aromatic side chains (i.e., the four tyrosine and the three phenylalanine residues) are 
candidates for stacking interactions with DNA bases. From NMR experiments on the 
binding of oligonucleotides by GVP it has been deduced that one tyrosine, one phenylala-
nine, no histidine and a number (but not all) of the arginine and lysine residues are 
involved in DNA binding (Alma et al., 1981; de Jong et al., 1987). Binding studies 
employing spin-labeled oligonucleotides have provided more detailed information about 
the DNA binding domain and which residues are involved in DNA binding (Folkers et al., 
1993). This information is summarized in one of the following sections. 
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The solution structure of M13 GVP mutant Tyr41->His. 
In 1994, a three-dimensional picture of the solution structure of mutant Tyr41->His of the 
ssDNA binding protein encoded by gene-V of phage M13 (M13 GVP Y41H) was reported 
(Folkers et al., 1994). It was deduced using NMR spectroscopy followed by calculations 
with appropriate distance geometry programs. 
In solution, the protein occurs as a dimer consisting of two identical monomers, each 87 
residues long, associated in such a manner that the complex has a two-fold axis of 
symmetry. 
The family of 20 structures calculated by Folkers et al. (1994) for this dimer are shown in 
superposition in Fig. 2. The structure of residues 1-15 and 29-87 of both monomers was 
reasonably well-determined, but the orientation of the exposed ß-Ioop formed by residues 
16-28 with respect to the core could not be determined due to the lack of long-range 
NOEs between the two. Within each monomer, the main secondary structure elements 
comprise a large five-stranded ß-sheet and three anti-parallel ß-loops. One of these loops 
is formed by the aforementioned residues 16-28. It is exposed and flexible as judged from 
its increased conformational disorder. This is supported by the absence of any slowly 
exchanging backbone amide protons within its region, despite the fact that the NOE data 
are clearly indicative of a ß-sheet and turn. 
In Fig. 3, a schematic representation is depicted of the dimer structure generated with the 
program Molscript (Kraulis, 1991). The drawing shows the presence of eight ß-strands 
within each subunit; they are formed by residues 3-6, 13-20, 24-35, 43-48, 59-63, 68-71, 
75-78 and 83-85. Of those, residues 3-6, 30-35, 43-48, 59-63 and 83-85 form the five-
stranded ß-barrel. The strands constituting residues 68-71 and 75-78 form an antiparallel 
ß-loop. A second antiparallel ß-loop is formed by residues 13-20 and 24-31 and connects 
at its base to the end of the ß-strand formed by residues 43-48. These structural elements 
are resumed in the two-dimensional representation of the secundary structure of M13 GVP 
Y41H that is depicted in Fig. 4 (Folkers et al., 1993). 
Proceeding along the primary amino acid sequence of M13 GVP Y41H, the following 
structural elements are encountered (Fig. 3): the somewhat disordered N-terminus (residues 
1-3); a ß-strand (3-6); a 3,0 helical turn (7-10); a long anti-parallel ß-loop (13-31); a 
continuing ß-strand (32-35); a long loop (36-42); a ß-strand (43-48); a ß-turn (49-52); an irregular 
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a. 
b. .γ-Ο 
Fig. 2. Views showing best-fit superpositions of the backbone (N, Ca, С) atoms of the 
structures of M13 GVP calculated by Folkers et al. (1994). The structures were best fitted 
to residues 1-15 und 29-87. a) View with the two-fold axis of the molecule perpendicular 
to the plane of the paper, b) View with the two-fold axis parallel to the plane of the paper. 
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Complex Loop 
24, 
831 
48 
71 i 
?78 
N 
N 
,«75 
78* 
68 
48 
183 
'24 
'71 
DNA Binding Loop 
Dyad Loop 
"35 
43 
Fig. 3. Schematic representation of the structure of GVP Y4ÌH made with Molscript 
(Kraulis, 1991 ) viewed with the symmetry axis perpendicular to the plane of the paper . 
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M13GVP 
76 78 83 85 87 
complex loop 
Fig. 4. Two-dimensional representation of the secundary elements in MI3 GVP. 
bend (53-59); a ß-strand (59-63); a 3 t0 helical turn (64-67); an antiparallel ß-loop (68-78); 
an irregular bend (79-81) and, finally, the C-terminal ß-strand (83-85). 
The dimer structure of the protein is primarily stabilized by interactions between hydrop-
hobic side chain residues. Roughly, three domains of the protein are involved in monomer-
monomer interactions. These are the so-called dyad domain (residues 64-82), the complex 
domain (residues 35-47) and the N-terminal part of the protein. 
A crystal structure model of wild-type MI3 GVP has recently been obtained by X-ray 
diffraction (Skinner et al., 1994). Its secundary structure elements are largely similar to 
those of the described solution structure of M13 GVP Y41H. 
In this thesis, we will focus on the so-called DNA binding loop (residues 13-31) of M13 
GVP. This loop consists of two ß-strands (residues 13-20 and 24-31) connected by a ß-
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turn (residues 21-23) which is not well determined and therefore not yet assigned to the 
classified loop structures (Sibanda and Thornton, 1985). As mentioned, the position of 
residues 16-28 could not be determined with respect to the core of the protein. Never-
theless, superposition of the 20 calculated structures shows that the approximate fold of 
this part of the DNA binding loop is reasonably well determined. It is clearly twisted (Fig. 
2 and 3) which is reflected in the presence of NOEs between the resonances of Tyr26 and 
those of residues Glyl8, Val 19 and Ser20. 
In the next section, the ssDNA binding characteristics of GVP Y41H is correlated to the 
recently deduced solution structure (Folkers et al., 1994) and the involved amino acid 
residues. 
The ssDNA binding domain of M13 GVP 
NMR binding studies using spin-labeled oligonucleotides have provided detailed informa-
tion on the binding of ssDNA by M13 GVP (Folkers et al., 1993). Binding of the spin-
labeled molecules results in broadening of resonances of amino acid residues which are in 
the close vicinity of the spin-label. In particular, strong effects are observed for the 
residues: Arg 16, Glyl8, Ser20, Arg21, Lys24, Tyr26, Leu28, Lys46, Thr48, Asp50, Glu51, 
Gln72, Phe73, Gly74, Ser75 and Arg80. Hence, it follows that Tyr26 and Phe73 are the 
only aromatic residues involved in DNA binding; Tyr34 and Tyr41 are not involved, in 
contrast with earlier suggestions. By analogy, of the positively charged residues the lysine 
residues Lys24, Lys46 and Lys69 are involved (but not Lys3, Lys7 and Lys87) as well as 
the arginine residues Arg 16, Arg21 and Arg80 (but not Arg82). Additionally, the hydro-
phobic residue Leu28 must play a role in DNA binding as well as the residues Ser20, 
Thr48, Asp50, Glu51 and Ser75, which possibly interact by hydrogen bonding and/or 
electrostatic interactions. 
By combination of the results of the NMR analysis of the solution structure (see previous 
section) and the spin-labeled oligonucleotide binding studies it was possible to visualize 
the location of the DNA binding domain of M13 GVP (Folkers et al., 1994). In Fig. 5, a 
ribbon drawing of the average GVP Y41H structure is depicted, showing only the side 
chains of the residues that are involved in DNA binding. 
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Fig. 5. Ribbon drawing of the backbone of the average energy minimized structure of M13 
GVP Y41H with only those amino acid side chains shown which are in close vicinity to 
the DNA. a) view with the two-fold symmetry axis perpendicular to the plane of the paper. 
b) view with the two-fold axis parallel to the plane to the paper (Folkers et al, 1994). 
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Two ssDNA binding clefts per protein dimer can be recognized, so the molecule can bind 
to two ssDNA strands at the same time. Most probably, the ssDNA is clamped between 
the flexible DNA binding loop (residues 16-28) and the tip of the dyad loop of the 
symmetry-related monomer (residues 71-75). Hereby, a part of the complex loop (residues 
44-51) running contiguous to the DNA binding loop is also in the close vicinity of the 
DNA. Additionally, residue Arg80 of the same monomer as the DNA binding loop is part 
of the DNA binding cleft. The ssDNA must be running along one of the sides of the ß-
ladder of the DNA binding loop, namely the one carrying the side chains of the even-
numbered residues (Arg 16, Glyl8, Ser20, Lys24, Tyr26 and Leu28). Strikingly, the side 
chain of Tyr26 is bent over to Gly 18 of the opposite strand (Fig. 5). The even-numbered 
residues of the ß-strand composed of residues 44-49 are positioned on the surface of the 
protein and may also be interacting with ssDNA. 
As already stated above, the non-specific binding of ssDNA to GVP is caused by an 
electrostatic interaction between the sugar-phosphate backbone of the nucleic acid and the 
positively charged side chain residues of the protein (Alma et al., 1983; Bulsink et al., 
1988; Stasseii et al., 1992). The DNA binding region has a highly positive electrostatic 
potential due to the presence of several arginine and lysine side chain residues (Folkers et 
al., 1994). It also contains several hydrophobic residues (Tyr26, Leu28, Phe73) that 
probably participate in hydrophobic (e.g. stacking) interactions with the nucleotide bases 
(King and Coleman, 1987). The specificity of GVP with respect to the binding of only 
single-stranded nucleic acids can be explained by the sizes of the two binding channels 
which simply cannot accommodate a double-stranded helix. The dyad domains of both 
symmetry-related monomers fill the cavity between the flexible DNA binding loops (Fig. 2 
and 5). 
The flexibilities of both the dyad loop and the DNA binding loop are probably important 
for the binding to ssDNA. The overall conformation of the MI3 GVP however hardly 
changes upon the binding of DNA. 
The calculated solution structure of M13 GVP Y41H is in excellent agreement with most 
of the existing biochemical and biophysical data of the protein and provides a clear view 
of its ssDNA binding path. The elucidation of the three-dimensional structure of the 
ssDNA binding proteins encoded by phages IKe and Pf3 is currently in progress (van 
Duynhoven et al., 1992; Folmer et al., 1994). The data available thus far suggest that Ike 
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G VP and Pf3 DBP have an architecture similar to the Ml 3 GVP. 
In fact, the first detailed structural analysis by means of NMR was undertaken on the 
gene-V protein encoded by the bacteriophage IKe (de Jong et al., 1989). This led to the 
identification of a ß-loop structure that was part of the DNA binding domain, as concluded 
from binding experiments with spin-labeled oligonucleotides. The first result obtained by 
NMR studies on M13 GVP actually was the structure of the DNA binding loop which was 
largely similar to that of IKe (van Duynhoven et al., 1990). Also the DNA binding protein 
encoded by phage Pf3 contains a similarly structured DNA binding loop, as deduced by 
NMR investigations (Folmer et al., 1994). These remarkable results can probably be 
extended to a number of other phages, as discussed below. 
METHODS OF PEPTIDE SYNTHESIS APPLIED 
Solid phase peptide synthesis. 
The solid phase peptide synthesis ("SPPS") introduced by Merrifield (1963) has become 
the method of choice for the routine synthesis of peptides in amounts ranging from the 
order of micrograms to grams. The classical synthesis in solution becomes more and more 
confined to special cases, to the synthesis of short peptides in larger amounts and to the 
coupling of protected fragments in the so-called convergent peptide synthesis (Lloyd-
Williams et al., 1993). In SPPS, the growing peptidyl chain is linked to an insoluble 
support and is lengthened stepwise by the coupling of N-protected amino acid derivatives. 
After coupling, the temporary amino-protection is removed and the coupling/deprotection 
cyclus is repeated until the complete chain has been assembled. Then the peptide is 
detached from the support by a suitable chemical procedure. The whole procedure can be 
automated and several types of (semi-)automated peptide synthesizers are presently 
available. 
Claims on the successful preparation of proteins even larger than 100 residues by this 
method have been made, but generally one should be cautious with respect to the purity of 
such long peptides. For example, even the often used purification and analysis by HPLC 
may give a false impression of homogenity, and for a critical assessment of identity and 
purity, complementary analytical techniques (e.g. NMR, MS, electrophoresis) may be 
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required (Miller et al., 1991). 
With respect to the chemistry involved, two SPPS methods are distinguished. One of them 
(the "Boc SPPS") employs the t-butyloxycarbonyl (Boc) group (McKay and Albertson, 
1957; Carpino, 1957) as the temporary ami no-protection (Rappeler and Schwyzer, 1960). 
After completed assembly of the peptidyl chain, the side chain protections and the linkage 
to the support are simultaneously cleaved with a strong acid such as hydrogen fluoride. 
Considerably milder chemical agents are applied in solid phase peptide synthesis employ-
ing the so-called Fmoc strategy ("Fmoc SPPS"), which is used in this work. The method 
employs the 9-fluorenylmethyloxycarbonyi group (Fmoc) group as a base-labile temporary 
amino-protection (Carpino and Han, 1972). It can be removed with a mild base such as 
piperidine. Cleavage of the assembled peptide from the solid phase anchor and deprotec-
tion of the side chains is usually simultaneously performed with trifluoroacetic acid (TFA). 
For a detailed review about all aspects of the Fmoc SPPS method, see Fields and Noble 
(1990). 
Various substances can be used as the solid phase in SPPS. Acid labile peptide esters can 
be synthesized on cross-linked polystyrene substituted with p-(hydroxymethyl)-phenoxy-
methyl residues (the 'Wang linker'; Wang, 1973). The ester link in these esters has the 
stability of feri-butyl derived protections and will hence be cleaved together with the semi-
permanent side-chain protections. Introduction of another methoxy function in the phenoxy 
group of the Wang linker stabilizes the intermediary carbonium-ion so well that selective 
fission of the anchoring ester link is possible, giving access to the synthesis of protected 
peptides (Mergler et al., 1988). The latter option was very important for the performance 
of this work. 
Protected peptide hydrazides and protected peptide disulfides can be prepared using our 
own trityl-type linkers devised for this purpose (van Vliet et al., 1993; see also chapter 6). 
Disulfide bond formation. 
As will be described in the following section, the formation of disulfide bonds plays an 
important role in our synthesis of constrained peptides related to the ssDNA binding loop 
of M13GVP. 
In peptide synthesis, several options exist for the formation of disulfide bonds; most of 
15 
these are documented in a review by Biiliesbach (1992). The strategies are governed by 
the side chain protections chosen for the cysteine residues which are to be linked. Three 
thiol protections commonly used in Fmoc SPPS are: the acetamidomethyl (Acm), the trityl 
(Trt) and the tert-bulyl (SfBu) group (Fig. 6). In principle, each of them is compatible 
with the reagents employed in Fmoc SPPS, although the Tit group is partially removed in 
TFA. The development of new protective functions for cysteine is continuing in many 
laboratories, including our own (chapter 7). 
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Fig. 6. Structures of the thiol protecting groups: trityl (Trt), t-butylsulfenyl (StBu) and 
acetamidomethyl (Acm). 
For the formation of disulfide bonds in the required model peptides, we chose the iodine-
mediated oxidation of Cys(Trt) and Cys(Acm) residues of Kamber et al. (1980). These 
authors showed that the selectivity for formation of a sulfenyl iodide from either the trityl 
or the acetamidomethyl group is controlled by the nature of the applied solvent and that 
the preferred method involves the use of both protections in one compound. 
The trityl type protection of the cysteine thiol group also offers a possibility for its 
immobilization on a solid phase. Subsequent Fmoc SPPS incorporating a Cys(Acm) 
residue, followed by treatment with iodine in a suitable solvent may directly afford the 
protected cyclic disulfide peptide. 
Disulfide cyclization can also be effected by oxidation of deprotected thiol groups with 
e.g. air, DMSO or potassium hexacyanoferrate (III). This is performed preferably in dilute 
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solution or directly on the solid phase. 
THE ssDNA BINDING LOOP OF M13 GVP; AIM OF THIS INVESTIGATION 
As mentioned in the previous section, the amino acid sequences of the DNA binding loops 
of MI3 GVP, IKe GVP and Pf3 DBP exhibit a high degree of identity. The DNA binding 
loop sequences of these GVPs also appear to be strikingly well conserved in a number of 
other phage-encoded ssDNA binding proteins as depicted in Fig. 7 (de Jong et al., 1989; 
Plyte and Kneale, 1991; Stassen et al., 1994). Among these proteins are those encoded by 
the earlier mentioned phages T4, Pf3 and Pfl (vide supra). Hence, the suggestion is strong 
that a common structural motif is exploited by a number of ssDNA binding proteins in 
their binding to ssDNA. 
It was demonstrated in the preceding sections that the so-called DNA binding loop 
(sequence 16-28) of M13 GVP indeed plays a most important role in the binding of 
ssDNA. The special features of this loop described here all contribute to this role. The 
most striking of these features are: the flexible position with respect to the protein core, 
the arrangement of residues which is (semi-)conserved in several DNA binding proteins, 
and the special conformations of some of the side chains, specially of tyrosine 26. 
Considering all this, the question became obvious whether these special features are 
governed by the primary sequence of part [16-28] alone. 
Synthesis and study of protein fragments (peptides) may provide a means of gaining 
insight into their conformational and/or biological properties of such fragments in the 
protein. In the case of M13 GVP, a fragment corresponding to sequence [16-28] seems an 
obvious object for synthesis in this respect. This is also valid because the (NOE) data 
available thus far suggest that this sequence has no interactions with the rest of the 
protein. Hence, influences of other parts of the protein can principally be ignored during 
synthesis and structure analysis. 
However, at the time we started this work it was believed that the well-defined ß-loop 
structure encompassed at least sequence [13-31] of M13 GVP and probably extends even 
further (Fig. 8). 
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Fig. 7. Schematic representation of the DNA binding loop structure of M13 GVP and IKe 
GVP. Putative DNA binding loop sequences as judged from amino acid homology analysis 
of the following phage-encoded ssDNA binding proteins: T4 g32P; Pf3 GVP; Pfl DBP; 
Phi29 p5. Residues identical to the M13 GVP sequence are boxed by solid lines. 
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Fig. 8. The putative (van Duynhoven et al,, ¡990) ssDNA binding loop of M13 GVP. The 
cystine bridging Loci in cyclic model peptides I and // are indicated. 
The sequences [17-27] and [11-33] of the putative antiparallel ß-loop of Fig. 8 seemed 
attractive with respect to both synthesis and structure analysis. Since the compounds are 
isolated protein fragments, it appeared necessary to consolidate their conformation by 
insertion of a constraint. The minimal variation of the native sequences, giving an accepta-
ble constraint, would consist of the formal exchange of the two oxygen atoms against 
sulfur atoms in the side-chains of the Seri7 and Ser27 residues, or insertion of one sulfur 
atom in the side chain of Alai 1, by introduction of Cys residues in these positions, which 
can be linked by oxidation to give a disulfide bridge. 
If the protein fragments indeed prefer the ß-loop conformation, the cyclization can be 
expected to occur with only minor violations of its secondary structure. This is because of 
the parallel positioning of the side chains of two opposite residues in the ß-ladder, and the 
relative similarity between the side chains of serine, alanine and cysteine. 
Hence, the synthesis of the disulfides [Cyt,727]-M13 GVP-(17-27)-undecapeptide (I) and 
[Cyt" 51]-M13 GVP-(I l-33)-tricosapeptide (II) and their careful purification and characte-
rization was the first aim of this work. 
The precise descriptions of the conformation and the oligonucleotide binding properties of 
the two cyclic peptides in aqueous solution were required to determine the similarity of 
these artificial loops and the natural binding loop of M13 GVP. A high degree of simila-
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rity between their conformations and those of the corresponding native sequences would 
indicate that the propensity for the specific folding is contained entirely in the primary 
structure. If so, the disulfide bridge may still be required as a constraint to maintain (a 
high population of) the preferred conformation. To confirm this, the synthesis and confor-
mation study of open analogues was also necessary. For example, in the case of sequence 
[17-27] also the 'linear' undecapeptide with two terminal unlinked serine residues (Serl7 
and Ser27) was prepared and investigated. 
With respect to DNA binding, the peptides may at most serve only partially as model 
systems as they represent only a part of the DNA binding domain. Oligonucleotide binding 
studies were performed with them in an attempt to obtain an impression of the contributi-
on of the involved sequences to ssDNA binding. 
During the course of this work it became clear that the ß-loop structure of the DNA 
binding loop is well-defined only for the sequence [16-28] (Folkers et al., 1994). The 
remaining parts of the initially suggested ß-loop [13-31] do not seem to constitute the 
well-defined ß-ladder previously suggested (van Duynhoven et al., 1990). 
Nevertheless, I and II can still be considered relevant for conformation and DNA binding 
studies. Compound I lacks the residues Arg 16 and Leu28 but since it comprises the largest 
part of sequence [16-28], it should, in principle, still be able to adopt the ß-loop confor-
mation. Folkers et al. (1993) found the lacking residues Arg 16 and Leu28 to play a role in 
ssDNA-binding by M13 GVP, but on the other hand, the undecapeptide still contains the 
residues Gly 18, Ser20, Arg21, Lys24 and Tyr26 which also participate in DNA binding. 
The other residues in the native loop are also affected by spin-labeled oligonucleotides 
(except Gly23) but to a lesser extent. 
Compound II contains the entire sequence [16-28], but it has, by its larger ring size, a 
higher degree of conformational freedom, and it lacks the effect of the covalent anchorage 
to the remainder of the protein, as well as the interaction with the complex loop in the 
native structure (see also chapter 3). It is therefore interesting to investigate whether these 
natural restrictions could be compensated for by the presence of the disulfide constraint 
and to what extent both the ß-loop structure and the oligonucleotide binding properties 
would be maintained. 
To our knowledge, this is the first time that the folding and DNA binding potentials of a 
primary sequence in a ssDNA binding protein arc investigated with the aid of constrained 
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.synthetic peptides. During the course of this work, it was reported by Barthwal et al. (J. 
van Duynhoven, personal communications) that the synthetic linear hexapeptide H-Lys-
Pro-Tyr-Ser-Leu-Asn-OH corresponding to sequence [24-29] of M13 G VP was able to 
bind to deoxy-oligonucleotide d-GACTCGTC as judged by a 0.09 ppm upfield shift of the 
aromatic protons of the tyrosine residue in the Ή NMR spectrum after titration. We found 
comparable maximum upfield shifts during the titration of the synthetic linear heptapeptide 
H-Lys-Pro-Tyr-Ser-Leu-Asn-Glu-OH with octanucleotide p(dT)8. However, these peptides 
do not represent the characteristic ß-loop structure of the DNA binding loop. Besides, the 
N-terminal lysine residue bears two positive charges and hence is capable of a much 
stronger electrostatic binding than the Lys24 residue in the native chain. 
Oligopeptides have been used currently as model systems for studies on protein-nucleic 
acid interactions (Robledo-Luiggi et al., 1991). Even simple peptides as H-Lys-Phe-NH2 
(Adawakar et al., 1975), H-Lys-Tyr-Lys-OH (Dimicoli and Hélène, 1975) and H-Lys-Trp-
Lys-OH (Toulmé and Hélène, 1977) have been shown to interact with DNA in different 
specific ways. 
With an increasing rate, conformation studies are performed on peptides meant as 
sequence-specific models for folded protein fragments. For a long time, it was believed 
that short linear peptides generally do not attain secondary structure in aqueous solution. 
This probably had two main reasons: 1) the problem of selecting appropriate sequences 
and 2) the lack of sensitive techniques to detect (possibly small) populations of folded 
conformations. The development of antipeptide antibody technology and, in particular, 
two-dimensional NMR spectroscopy (Ernst et al., 1987) has largely eliminated the second 
problem. It has now been established that a number of (sometimes even very short) linear 
peptides adopt folded structures (hydrophobic clusters, helices, turns) in water (for a 
review: see Wright et al., 1988). Nevertheless, many linear peptides shorter than 20 
residues do not attain a secondary structure in water. In contrast, they often show well-
defined structures in organic solvents, but these are generally irrelevant with respect to the 
folding of protein fragments in a natural aqueous environment. 
The usually high conformational entropy of short linear peptides in water is probably 
caused by the lack of effective hydrophobic interactions and by their flexibility (Vita et 
ai., 1990). It can be reduced by binding to a biological interface, by the introduction of 
constrained nonnatural amino acid residues or by the introduction of a constraint on a 
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larger segment of the peptide (Taylor and Ösapay, 1990). For the latter purpose, amide or 
disulfide bridges are usually employed. 
With respect to our investigations, it is important to note that conformational analysis of 
proteins and some model peptides has shown that disulfide bridging across the nearest 
residues on two antiparallel ß-strands "in register" is well possible (Srinivasan et al., 
1990), in contrast to earlier suggestions (Richardson, 1981). However, to our knowledge, 
cyclic disulfide peptides preferring a ß-loop structure with the bridging over two antiparal-
lel ß-strands "in register" in aqueous solution, had not been reported at the start of this 
work. For this reason, the outcome of the structural study on our cyclic model peptides 
was considered interesting not only with respect to the folding of the native DNA binding 
loop of M13 G VP, but also with respect to the folding of peptide fragments in general. 
OUTLINE OF THIS THESIS 
This thesis deals with the synthesis and conformational studies of (constrained) peptides 
representing the DNA binding loop of the gene-V protein encoded by coliphage M13 
(M 13 GVP). Chapter 2 describes in detail the synthesis of a cyclic undecapeptide and a 
cyclic tricosapeptide representing sequence [17-27] and [11-33] of the protein, respective-
ly. An unexpected side reaction of a N-acyl cysteine ester moiety during Fmoc SPPS is 
also described and elucidated. 
Chapter 3 describes a 2D NMR study on the solution conformation of the model peptides 
in water. Subsequent structure calculations and chemical shift comparisons showed that the 
cyclic undecapeptide adopts a conformation that is strikingly similar to that of the 
corresponding native sequence in M13 GVP. 
Chapter 4 describes the qualitative results of oligonucleotide binding studies on the cyclic 
peptides, performed by means of NMR-monitored titrations. Chapter 5 describes the 
results of FT-IR studies on the cyclic peptides in the dry state; it is qualitatively shown 
that in this state similarly structured elements are present as in solution. 
Chapter 6 describes a new method for efficient solid phase synthesis of protected disulfide 
peptides; it employs a novel linker of the trityl-type and the selective oxidation of 
thioethers investigated by Kamber et al. (1980). A protected cyclic undecapeptide related 
to sequence [17-27] of M13 GVP was efficiently prepared in this way. 
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Chapter 7 describes an efficient novel preparation of S-(alkylsuIfenyl)cysteines, which are 
important derivatives in the synthesis of cysteinyl peptides. Chapter 8 describes how these 
derivatives can be used for the synthesis of model compounds for stability and racemiza-
tion studies on cysteine derivatives under the conditions of Fmoc SPPS. It is shown by 
attempted synthesis of the cyclic undecapeptide I that Fmoc SPPS is not well compatible 
with the presence of an S-(alkyIsulfenyl)cysteine ester unit in the peptidyl chain. 
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CHAPTER 2 
The synthesis of peptides [Cyt17 27]-M13 GVP-U7-27)-
undecapeptide and [Cyt1133]-M13 GVP-(ll-33)-
tricosapeptide* 
ABSTRACT. 
Two linear peptides, each containing two cysteine residues, were synthesized using the 
solid phase method and then cyclized in solution. An anchor with a super acid sensitive 
linker was used to enable the detachment of protected peptide derivatives. The protection 
of the cysteine residues was such, that iodine mediated oxidation cyclization could be 
performed optimally. Following cyclization, the compounds were deprotected using triflu-
oroacetic acid. The readily soluble peptides and peptide derivatives were purified and 
characterized using Edman degradation, chromatographic techniques, nuclear magnetic 
resonance and mass spectrometry. 
From these characterisations it became evident that a side reaction, at that time unknown, 
of the cysteine ester had taken place during the (repetitive) removal of protecting 9-(fluo-
renylmethyl)oxycarbonyl groups with piperidine. 
INTRODUCTION 
Gene-V protein is a ssDNA-binding protein encoded by coliphage M13 that is required by 
the phage during replication. In this process, the protein interacts with ssDNA via the 
special fragment of its sequence known as the ssDNA-binding loop (cf. chapter 1). 
In chapters 1 and 3 the choice is explained of the cyclic peptides I and II (Fig. 1) as 
targets of synthesis. Their sequences are closely related to that of the ssDNA binding loop 
*) The symbol Cyt""'" is used to designate a cystine residue bridging the positions η and m. 
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and were expected to act as biochemically interesting, constrained analogues of this loop. 
These expectations were borne out, as described in the folowing three chapters (3, 4 and 
5). 
Peptide I: 
H-Cys-Gly-Val— Ser-Arg-Gln-Gly-Lys-Pro—Tyr-Cys-OH 
Peptide Π: 
H-Cysr-Gln-Phe-Thi-Thr-Arg-Ser-Gly-Val-Ser-Arg-Gln— 
I •  
—Gly-Lys-Pro-Tyi-Ser-l^ir-Asn-Glu-Gln-Leu-Cys-OH 
Fig. I: Sequences of peptides I and II. 
Outline of the synthesis 
A strategy for the synthesis of peptides I and II is outlined in Fig. 2. 
For the preparation of both I and II the solid-phase method was chosen. The desired 
disulfide bridge was formed using the iodolytic oxidative cyclization as developed by 
Kamber (Kamber et al., 1980). To fulfil the requirements of this approach, one of the 
cysteine-sulfurs should be protected with the acetamidomethyl group and the other with 
the trityl group. Since the latter thioether is the product of an acid catalyzed equilibrium 
alkylation, it shows limited stability in acidic media. Consequently, the solid phase syn­
thesis had to be performed using base-labile temporary protections, e.g. the 9-(fluore-
nylmethyl)oxycarbony! group (Fmoc). On completion of assembly, the most acid sensitive 
bond should be the anchoring bond, to allow very mild acidolytic detachment of the 
desired derivative. To this end, the commercially available 'Super Acid Sensitive Resin' 
(SASR1N) was chosen as the support. Conservation of the trityl thioether in the N-terminal 
cysteine residue can be ensured by the addition of some triphenylmethanol, to shift the 
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Fmoc-Cys(Acm)-OH linked 
to the SASRIN-suppoit ' 
Tit 
Boc—Cys—AAn-
H2 Acm Н з С ° > _ _ СЦ 
r
 Fmor-Qs-0-CH2-/~^>~0-CH2-4r~VcH 
Fmoc—ι 
Acm · 
-Cys—O—I 
Acm ι 
-AA2—c|s—O—| 
1) Pip/DMF (1:4) 
2) X-AA-OH 
DCXVHOBt 
X * Fmoc in etch cycle but 
the last, when X - Boc 
ITA : DCM -1:99 
Trt Acm 
Boc-cls—AAn AA2—Cys-OH Protected open peptide 
» ** * ТА л+ HA lAorllA 
2-cjs-C Boc—CJrs—ААц A A 2 — C y — O H Protected сусІШ peptide 
IB or IIB 
ITA 
Η — C y s — AAn- А А з — C y s — O H Free cyclized peptide 
I or Π 
equilibrium in the desired direction. 
Additional advantages of this mode of operation are: 
I) during the acidolytic detachment from the support, the protections with stabilities 
comparable to those of the /e/7-butyl type are conserved, facilitating the isolation of 
the products of the first acidolysis (IA and IIA) and of the oxidative cyclization (IB 
and IIB). 
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2) since the contact-time of the detached peptide derivative and the transient carbonium 
ion originating from the support can be short, sulfonium-ion formation from cysteine 
derivatives is minimal in comparison with the Wang-resin *). 
The sulfane moiety is extremely stable to acidolysis and is therefore compatible with a 
final acidolytic deprotection using less mild conditions (e.g. trifluoroacetic acid containing 
scavengers) giving the desired cyclic disulfides I and II. 
*) An important improvement of the original prescription (Mergler et al., 1988), has 
been presented by Flörsheimer and Riniker (1990). These investigators found that 
fission from the support (which gradually turns deep purple by carbonium ion formati-
on) is preceded by protonation of bases occurring in the peptidyl chain (e.g. amide-
nitrogens, ether- and ester-oxygens). Treatment of the peptidyl resin with a known 
excess of acid during shorter periods on funnels (4x2 min., instead of the original 4x15 
min.) and quenching of it in the filtrate with a base like pyridine, afforded rapid and 
quantitative detachment. 
Kamher's cvclhation (Fig. 3) 
-Nature of the S-protections. The use of two different S-protections in IA and IIA origina-
tes from the observations of Kamber (Kamber et al., 1980). He found the oxidative cycli-
zation to be dependent on the nature of the solvent used for the reactions and defined 
three groups of solvents (Groups I, II and III) with respect to the reaction velocity of the 
intermediary sulfenyl iodide. In the solvents belonging to Group I (chloroform/methanol 
1:1 [v/v], pure methanol), formation of the sulfenyl iodide from trityl thioethers is more 
rapid than from acetamidomethyl thioethers. The reaction of a transient sulfenyl iodide 
with this acetamidomethyl thioether finally gives the cyclized product. The course of the 
reaction is therefore more selective than with two identical thioethers which are to be uni-
ted in a disulfide link. If a solvent of Group HI {e.g. Ν,Ν-dirnethylformamide) is used, the 
situation is reversed: acetamidomethyl thioethers will give a sulfenyl iodide more rapidly. 
-By-products. A cyclization reaction is usually accompanied by di- or polymerization. This 
unwanted course of the reaction can be counteracted by employing conditions furthering 
monomolecular reaction kinetics, such as high dilution. Addition of the peptide derivative 
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to an excess of iodine with vigorous agitation according to the reaction scheme of Fig. 3 is 
evidently much more preferable than the inverse way of addition. 
The advocated excess of iodine implies a risk of iodination of sensitive aromatic rings 
(Tyr, Tip, His) but this reaction can be retarded beyond the level of real difficulty by the 
use of well-chosen solvents (Kamber et al., 1980). However, Kamber also found protection 
of tyrosine as the tert-butyl ether to induce complete resistance to iodination of the aro-
matic ring in solvent. As this ether is notoriously sensitive to acid, and hydrogen iodide is 
set free during the oxidation, addition of bases like pyridine or N-methylmorpholine has 
been recommended (Kamber et al., 1980). 
Tit 
Boc—Cys-
Acm 
-Cys—OH 
I 
Boc— Cys-
I 
Cys-OH 
Boc—Cys Cys—OH 
Fig. 3. The intramolecular oxydative cyclization of thioethers is dependent on the nature 
of the solvents. 
All other protective functions of the <erf-butyl type (Boc, OiBu and the aliphatic ethers), 
the tritylamido (Sieber and Riniker, 1991) and the pentamethylchromanesulfonyl group 
(Ramage and Green, 1987) were found to be sufficiently stable during the iodine mediated 
oxidation. The risk of over-oxidation by iodine of a protected cysteinyl- to a cysteic acid 
residue appears negligible, since this reaction, even in the presence of 10 equiv. of iodine, 
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¡s too slow (Ruiz-Gayo et al., 1989). The same applies to disproportionation of sulfanes in 
the presence of iodine: this reaction has been observed under much more stringent condi-
tions (Kamber et al., 1980). 
Final deprotection. (Fig. 2) 
Acidolytic removal of the protective functions occurring in the protected derivatives IB 
and IIB results in the formation of reactive íerí-butyl- and pentamethylchromanesulfonyl 
cations and harmless trityl cations. Addition of appropriate scavengers is necessary to 
prevent alkylation and/or sulfonation of e.g. the aromatic ring of tyrosine residues; we also 
paid attention to this matter. 
RESULTS AND DISCUSSION 
SYNTHESIS OF PEPTIDE I 
Solid Phase Synthesis of IA (Fig. 2) 
Boc-Cys(Acm)-GIy-Val-Ser(rBu)-Arg(Pmc)-Gln-Gly-Lys(Boc)-Pro-Tyr(iBu)-Cys(Trt)-OH 
(IA) 
The solid phase synthesis of IA was performed in a semi-automatic or an automatic 
synthesizer. The standard protocol used for Fmoc SPPS in this laboratory was applied 
(Fig. 4). Coupling was performed with TBTU (in presence of HOBt and NMM) or with 
DCC (in presence of HOBt) as coupling agents. Deprotection was performed with piperi-
dine in DMF. According to the ninhydrine test (Kaiser et al., 1970) none of the couplings 
needed to be repeated. As determined by weight increase, the peptidyl yield was 80 % 
calculated on starting Fmoc-Cys(Acm)-0-SASRIN which corresponds to an average 
coupling efficiency of 97.8 %. Acidolytic cleavage with 1% TFA in DCM for 8 χ 2 min 
according to the prescription of Riniker and Flörsheimer (1990) gave crude IA (46 % 
yield) indicating that not all peptide material was detached. Probably detachment of the 
remaining peptide was hampered by the same modification of the C-terminal residue as 
could be demonstrated to occur during the synthesis of peptide II (vide infra). 
TLC indicated that the crude detached peptide material contained a prominent main 
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1) 
2) 
3) 
4) 
5) 
6) 
7) 
Operation 
Swelling of the resin 
Removal of Fmoc groups 
Wash 
Wash 
Kaiser test *) 
Wash 
Activation of amino acid 
derivative 
Solvent / Reagent 
N,N-dimethylformamide 
(DMF) 
Piperidine (20% in DMF) 
DMF 
Altematingly dichlorome-
thane and isopropanol 
DMF 
Mix: Fmoc-amino acid (3 
eq.) in 5 ml DMF, and 
Time 
1 min 
6 min 
0.5 min 
0.5 min 
1 min 
repetitions 
3 times 
3 times 
3 times 
2 times 
2 times 
TBTU / HOBt (3 eq. each); 
add NMM (4.5 eq.); mix, 
add the mixture to the re­
sin. 
8) 
9) 
10) 
11) 
12) 
Acylation 
Wash 
Wash 
Kaiser test **) 
Capping 
Shake the suspension 
DMF 
As in step 4. 
5 ml DMF containing Ac20 
(250 μΐ) and DIPEA (500 
Ml). 
30 min 
1 min 
0.5 min 
10 min 
once 
once 
2 times 
once 
13) Wash As in step 6. 1 min 2 times 
*) If positive proceed; if negative stop the synthesis. 
**) If negative proceed; if positive resume from step 7. 
Fig. 4. Standard Protocol for solid phase peptide synthesis using the Fmoc strategy. 
product contaminated with small amounts of by-products. Accordingly, FAB mass spectra 
showed the signals expected for IA (m/e 2089), and the presence of small amounts of 
some by-products, none of which could be identified with certainty. There was no indica­
tion of premature loss of acid-labile protections. A small peak at m/e 4178 (2MH+) may 
be explained by the formation of a small amount of non-covalent bimolecular cluster 
during MS measurements. 
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The open protected undecapeptide IA was subsequently purified by flash chromatography 
on silica. For purification of larger amounts, counter current distribution (employing the 
system chloroform/tetra/methanol/aqueous ammonium acetate buffer 6:11:7:3 by volume, 
K=0.85, n=130, r
mox
=60) was found to be applicable but rather tedious. Peptide IA was 
purified until it appeared to be pure by TLC with a variety of solvent systems and by UV-
detection during the MPLC elution (one symmetrical peak). 
It also appeared to be homogeneous by FAB-MS and by amino acid analysis, but Ή NMR 
indicated isomerism by the appearance of double tyrosine resonances in the aromatic 
region ( Fig. 5). 
Cyclization of IA (conversion to IB) 
A) Cyclization of I A in solution (Fig. 2 and 3) 
r
 _ _ . , j 
Boc-Cys-Giy-Val-Ser(íBu)-Arg(Pmc)-Gln-Gly-Lys(Boc)-Pro-Tyr(íBu)-Cys-OH (IB). 
Cyclization of the purified protected open 11-peptide IA was performed with iodine 
following the methods of Kamber et al. (1980). As solvents were chosen: dry methanol or 
chloroform/methanol 1:1 (v/v). They belong to the 'group Γ of media, specified by Kam­
ber, in which a Cys(Trt) residue is preferentially attacked. With respect to yield and 
reaction selectivity, no significant difference between the two media was found. After the 
reaction, the excess of iodine was reduced with an aqueous solution of thiosulphate. TLC 
of the product using two different solvent systems indicated the disappearance of the 
starting material and the formation of main product and some tail-forming by-products. 
The peptide derivatives formed did not contain the trityl group; the detached trityl cation 
had been converted, by reaction with methanol, into methyl trityl ether, which was detec­
ted as an apolar by-product on TLC. It was identified by TLC, NMR and MS. Like 
Kamber, we did not investigate the fate of the Acm moiety. 
Proton NMR spectroscopy confirmed the loss of the trityl moiety, which is the only group 
with aromatic protons present in IA, apart from the tyrosine side chain (see Fig. 5). FAB-
MS proved that the formation of the desired cyclic disulfide IB had taken place by the 
presence of signals expected for the monoisotopic and average m/z values for MH*, MNa+, 
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and MK+. 
JJLAJI 
A 
--^VVw-*A»A>r 
—τ— 
7.5 
To" 7.0 6.5 
Ρ P M 
Fig. 5. From bottom to top: aromatic part of the Ή NMR (400 MHz) spectra of protected 
open peptide ¡A (in CD ¡OD), of protected cyclized peptide IB (in CD ¡OD) and free cycii-
zed peptide I (in D20; pD 5.0). 
35 
The occurrence of smalt amounts of by-products was indicated by the appearance of some 
small but unidentified peaks at m/e values higher than that for ΜΗ*. It is noteworthy that 
NMR and MS gave no indication of iodination of tyrosine, which confirms that protection 
with the iBu function indeed prevents this side reaction. There was also no indication of 
formation of cysteic acid derivatives. A small peak at m/e 3548 might indicate the forma­
tion of a cyclic dirner with a mass twice of that of IB, but more probably, it represents the 
mass (m/e 2MH*) of a non-covalent bimolecular cluster formed during the MS measu­
rement, as observed with the open peptide IA (vide supra). 
The yields of crude product were nearly quantitative (99 %) and the result was found to 
be quite reproducible. Polymerization either did not occur or was negligible. There were 
also no problems with poor solubilities, although precipitation of the crude product from 
chloroform extracts was occasionally observed. This tendency for aggregation may reflect 
ß-sheet conformation of IB, resulting in limited solubility. 
Peptide IB, like IA, was purified by flash chromatography on silica, until it was homoge-
neous as judged by UV-detection during elution, TLC, amino acid analysis, and FAB-MS. 
The total yield of purified IB (calculated on IA) was 79 %. Proton NMR spectroscopy 
indicated two different resonances for the aromatic protons of the tyrosine residue in the 
spectra of both IA and IB (Fig. 5). This can be caused either by the presence of two 
different conformers in solution or by a structural isomerism. It is possible that this iso-
merism is caused by partial racemization (L -» D) of one of the cysteine residues (and that 
it becomes pronounced by the closure of the disulfide bridge). By rotation around he Ccc-
Cß bond, the tyrosine residue can bring its phenolic ring close to the C-terminal cysteine 
residue. If the latter occurs in two enantiomeric forms, two diastereomers arise; they may 
well manifest themselves by two different signals for both the δ and the ε aromatic pro­
tons of Tyr. 
Ö) Cyclization on the resin 
We performed one attempt to cyclize the peptidyl chain corresponding to IA directly on 
the resin, according to the procedure descrided by Mergler and Nyfeler (1992). After 
detachment of the crude product with 1% TFA in DCM, its yield and purity were asses-
sed. They were compared to that of crude IB obtained by cyclization in solution (vide 
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supra) of crude IA obtained from detachment from a batch of the same initial peptidyl 
resin. 
Judged by mass, the yields of both procedures were about the same. However, TLC and 
FAB-MS both indicated that the product obtained by cyclization in solution was substan­
tially purer. TLC showed that the product obtained by cyclization on the resin contained 
much more of 'tailing' and non-mobile by-products. 
In addition, FAB-MS indicated the presence of a substantial by-product with m/z 1905.5, 
corresponding to a MH+ with a molecular mass 132 higher than that of the desired pro­
duct. We could not readily explain this, but it is clear anyway that this application of the 
pseudo-dilution principle, the apparent greater efficiency of the procedure is counteracted 
by lesser purity of the final product. We doubt whether the recommended long reaction 
time (60 min) of the method of Mergler and Nyfeler, as well as the addition of DIPEA to 
the water-containing reaction medium, are really harmless to the peptide. 
Deprotection of IB (Synthesis of I from IB) 
ι — — ' "~ 1 
H-Cys-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr-Cys-OH (I) 
As expected, it was possible to remove the N-terminal Boc-group and all side chain 
protections [of Ser(fBu), Tyr(iBu), Lys(Boc), and Arg(Pmc)] simultaneously with TFA at 
room temperature. The extent of side reactions was minimized by varying conditions as 
peptide concentration, character and amount of scavengers. Initially, deprotection reactions 
were performed with the mixture TFA/DCM/H20 (95:100:5 v/v/v) to which was added p-
cresol (10 eq. per eq. of protected peptide) in a 10% overall concentration. Reaction for 
1.5 hours was insufficient to completely remove all protective functions. Predominantly 
the Pmc group of the arginine side chain was retained, as proved by a negative Sakaguchi 
test on TLC. Ή NMR spectroscopy and FAB-MS indicated the presence of a substantial 
main product, but also that of several by-products. FAB-MS indicated that the main 
product was the partially deprotected cyclic 11-residue peptide, with the Pmc group and 
one /Bu group still present. Evidently, the Arg(Pmc) and the Ser(/Bu) residues had been 
left intact. The cyclic peptide still containing only the Pmc protection and a small amount 
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of the desired free cyclic peptide I were also present in the mixture. To achieve full depro-
tection, the crude product was redissolved in the same reagent, till TLC indicated full 
deprotection of the Arg(Pmc) function after a total reaction time of 3.5 hours. FAB-MS 
indicated that I (m/e 1195.3, average MH+) had now indeed been formed as the main pro­
duct, but also that it still contained contaminations, indicated by smaller peaks at m/e 
1211.7, 1243.9, 1349.8, 1400.0, 1406.8 and 1464.1 (МНЧРтс). 
Our finding that the full deprotection of an Arg(Pmc) residue takes 3.5 h instead of the 
announced 1.5 h (Ramage and Green, 1987) in cleavage mixtures containing water is in 
agreement with independent observations of Riniker and Hartmann (1990). They found 
that complete cleavage of the Pmc group in 90% TFA was slower than in 100% TFA and 
required 3 to 4 h at 22°C. They also established the presence of water to be necessary to 
counteract the reactivity of the electrophilic reaction products (R-SO/ and гВи+) on 
sensitive aromatic aminoacyl groups (Tyr and Trp). 
Water was suggested earlier as a scavenger for r-butyl cations which may alkylate the 
tyrosine ring to a small extent (Sieber 1968). 1,2-Ethanedithiol (EDT) has been shown to 
be effective for scavenging f-butyl trifluoroacetate, which is also an alkylating species 
(Lundt et al., 1978). Until 1990, EDT was however not recommended as a scavenger 
during the acidolytic deprotection of cystine peptides, because the thiol functions were 
expected to attack the disulfide bond (Eritja et al., 1987). During the course of this work 
however, other investigators reported the conservation of cyclic peptide disulfides, after 
using EDT as a scavenger during the final deprotection with TFA (Seidel et al., 1990). 
This new information led us to compare: 
A) TFA/H20 (9:1, v/v, Riniker and Hartmann, 1990) 
B) TFA/phenol/thioanisole/EDT/H20 (82.5 : 5 ; 5 : 2.5 : 5, v/v/v/v/v, 'Reagent K', King et 
al., 1990) 
C) TFA/EDT/H20 (95 : 2.5 : 2.5, v/v/v) 
as reagent solutions for deprotection of compound IB. 
Typically, deprotection times were 3-4 h and peptide concentrations were 7%. There were 
only small differences in the results of deprotections with А, В and C. The mixtures В and 
С (both containing EDT) appeared to give slightly better results (again as judged by Ή 
NMR and FAB-MS). The MS results indicated that the desired product I was formed as 
the main product in case, but also that still small amounts of by-products were formed, 
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represented by molecular ions with m/e 1251.3 (MH+ + /Bu), 1357.1 and 1460.9. 
Dilution to 1 % (10 mg peptide/1 ml reagent solution) was even more advantageous and 
did not give by-products with molecular masses higher than that of the desired product. 
Apart from FAB-MS, Amino Acid Analysis, TLC, Edman sequenching and reversed-phase 
HPLC (one symmetrical peak, Fig. 6) gave also the impression of homogeneity of I. 
Edman sequencing gave the expected result for this cyclic cystine peptide, including the 
absence of response in the first cycle. However, Ή NMR spectroscopy again indicated 
isomerism in I by the presence of two resonances for the δ and ε protons of the phenolic 
ring in the tyrosine residue (Figs. 5 and 7). It is likely that this kind of isomerism is 
similar to that observed in the spectra of IA and IB, and that it originates from racemiza-
tion of the C-terminal cysteine residue. Hence, the minor isomer or 'by-product' (con­
stituting 10-15 mol % of I, by integration of the NMR signals of the aromatic protons) 
may well be the diastereomeric peptide with the C-terminal cysteine residue in the D 
configuration. A possible mechanism for the racemization of the C-terminal Cys ester 
during the SPPS is described below in the discussion of the synthesis of peptide II (see 
'structure eludication of by-products'). 
The isomerism evades separation by size exclusion techniques, while we also found ion 
exchange chromatography or reversed phase preparative FPLC not to be successful in this 
respect. This implies that the diastereomeric peptides are too similar in their physical 
properties to be separated by the interaction mechanisms involved in the applied techni­
ques. Synthesis of ultrapure products in this case and related ones might in the future be 
achieved with the use of chiral HPLC columns, which become increasingly available. 
Fortunately, the minor isomer did not interfere seriously with the intended investigations 
into the conformation and oligonucleotide-binding properties of the major isomer with the 
the C-terminal cysteine residue in the L configuration (cf. chapter 3). 
However, the observations with respect to the synthesis of I accentuate the fact that one 
should not rely on a small set of analytical techniques (e.g. RP-HPLC, AAA and/or FAB-
MS) for the critical assessment of purity of a synthetic peptide (cf. chapter 1). 
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Fig. 6. RP-HPLC diagrams of (A) peptide I; (B) crude peptide ¡I; (C) peptide II after 
FPLC purification. Conditions: see 'MATERIALS AND METHODS'. 
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Fig. 7. 'H NMR spectra (400 MHz) of cyclic I ¡-residue peptide I in D20; (A) at pD 5.0; 
(B) at pD 7.0. 
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SYNTHESIS OF PEPTIDE II 
Solid nhase synthesis of HA and HA' : formation of bv-products <Fi%. 2) 
Boc-Cys(Trt)-GIn(Trt)-Phe-Thr(/Bu)-Thr(/Bu)-Arg(Pmc)-Ser(rBu)-GIy-VaI-Ser(iBu)-
Gln(Trt)-Gly-Lys(Boc)-Pro-Tyr(íBu)-Ser(/Bu)-Leu-Asn(Trt)-Glu(0/Bu)-Gln(Trt)-
Leu-Cys(Acm)-OH (IIA') 
ПА: as IIA', but containing Thr instead of Thr(iBu). 
In the first synthesis that was carried out (leading to IIA'), all amino acid side chains were 
protected, including those of Asn and Gin (all five residues protected by Trt) and of Thr 
(both residues protected by ÍBU). According to the Kaiser tests, all couplings and deprotec-
tions proceeded smoothly. All peptide material could be detached with 1 % TFA in DCM 
(as judged by weight) but full detachment took many more treatments (11 χ IS min) than 
initially prescribed by Mergler et al. (1988). TLC (Fig. 8) showed that at least four diffe­
rent products were formed which were not removed simultaneously. The two close-running 
main products (with the Rf values of HAI and IIA2 in Fig. 8) constituted ca. 70 % of the 
total mass of peptide material and were present largely in the first three fractions of the 
detachment. Two by-products (with the R
r
 values of ПАЗ and IIA4 in Fig. 8) that ran 
higher (and also close to each other) were detached later in the procedure and were 
present, for the most part, in fractions 4 up to and including 11. 
FAB-MS on a sample of IIA'1/2 mixture gave a main peak corresponding with the mole­
cular mass of the desired product ΙΙΑΊ. It also indicated substantial by-products arising 
from a preliminary termination and a deletion, both probably caused by a partially failed 
coupling between the two Thr(fBu) units. Amino acid analysis gave similar compositions 
for IIA'1,2,3 and 4. It also indicated that the coupling between the two Thr(iBu) units had 
failed for about 30 mol %, as judged by the incomplete incorporation of Thr and Phe. This 
partial failure was also reflected by the ratio of integrated intensity of the aromatic proton 
signals of Phe and Tyr in the Ή NMR spectrum of crude II. 
However, the desired end product II could still be obtained by the cyclization of the 
IIA'1/2 mixture and subsequent deprotection. The crude products of these operations 
constituted the desired cyclic compounds but also still truncated sequences, as judged by 
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Fig. 8. Schematised Thin Layer Chromatogram (solvent system A) of the combined fracti-
ons 1.-4 and the combined fractions 5-/1 obtained during the detachment of the open 
protected 23-residue peptide HA or HA '. 
FAB-MS, AAA, NMR, and FPLC. Separation of the crude product by preparative FPLC 
gave pure II, as well as some homogeneous truncated peptide missing Phe. 
The experimental performances and observations with respect to the cyclization of IIA'1/2 
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and its subsequent deprotection largely resemble those for HA 1/2 and are therefore not 
described separately. 
Incomplete couplings between Thr(rBu) residues have also been reported by other workers 
(Drijfhout and Bloemhoff, 1993) and probably arise from the extra steric hindrance exerted 
by the bulky O/Bu-substituent on the ßC-atoms. We support their proposal to leave the 
threonine side chains unprotected as a remedy. This is compatible with the use of TBTU 
as the coupling reagent provided the capping with acetic acid anhydride is omitted. Cap-
ping was performed with AcONSu since it does not acetylate alcoholic functions. 
All couplings in the synthesis of peptide HA (with side chain unprotected Thr residues) 
proceeded nearly quantitatively, as judged by Kaiser tests, weight increase, amino acid 
composition, FAB-MS, and Ή NMR. Acidolytic detachment with portions of 1% TFA in 
DCM lead to observations largely comparable with that of the SPPS of IIA'. Again, an 
abnormally high number of treatments with acid (totally, 12 χ 2 min) was needed to 
detach all peptide material. Also, TLC of the fractions again gave the picture of Fig. 8; 
two close-running preponderant main products (HAI and IIA2) and two close-running by­
products (ПАЗ and IIA4). 
It was possible to separate the isomer pairs IIA 1/2 and IIA3/4 by chromatography on 
silica, but complete separation of the isomers HAI and IIA2 was not possible. 
FAB-MS and AAA confirmed that HAI and IIA2 were isomers since their amino acid 
compositions corresponded with the desired compound IIA. Most probably, the compounds 
are diastereomers with respect to the C-terminal cysteine residue. Investigations into the 
identity of the by-products ПАЗ and IIA4 are described below, in connection with the 
formation of two main products 1IA1 and IIA2 (see 'Elucidation of by-products in the 
synthesis of HA). 
Cvclization (Synthesis of ¡IB from HA; cf. Figs. 2 and 3) 
Boc-Cys-Gln(Trt)-Phe-Thr(íBu)-Thr(rBu)-Arg(Pmc)-Ser(íBu)-Gly-Val-Ser(/Bu)-Gln(Trt) 
-Gly-Lys(Boc)-Pro-Tyr(íBu)-Ser(íBu)-Leu-Asn(Trt)-Glu(OíBu)-Gln(Trt)-Leu-Cys-OH (IIB') 
HB : as IIB', but containing Thr instead of Thr(/Bu). 
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Cyclization of HA' or IIA affording the disulfides IIB' or IIB was performed in essentially 
the same way as described for the conversion of IA to IB. The iodine-mediated oxidation 
was performed in chloroform/methanol 1:1 (v/v) because it was one of the few solvents in 
which HA' and HA were sufficiently soluble, which belongs to the solvents of 'group Γ 
according to Kamber (Kamber et al., 1980), and which allow easy work-up of the reaction 
mixture. In pure methanol, HA' and HA were poorly soluble. The yields of HB' and IIB 
were nearly quantitative; polymerization did not occur or was negligible. There were also 
no problems arising from poor solubilities. In contrast to the protected open chain pepti­
des, the cyclized compounds were even soluble in pure chloroform. This may indicate that 
cyclic peptides IIB 1/2 have no ß-sheet forming tendency, which is usually reflected in 
poor solubility of the peptide. 
Again, the reaction could be followed with TLC, since the starting compounds and pro-
ducts had clearly different Rf values. Like IIA' and IIA, also IIB' and HB both comprised 
two isomers, just separated by TLC. The detached trityl function could be detected as 
trityl methyl ether, which is apolar and has a high Rf on TLC; it is easily extracted with 
ether, and identifiable by NMR and MS. 
In contrast to the cyclization IA-ИВ, the loss of the trityl function could in this case not be 
unambigously confirmed by IH NMR spectroscopy of the peptide, because of the overlap 
with the accumulated signals of the trityl functions of the four Gin(Trt) residues. However, 
FAB-MS established the molecular masses expected for IIB' and IIB. 
It turned out to be practically feasible to oxidize the crude HA (i.e., the mixture of IIA 
1,2,3 and 4) detached from the resin, and subsequently deprotect the crude cyclized 
product (below referred to as 'crude IIB'), postponing complete purification to the very end 
of the synthesis (FPLC). 
Deprotection (synthesis of ¡l from HB) 
H-Cys-Gln-Phe-Thr-Thr-Arg-Ser-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr-
i _ . , ,
 t 
-Ser-Leu-Asn-Glu-Gln-Leu-Cys-OH (Π) 
The composition of the reagent used for the final acidolytic deprotection of the mixture 45 
IIB 1/2 with TFA was optimized in the same way as described above for the synthesis of I. 
Fig. 9. Ή NMR spectrum (400 MHz) of the cyclic 23-residue peptide II in D20, pD 5.0, 
298 K. 
Also in the synthesis of II, it was found that reagent solutions containing EDT as a sca­
venger gave slightly purer products. In the end, we found that a convenient deprotection 
procedure was: dissolve the peptide to a concentration of 2%, and leave the resulting 
solution for 3.5 h at room temperature. The product thus obtained from 'crude IIB2' was 
quite heterogeneous as judged by reversed-phase HPLC (Fig. 6). 
The main product II was isolated by reversed-phase FPLC and analyzed and characterized 
by FAB-MS, Ή NMR (Fig. 9), TLC, RP-HPLC, AAA and Edman sequenching. The most 
prominent (by recovered mass) by-product gave similar analytical data as II except a 
slightly more upfield shift of the aromatic proton NMR signals of the Tyr residue. It is 
possible, but not very likely that this isomer is the diastereomer of II resulting from race-
mization of the C-terminal residue, in an analogous way as I and its isomer (vide supra). 
The long distance (six amino acid residues) between the Tyr residue and the C-terminal 
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Cys residue makes it improbable that inverted chirality at the C-terminus will influence the 
chemical shift of the aromatic ring protons to that extent. It is more probable that the 
different shift for Tyr is caused by another kind of isomerism, e.g. a cis/trans isomerism of 
the peptide bond between Lys and Pro of which the latter residue is adjacent to the Tyr 
residue. 
Structure eludjcation of by-products in the solid phase synthesis of HA: mechanism of 
racemization of the C-terminal residue 
The by-products IIA3 and IIA4 formed in the spps of IIA were separated from HAI and 
1IA2 and from each other by chromatography on silica. Their identity was investigated 
using AAA and FAB-MS. The amino acid analysis did not give substantially different 
results for HAI, ИА2, ПАЗ and IIA4 (with the reserve that the Cys(Acm) content was not 
determined). It was therefore clear that IIA 1/2 were not formed as a result of a deletion, 
insertion or premature termination during the SPPS. 
As already mentioned above, low resolution FAB-MS detected for both HAI and ПА2 the 
molecular ion expected for HA (m/e 4900.4; average MH+). For both HA3 and IIA4, FAB-
MS detected a molecular ion with average m/z 4880.4. The difference of 20.0 amu be­
tween the average molecular masses of HA 1/2 and IIA3/4 could not be satisfactorily 
explained by the simple loss of a part of an amino acid residue or protecting group during 
spps or detachment.4 
The following proposal (see also Fig. 13) may explain the mass difference of 20 amu be­
tween HA 1/2 and IIA3/4. Elimination of the acetamidomethylthio moiety (S-Acm) from 
the C-terminal Cys(Acm) residue of HA 1/2 and subsequent addition of a piperidine mole­
cule (Pip) would afford the molecular mass (MM) of IIA3/4. The mass difference is in 
accordance with this: -MM(S-Acm) + MM(Pip) = -MM(C3H6NOS) + MM(C5HI0N) = -
104.15 + 84.14= -20.01 amu. 
Further investigations by FAB-MS techniques gave support to this proposal. If IIA3/4 
indeed would be the piperidine adduct, its empirical formula would be C267HM7N35046S4. 
The calculated molecular cluster for the corresponding MH+ values is depicted in Fig. 10, 
together with the cluster actually measured for IIA3/4 by medium resolution FAB-MS. 
The congruence supports the proposed formula for IIA3/4. 
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A second argument for the presence of the ß-piperidyl alanyl residue [abbreviated here as 
Ala(Pip)} as the C-terminal residue in IIA3/4 was obtained by tandem mass spectrometry 
(MS/MS). The partial tandem mass spectrum of IIA3/4 in the region 4600 - 4880 is 
depicted in Fig. 11. It shows at least four peaks consistent with the loss of fragments of 
the C-terminal Ala(Pip) residue, as depicted. The corresponding partial tandem mass 
spectrum [m/e 4400 - 4900] of IIA 1/2 did not show any of these characteristic peaks (Fig. 
12). 
Abstraction with piperidine of the acidic α-proton of the esterified Cys(Acm) residue will 
give a resonance-stabilized (achiral) carbanion. Removal of the base, and re-addition of the 
α-proton would thus result in a product consisting of a pair of diastereomers (HAI and 
IIA2). In this mixture the components need not to occur in 1:1 ratio, since the returning 
proton enters into a diastereotopic environment. 
The resonance-stabilized carbanion can also eliminate the acetamidomethylthio-moiety, 
(undoubtedly at a slower rate) giving an esterified dehydroalanyl residue as the C-termi-
nus. If this moiety undergoes nucleophilic 1,2-addition with the abundantly present amine 
piperidine (which fortunately is not highly nucleophile by its bulky structure), 3-( I -piperi-
dyl)-alanine is formed as the esterified C-terminus. This, by its chirality, causes the 
formation of two new diastereomers (IIA3 and IIA4), not necessarily in equal amounts, 
since again a diastereotopic environment is operative during the return of the α-proton. 
The techniques employed here cannot distinguish whether one of the four products will 
correspond with either the L or the D configuration of the C-terminal residue. 
Since the products of this addition (IIA3/4) are again bases, they consume acid for salt 
formation during the acidolytic detachment from the SASRIN linker. The positive field 
caused by protonation of the piperidyl moiety certainly delays the protonation of the 
alkoxy-oxygen of the super acid sensitive linker. This explains why compounds IIA3/4 are 
detached more slowly than IIA 1/2. 
EXPERIMENTAL 
MATERIALS AND METHODS 
Syntheses. Starting resin Fmoc-Cys(Acm)-0-SASRIN was purchased from Bachern (Bube-
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ndorf, Switzerland). Amino acid derivatives were obtained from Bachern or home-made. 
C267 H348.N35.046.S3. 
4880 4885 
C 2 6 7 . H 3 4 8 . N 3 5 . 0 4 6 . S 3 . 
Fig. 10. Calculated (above) and measured (below) molecular clusters for the protonated 
peptides ПАЗ/4. 
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Fig. II. Collision-induced MS/MS spectrum of ПАЗ/4 (parent molecular ion at 4878.3); 
some fragments are visible that may correspond to losses of (parts of) the Ala(Pip) moiety, 
as indicated in the structural formulae: 4795.2 (MH-84), 4779.6 (MH-98), 4722.1 (MH-
171). The theoretically expected values all fall within the margins formed by the measu­
rement inaccuracy ( ± 0.3 amu) plus the possible proton transfer (± 1 amu). 
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Fig. 12. Collision-induced MS/MS spectrum of НАШ (parent molecular ion at 4898.2); 
visible are peaks corresponding to loss of one Boc group (4798.1, MH-100) and to the 
loss of a 176 amu part (4722.9, indicated with arrow) as depicted in the structural formu­
lae. 
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Fig. 13. Mechanism for the base-induced racemization of N-acyl-S-Acm-cysteine esters and 
the subsequent addition of piperidine. 
Fmoc amino acids were prepared according to the method of ten Kortenaer et al. (1986), 
Boc-Cys(Trt)-OH was synthesized from H-Cys(Trt)-OH according to a modification of the 
method of Zervas et al. (1965) [vide infra]; S-tritylcysteine was synthesized according to a 
modification of a tritylation method of Photaki (1976) [vide infra]. Crystalline Fmoc-Thr-
OH was prepared according to a modification of the procedure by Paquet (1982) [vide 
infra]. 
Melting points were determined with a Buchi melting point apparatus and are uncorrected. 
Specific rotations were measured with a Perkin Elmer Polarimeter 241. Ή NMR spectra 
were recorded with a Bruker AM400 spectrometer. 
Solid phase syntheses were performed using the semiautomatic synthesizer SP 650 Labor-
tec (Bubendorf, Switzerland) or the automatic peptide synthesizer Advanced Chemtech 200 
from Zinsser Analytic. 
The DMF used for SPPS was pre-dried on molecular sieve 4À. The dichloromethane 
(DCM) used for peptide detachments was also kept over molecular sieve 4Â. The metha-
nol that was used as solvent for cyclizations was pre-dried on molecular sieve 3Â. 
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Chromatography. Thin-layer chromatography (TLC) was performed on pre-coated silica 
gel plates Kieselgel 60F254 (Merck) in the following solvent systems (v/v): (A) chloro-
form/methanol/acetic acid (95:20:3), (B) 1-butanol/acetic acid/water (4:1:1), (C) 1-buta-
nol/pyridine/acetic acid/water (2:1:1:2), (D) phenol/water (3:1). Detection was by UV-fluo-
rescence quenching, by the Reindel-Hoppe reagent modified according to von Arx et al. 
(1976), by ninhydrine spray, and/or methanol/sulphuric acid 1:1; the latter reagent reveals 
the presence of trityl groups through formation of the characteristic yellow colour of trityl 
cations. 
High Performance Liquid chromatography (HPLC) was performed on a RP-18 column 
(Techsil 5 С18, 250 χ 4.6 mm, HPLC Technology, Cheshire, UK) or a RP-2/18 column 
(Pep s prepacked HR 5/5 column, 250 χ 4 mm, Pharmacia LKB). A 30 min. linear gra­
dient from 0.1% TFA in water to 90% (v/v) acetonitrile and 0.08% (v/v) TFA in water 
was used. Peaks were detected by UV measurement at 215 nm. The UV data were analy­
zed using JCL 6000 Chromatography Data System software (Jones Chromatography, Mid 
Gian, UK). 
Preparative FPLC separations of deprotected peptides were performed with the Pharmacia 
Liquid Chromatography Controller LCC-500, equipped with two pumps P-500, a peristaltic 
pump P-l, a motor valve MV-7, a UV-detector LKB UV-МП operating at 280 nm and a 
LKB Bromma 2070 ultrorak fraction collector. A linear gradient of 0 to 100% buffer В in 
100 ml was used. Buffer A was 0.1% TFA and 10% acetonitrile in water, buffer В was 
0.07% TFA and 90% acetonitrile in water; flow rate was 1.5 ml/min. Typically, batches of 
ca 5 mg of crude peptide were separated on a preparative C2/C18 reversed phase column 
(PEP RPC™ 15 μηι HR ÌOO χ 10 mm, Pharmacia LKB). 
Preparative low pressure chromatography of protected peptides on silica gel was perfor­
med with a Merck Lobar 60B column equipped with a Kontron analytical LC pump 414, a 
LKB Uvicord 2138 UV detector operating at 250 nm, a LKB 2210 Recorder 1 channel; 
flow rate 0.1 ml/min, detection by UV absorbance or TLC. 
Amino acid analyses: peptides were hydrolysed in 5.7 M HCl (Merck Suprapur) in eva­
cuated sealed glass tubes for 24 hours at 120°C and analyzed with a Varían 9095 amino 
acid analyzer using the Fmoc-protocol or the ninhydrine-protocol. 
Automated Edman degradation of free peptides was performed in the USA with the 
acknowledged mediation of Dr. W.J.G. Schielen (Organon Teknika). 
53 
Mass Spectrometry (MS). Mass spectra of protected amino acid derivatives were obtained 
using a double focussing VG 7070E apparatus with the chemical ionisation (CI) technique 
and methane as reaction gas. Mass spectra of peptides were recorded on a JEOL HX110 
mass spectrometer, equipped with the DA5000 data system, after ionization/desorption 
with Fast Atom Bombardment (FAB) using xenon, and nitrobenzyl alcohol as matrix. 
When the isotopie peaks were resolved with 10% valley-definition, the assigned m/e 
values are referred to as 'monoisotopic' (medium resolution). When the isotopie peaks 
were not resolved, the assigned values are referred to as 'average' (low resolution). 
Synthesis of amino acid derivatives 
Synthesis of S-tritylcysteine [H-Cys(Trt)-OH]. Cysteine hydrochloride (7.88 g, 0.05 mol) 
and trityl alcohol (13 g, 0.05 mol) were dissolved in glacial acetic acid (130 ml) with 
magnetic stirring at 90°C. After continued stirring at this temperature for another 4 hours, 
the clear solution was cooled to room temperature. The acetic acid was removed in vacuo 
at ca. 40°C and the residue was triturated three times with ether affording the crude 
zwitterionic product as a colourless solid. It was washed successively with water, acetone 
and ether, and dried affording 15.6 g (86%) of a colourless, crystalline solid, m.p. 178-
180°C (dec), [oc]27D +14.5° (c 2.0 in 0.1 N NaOH) [Litt. Photaki : m.p. 178-179°C (dec), 
[a]2 7 D +15.7° (c 2 in 0.1 N NaOH)]. TLC: Rf 0.21 (System A), Rf 0.63 (System B); 
detection: UV-fluorescence quenching, chlorine/TDM, ninhydrine, sulphuric acid/methanol. 
Solubility: soluble in: chloroform, tetrahydrofurane, 0.1 N NaOH; insoluble in: dichloro-
methane (gel formation), water, ether, acetone, aqueous HO. 
Synthesis of N-(t-butyloxycarbonyl)-S-trityl-cysteine [Boc-Cys(Trt)-OHJ. This compound 
was prepared according to a small modification of the procedure of Zervas et al. (1965), 
starting from S-tritylcysteine (prepared as described above) and r-butyloxycarbonyl azide. 
The yield was 69% (Litt.: 51%). TLC: Rf 0.70; detection: UV-fluorescence quenching, 
chlorine/TDM, sulphuric acid/methanol; the ninhydrine reaction was negative. 
For analysis, 700 mg of the obtained amorphous Boc-Cys(Trt)-OH was converted into its 
diethylammonium salt, as follows. It was dissolved in a minimum amount of ether and 
600 μ! of diethylamine was added with swirling. Petroleum ether (60-85) was added up to 
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slight turbidity of the solution. The solution was set aside and the salt crystallized in 
colourless aggregates. It was collected by filtration and washed with ether. Yield: 530 mg, 
mpt. I64-168UC, [ot]24D +26.6° (c=1.2, chloroform). [Litt. Kamber and Riltel (1969): mpt. 
165-168UC, [a]2 0 D +27,0° (c=1.2, chloroform)]. Elemental analysis caled: С 69.37, H 7.51, 
Ν 5.22; found: С 69.48, Η 7.61, Ν 5.31%. 
Synthesis of Na-(9-fluorenylmethyloxycarbonyl)threonine [Fmoc-Thr-OH. Η ¡О]. Threonine 
(5 g, 42.0 mmol) and sodium hydrogen carbonate (14.2 g, 42.0 mmol) were dissolved in a 
mixture of water (120 ml) and acetone (60 ml). The apparent pH was 9.0 (pH-paper). 
Fluorenylmethyl succinimidyl carbonate (14.2 g, 42.0 mmol) was dissolved in acetone (90 
ml) and was added in four or five portions to the solution of H-Thr-OH and NaHC03. 
Sodium bicarbonate precipitated but slowly dissolved again, with evolution of carbon 
dioxide, after completed addition of Fmoc-ONSu. The reaction was stirred magnetically at 
room temperature overnight during which the solids dissolved. A clear colourless solution 
resulted (apparent pH ca. 5). The acetone was removed in vacuo and the obtained aqueous 
solution of the sodium salt Fmoc-Thr-O Na+ was set aside at room temperature. The 
sparingly soluble salt crystallized and a thick crystalline mass formed. 
The colourless crystals were filtered, washed successively with water, chloroform and 
ether, and dried (yield: 10.8 g). The mother liquor and the washings were combined and 
kept. 
The crystalline Fmoc-Thr-O Na+ was converted into crystalline Fmoc-Thr-OH as follows. 
The compound was partitioned between 0.1 N HCl and chloroform until it had dissolved 
in the organic phase. The chloroform phase (containing Fmoc-Thr-OH as the acid) was 
separated, washed with water to remove excess acid, and then extracted twice with 1 M 
aqueous KHC03 (25 ml). The combined KHC03 extracts, containing the potassium salt 
Fmoc-Thr-O K+ were washed with chloroform (2x10 ml), and acidified with 3 N HO to 
pH 3. At this point, the compound Fmoc-Thr-OH.H20 crystallized as a fine colourless 
powder. It was collected by filtration, washed with water, and dried. Yield: 9.25 g. 
A second crop of product was obtained from the initial mother liquor and washings of the 
sodium salt Fmoc-Thr-0"Na+ (vide supra). For this purpose, the organic solvents were first 
removed in vacuo. The aqueous residue was washed with chloroform and acidified with 
concentrated HCl to pH 3. When a crystalline solid precipitated, it was collected by 
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filtration and washed with water. When an oil separated, it was taken up in chloroform, 
converted to the potassium salt, and set free as the carboxylic acid as described above. In 
this way, a second crop (3.78 g) of the crystalline monohydrate Fmoc-Thr-OH.H20 was 
obtained. Total yield: 13.03 g (86%). 
Cubic colourless crystals, mpt. 81-82°C, [a]25D -4.8° (c 1.0 in methanol) [Litt. Kisfaludy 
and Schön (1983): amorphous, [ct]25D -4.8° (c 1.0 in methanol); Snow (1988): mpt. 92-
94°C, [a]25D -5,5° (c 1.0 in methanol); SENN Product list: mpt. 84-88°C, [oc]D -16.5° (c 1.0 
in DMF)]. MS(CI+): m/e(fragment, intensity) 342(ΜΙΓ, 5.7), 179(9-fluorenylmethyl 
cation, 100). TLC: Rf 0.44 (System A); detection: UV-fluorescence quenching, chlori­
ne/TDM (ninhydrine reaction was negative). Element analysis caled, for C|9H19N05.H2O : 
С 63.49, H 5.90, Ν 3.93 % ; found: С 63.50, Η 5.90, Ν 3.93 %. 
SYNTHESIS OF I 
Solid Phase Synthesis of IA (cf. Fig. 2) 
Assembly. The linear sequence corresponding to IA was assembled using the Fmoc strate­
gy. Syntheses started with 1000 mg of Fmoc-Cys(Acm)-OSASRIN (loading 0.55-0.60 
mmol/gr). The Tyr residue was introduced as Fmoc-Tyr(tBu)-OH, Pro as Fmoc-Pro-OH, 
Lys as Fmoc-Lys(Boc)-OH, Gly as Fmoc-Gly-OH, Gin as Fmoc-Gln-OH, Arg as Fmoc-
Arg(Pmc)-OH, Ser as Fmoc-Ser(tBu)-OH, Val as Fmoc-Val-OH, and the assembly was 
terminated with the coupling of Boc-Cys(Trt)-OH. Coupling was performed with 
DCC/HOBt, or, preferably, with TBTU/HOBt/NMM. The qualitative Kaiser ninhydrine 
test was performed after each deprotection and coupling step. Capping of eventual unreac-
ted amino functions was performed consequently after each coupling, using acetic acid 
anhydride and DIPEA. The protocol for one deprotection/coupling cycle is depicted in Fig. 
4. 
According to the Kaiser test, no deprotection or coupling step needed to be repeated. On 
completion of the assembly, the peptidyl resin was washed successively with DMF ( 2 x 1 0 
min), DCM ( 3 x 5 min), isopropanol ( 1 x 5 min), ether ( 1 x 5 min) and dried. In a typical 
experiment, the dry peptidyl resin weighed 1694 mg after completed assembly on a 1000 
mg batch of starting resin with an initial load of 0.55 mmol/gr. The weight increase of 694 
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mg corresponds to an overall yield of 80 % and an average coupling yield of 97.8 %. 
The SPPS was performed initially in the semi-automatic machine; after confirmation of 
acceptable results, it was repeated with the fully automatic synthesizer, without performan­
ce of Kaiser tests. 
Cleavage. The peptidyl resin (weighing 1694 mg) was brought on a sintered glass filter 
(G3) and pre-swollen with 15 ml of DCM. Then it was shaken gently for 2 minutes with 
10 ml of 1 % of TFA in DCM, after which the solution was filtered by nitrogen-pressure 
into 2 ml methanol containing 200 μΐ pyridine. This procedure was repeated 7 times, 
during which the resin gradually turned deeply violet. The filtrates were coloured yellow 
(presence of trityl cations) and decolourized upon the neutralization. TLC showed that the 
maximal peptide concentration was present in fraction 6. The purple resin on the filter was 
washed with DCM until the filtrates became colourless. 
The combined filtrates, containing peptide IA, were evaporated. The residue was triturated 
with water affording either a white precipitate or a yellowish gum, which was extracted 
into chloroform. The combined chloroform extracts were washed two times with 10 ml 
water, dried over sodium sulphate and evaporated to afford a colourless syrup. After 
drying in vacuo, its weight was 525.1 mg, which corresponds to an overall yield of 46 % 
of crude peptide (calculated on starting resin). It was thoroughly triturated with ether to 
afford a white solid that was collected by filtration and dried: dry weight 512.3 mg. The 
ether washings contained mainly trityl methyl ether and some other apolar contaminants, 
according to TLC and NMR. 
Purification of IA. TLC (System A and B) indicated a main product and some contami­
nants with higher and lower Rf values than the product. A partial purification was effected 
by taking the crude product up into a minimum amount of chloroform and precipitating 
with the tenfold volume of ether. The precipitate, weighing 484 mg after drying, was 
enriched in the desired product (TLC), but for further purification chromatography on 
silica proved necessary. This was effected as described under "Materials and methods". In 
a typical procedure, a 60 mg batch of crude IA, dissolved in 2 ml of eluent, was injected 
on the column. The fractions containing pure IA were pooled and the solvents were 
removed in vacuo. This afforded 50.6 mg of IA as a colourless glass or as a white amorp­
hous semi-solid. It was homogeneous as judged by TLC, FAB-MS and AAA. The total 
yield of pure IA was: 78 % on initially cleaved crude product, and 35.5 % on starting 
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resin. 
IA is soluble in: methanol, chloroform, dichloromethane. 
TLC: Rf 0.30 (System A), Rf 0.96 (System B); detection: UV-fluorescence quenching, 
chlorine/TDM, sulphuric acid/methanol (trityl cations). 
Amino Acid Analysis: Cys 1.01 (1), Gly 1.84 (2), Val 1.00 (int.st.), Ser 0.98 (I), Arg 1.00 
(I), Glu 1.05 (1), Lys 0.95 (1), Pro 0.99 (1), Туг 0.99 (1). 
MS(FAB+. low resolution): m/e 2089.7 (MH+, average; calculated for C103H150N l7O23S3: 
2090.0). Also observed occasionally: m/e 4179.1 (M2H+, non-covalent dimer formed in 
situ, abundance relative to MH+ ca. 2 %), 2111.7 (MNa+), 1847.3 (MH+-C(C6H5),), 243 
((C6H5)3C+). MS(FAB+, medium resolution): calculated and measured molecular isotope 
clusters agreed for MH+ and MNa*. 
MS(FAB-, low resolution): m/e 2088.3 ((M-H)\ average). Also observed occasionally: m/e 
2031.5 ((M-H-C(CH3),)), 1845.3 ((M-H-C(C6H5)j)"). 1789.4 ((M-H-C(CH3)3)-C(C6H5)3)). 
MS(FAB-, medium resolution): calculated and measured molecular isotope clusters agreed 
for (M-H)". 
*H NMR: cf. Fig. 5 (only aromatic part) 
Cyclhation of IA ipreparation of IB) 
100 mg (47.9 μηιοί) of open-chain peptide IA was dissolved in 50 ml chloroform/methanol 
(1:1 by volume). The clear solution was added within 5 minutes, to a magnetically stirred 
solution of 49.3 mg (194 μιηοΐ) of iodine in 50 ml chloroform/methanol (1:1 by volume) 
at room temperature. The stirring was continued for another 10 minutes, after which the 
excess of iodine was reduced by the additon of 30 ml of a 0.01 M solution of sodium 
thiosulfate. The colourless mixture was extracted three times with 50 ml of chloroform*. 
The combined organic phases were washed two times with water (20 ml), dried over 
sodium sulphate and evaporated in vacuo (t<40°C). The colourless glassy residue was 
triturated three times with 20 ml of ether, which afforded the crude product as a white or 
yellowish powder (yield 84 mg; 99 %). The combined ether fractions were evaporated 
yielding 15.4 mg of a colourless oil which crystallized upon standing. TLC, MS and NMR 
indicated that it comprised the by-product trityl methyl ether and some other apolar 
contaminants [TLC (System A): Rf 0.79; (System B): 0.84); detected by rapid intense 
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yellow colour formation with the sulphuric acid/methanol reagent]. The crude product gave 
on TLC a distinct main product spot, accompanied by a weak spot on the starting line, a 
faint 'tail' between starting line and product spot and a very faint spot representing a trace 
of unreacted IA, which ran higher than IB. Of all peptide TLC spots, only the residual IA 
generated a yellow colour (trityl cations) upon treatment with sulphuric acid. This indica­
ted that most of the starting compound had been converted with oxidative loss of the trityl 
function. Also FAB-MS indicated the formation of the desired main product and of small 
amounts of by-products. 
At the moment of extraction with chloroform, or the subsequent washing with water, 
partial precipitation of the product IB may occur. A substantial amount of white preci­
pitate formed at this point should therefore not be mistaken for polymers and should be 
isolated by filtration or more intensive extraction. 
Purification of IB. The cyclic disulfide peptide IB was purified by chromatography on 
silica as described under 'materials and methods'. Batches of 50-75 mg of crude IB, 
dissolved in 2 ml of solvent system A or B, were injected on the column. Upon evapora­
tion of the combined appropriate fractions, IB was obtained as a white amorphous semi­
solid. In a typical procedure, 74 mg of crude product gave 59 mg of pure IB, which was 
homogeneous as judged by TLC, FAB-MS and AAA. Some of the separated contaminants 
showed Rf values that corresponded with the tail and the base line spot observed on the 
TL chromatograms of the crude product, which proves that these locations were not due to 
physical effects. Yield of pure IB: 79% (calculated on open peptide IA). Soluble in: 
methanol, chloroform. 
TLC: Rf 0.23 (System A), Rf 0.69 (System B); detection: UV-fluorescence quenching, 
chlorine/TDM (no reaction with sulphuric acid). 
Amino Acid Analysis: Cys 0.76 (2), Gly 2.19 (2), Val 1.00 (int.st.), Ser 0.74 (1), Arg 0.91 
(I), Glu 1.05 (1), Lys 1.07 (1), Pro 0.92 (1), Туг 0.95 (1). 
MS(FAB+, low resolution): m/e 1773.9 (MH+, average; calculated for C81HI29NI6022S3: 
1773.9). Also observed occasionally: m/e 3548.9 (M2H3*, non-covalent dimer formed in 
situ, abundance ca. 2% relative to ΜΗ*), 1811.9 (MIC), 1796.0 (MNa+), 1672.9 (MH*-
Boc), 1507.5 (MH+-Pmc). MS(FAB+. medium resolution): calculated and measured 
molecular isotope clusters agreed for MH+, MNa* and MK+. 
Ή NMR: cf. Fig. 5 (aromatic part). 
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np.protection of IB (formation of lì 
50 mg (28.2 цтоі) cyclic protected peptide IB was dissolved in 5 ml of TFA containing 
2.5 vol % of water and 2.5 vol % of ethanedithiol. The colourless* solution was left 
standing at room temperature for 3.5 hours". Then the solution was added dropwise to 25 
ml of dry ether at -50UC with magnetic stirring. The peptide precipitated as a white flaky 
substance, which was spun down in a centrifuge tube for 10 minutes at 3000 rpm. The 
pellet was re-suspended in 20 ml ether and then spun down again in the centrifuge tube. 
This washing procedure was repeated four times, after which the last ether supernatant 
reacted neutral on pH-paper. The peptide was air-dried affording 40 mg of an off-white 
semi-solid. HPLC-analysis of samples of this material, using two different reversed-phase 
columns, gave only one peak (Fig. 6.) Ή NMR spectroscopy (D20) indicated the presence 
of ca. 10 % of a by-product manifesting itself by extra signals in the aromatic part of the 
spectrum (Fig. 5). As expected from the HPLC results, reversed phase FPLC proved 
unable to remove the isomeric by-product. 
In order to remove the adhering TFA and to exchange the trifluoroacetate ions, the peptide 
was dissolved in water and the acidic solution was treated with Merck II anion exchanger 
(weakly basic, acetate form) up to pH 4.5. The ¡on exchanger was removed by filtration 
and the aqueous solution was lyophilized affording 25 mg of a fluffy white solid (yield 74 
% calculated on IB). As described above, homogeneity of peptide I was indicated by TLC, 
AAA, FAB-MS and by RP-HPLC but not by Ή NMR spectroscopy (Figs. 5 and 7). I was 
soluble in water, methanol and 1-butanol. 
TLC: non-mobile with system A and B, Rf 0.50 (System C); detection: UV-fluorescence 
quenching, chlorine/TDM, ninhydrine, Sakaguchi (positive reaction). 
HPLC: ret. time 15.55 min. (also cf. Fig. 6). 
Amino Acid Analysis: Cys 0.92 (2), Gly 1.80 (2), Val 1.00 (int.St.), Ser 0.94 (1), Arg 1.03 
(1), Glu 1.04 (1), Lys 1.03 (1), Pro 0.95 (1), Туг 0.87 (1). 
Edman degradation: nr. of cycle (amino acid assigned): l(no signal), 2(Gly), 3(Val), 
4(Ser), 5(Arg), 6(Gln), 7(Gly), 8(Lys), 9(Pro), 10(Tyr). 
MS(FAB+. low resolution): m/e 1195.3 (MH+, average; calculated for C49H79N16015S2: 
1195.4). Also observed occasionally: m/e 1197.4 (MH3\ average, in situ reduced disulfi­
de). MS(FAB+. medium resolution): calculated and measured molecular isotope clusters 
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agreed for MIT and MH3+. MS(FAB-, low resolution): m/e 1193.9 ([M-H]", average). 
*H NMR: cf. Fig. 5 and Fig. 7. 
A bright yellow colour of the solution indicates the presence of trityl cations, stem-
ming e.g. from unremoved traces of the open peptide IA. 
"Treatment of IB with the TFA-cocktail for only 1.5 h gave only traces of the desired 
I. As judged by TLC, FAB-MS, NMR (íBu signals) and solubility properties, the main 
products were only partially deprotected and still contained the Ser(iBu) and the 
Arg(Pmc) residues. TLC: Rf 0.33 (System B); detection: UV-fluorescence quenching, 
chlorine/TDM, ninhydrine (positive reaction), Sakaguchi (negative reaction). Amino 
Acid Analysis: Cys 0.89 (2), Gly 1.81 (2), Val 1.00 (int.st.), Ser 0.97 (1), Arg 1.08 (1), 
Glu 1.13 (1), Lys 1.00 (1), Pro 0.96 (1), Туг 0.79 (1). MS(FAB+, low resolution): m/e 
(ion, relative abundance) 1194.7 (MH+, 23), 1251.8 (МН+ + гВи, 100), 1460 (МНЧ 
Рте, 40), 1517.9 (МНЧгВи+Ртс, 100). Soluble in DMF, only sparingly in water. 
SYNTHESIS OF PEPTIDE II 
SuM phase synthesis of IIA (cf. Fig. 2.) 
Assembly. The linear sequence corresponding to IIA was assembled employing the Fmoc 
strategy with essentially the same protocol as used for the SPPS of IA (Fig. 4). The 
assembly was performed in the semi-automatic synthesizer. Again, the starting resin was 
1000 mg of Fmoc-Cys(Acm)-0-SASRIN with a loading of 0.55 mmol/gr. The Leu resi­
dues were introduced as Fmoc-Leu-OH, Gin was introduced as Fmoc-Gln(Trt)-OH, GIu as 
Fmoc-Glu(OrBu)-OH, Asn as Fmoc-Asn(Trt)-OH, Ser as Fmoc-Ser(iBu)-OH, Tyr as 
Fmoc-Tyr(iBu)-OH, Pro as Fmoc-Pro-OH, Lys as Fmoc-Lys(Boc)-OH, Gly as Fmoc-Gly-
OH, Arg as Fmoc-Arg(Pmc)-OH, Val as Fmoc-Val-OH, Thr as Fmoc-Thr(H)-OH, Phe as 
Fmoc-Phe-OH and the assembly was terminated with the coupling of Boc-Cys(Trt)-OH. 
Coupling was performed using TBTU/HOBt/NMM. Capping was performed with acetic 
acid anhydride/DIPEA up to the coupling of the first Fmoc-Thr(H)-OH unit. After this 
coupling, subsequent cappings were performed with AcONSu/DIPEA in order to avoid 
acetylation of the hydroxylic group of Thr. 
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According to the Kaiser test, no deprotection or coupling needed to be repeated. On com­
plete assembly, the swollen peptidyl resin was washed with DMF (1 χ 10 min), alterna­
ting^ with DCM and isopropanol ( 3 x 5 min), with ether, and dried. The dry peptidyl 
resin weighed 2791.5 mg. The weight increase of 1791.5 mg corresponds with a net yield 
of 75 % of 23-residue-peptidyl chain, and an average coupling yield of 98.7 %. 
Cleavage. Cleavage of peptide IIA from the resin was performed according to the pres­
cription of Riniker and Flörsheimer (1990)), in essentially the same way as described for 
the cleavage of IA (vide supra). In total, the peptidyl resin was treated 1 1 x 2 min with 20 
ml of 1 % TFA in DCM before all peptide material was cleaved, according to TLC. TLC 
showed that the composition of the peptide material held in fractions 1,2,3 and 4 was 
different than that held in fractions 5 up to and including 11. On this basis fractions 1-4 
were combined. Also were combined: fractions 5-11 and the DCM washings of the resin 
after completed cleavage were combined. The solvents of the two fractions (to be referred 
to as fr 1-4 and fr 5-11) were evaporated and both residues were triturated thoroughly with 
water and ether, respectively, affording 1709.1 mg (fr 1-4) and 94.9 mg (fr 5-11) of off-
white powders. Evaporation of the ether washings gave a small amount of sticky residue, 
mainly comprising trilyl detachment by-products and some other apolar non-peptide 
contaminants. 
The qualitative composition of fractions 1-4 and 5-11 as judged by TLC (System A) is 
depicted in Fig. 8. Four products, to be referred to as HAI, IIA2, IIA3 and IIA4, were 
detected. The main products HAI and IIA2 dominated in fraction 1-4 (together ca 75 % of 
total mass), while by-products IIA3 and IIA4 dominated in fractions 5-11 (ratio not 
quantified). With TLC system В instead of A, the relative elution order (IIA 1/2 compared 
to IIA3/4) was reversed. After establishment of the molecular masses of the four compo­
nents (vide infra), the approximate total yield of peptide material was estimated as 67 % 
on starting resin. 
Different chemical identities of fr 1-4 and fr 5-11 was also indicated by the solubility 
properties. Fr 1-4 was soluble in acetic acid, in chloroform/methanol 1:1 (v/v), but not in 
pure chloroform (gel formation) and in pure methanol; fr 5-11 was also soluble in pure 
chloroform. 
Separation and characterization of HAI, IIA2, 1IA3 and IIA4 
The four components (IIA 1, IIA2, ПАЗ and IIA4) present in fr 1-4 were partially separa-
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ted by chromatography on silica gel, as described under 'materials and methods'. Solvent 
system A was used throughout as eluent. In a typical separation, 65 mg of fr 1-4, gave 
48.7 mg of a colourless glass, comprising only the main products IIA1 and IIA2. From the 
same separation, also 5.5 mg of pure IIA4 and 4.2 mg of pure ПАЗ were obtained, as a 
colourless glass, resp. a white semi-solid. It was not possible to separate IIA1 and IIA2 by 
further chromatography. The total yield of purified IIA1/IIA2 (which had the molecular 
mass of the desired product, see below) was 50 % calculated on Fmoc-Cys(Acm)-0-SAS-
RIN. 
Analysis ofllAl, 1ІА2, ПАЗ and IIA4 
ΗΑΙ/ΠΑ?; 
TLC: Rf 0.57 and 0.63 (System A, see also Fig. 8), 0.90 (System B, coinciding); detection: 
UV-fluorescence quenching, chlorine/TDM, sulphuric acid/methanol. 
Amino Acid Analysis: Cys 0.83 (1), Glu 4.04 (4), Phe 1.06 (1), Thr 1.73 (2), Arg 2.14 (2), 
Ser 2.59 (3), Gly 1.88 (2), Val 1.00 (int.st.), Lys 0.99 (1), Pro 1.01 (1), Туг 0.94 (1), Leu 
2.05 (2), Asp 1.01 (1). 
MS(FAB+, low resolution): m/e 4900.1 (MH\ average; calculated for C ^ H ^ ^ O ^ S , , : 
4900.1). MS(FAB+. medium resolution): calculated and measured molecular isotope 
clusters agreed for MH+. 
MS/MS: cf. Fig. 12. 
TLC: Rf 0.69 (System A, also cf. Fig. 8), Rf 0.79 (System B); detection: as for HA 1/2. 
Amino Acid Analysis: Cys 0.91 (1), Glu 4.08 (4), Phe 0.93 (1), Thr 1.69 (2), Arg 2.02 (2), 
Ser 2.50 (3), Gly 1.85 (2), Val 1.00 (1), Lys 1.05 (1), Pro 0.99 (1), Туг 0.92 (1), Leu 2.10 
(2), Asp 1.06(1). 
MS: cf. results for IIA4. 
IIA4: 
TLC: Rf 0.73 (System A, also cf. Fig. 8), Rf 0.75 (System B); detection: as for IIA 1/2. 
Amino Acid Analysis: Cys 0.73 (I), Glu 4.03 (4), Phe 0.99 (1), Thr 1.78 (2), Arg 2.16 (2), 
Ser 2.74 (3), Gly 2.07 (2), Vai 1.00 (int.st.), Lys 1.08 (1), Pro 1.04 (1), Туг 0.97 (1), Leu 
1.99(2), Asp 1.03 (1). 
MS(FAB+, low resolution): m/e 4880.4 (MH+, average; calculated for C ^ H J ^ N J J O . , , ^ : 
4880.1). MS(FAB+, medium resolution): calculated and measured molecular isotope 
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Clusters agreed for MH+ {cf. Fig. 10). 
MS/MS: cf. Fig. 11. 
Cyclization of 11 Ai/2 (formation of IIB 1/2) 
Oxidative cyclization of either crude (i.e. fr 1-4 of the detachment) or purified IIA1/2 was 
performed in a similar way as described for the cyclization of IA. In a typical experiment, 
100 mg (20.4 μπιοί) of fr 1-4 was dissolved, with slight agitation, in 20 ml of chloro­
form/methanol 1:1 (v/v). It was added, within 5 minutes, to a magnetically stirred solution 
of 20.3 mg (80 pmol) of iodine in 20 ml of chloroform/methanol 1:1 at room temperature. 
After another 10 minutes of stirring, the reaction mixture was worked up in the usual way. 
The trituration of the crude reaction product with ether gave 8.3 mg of trityl methyl ether 
and left 92.7 mg (99 %) of crude IIB as a white or yellowish semi-solid. 
In a similar experiment, 15 mg of purified IIA1 /2 (vide supra) was oxidized obtaining 
IIB 1,2 without non-cyclic by-products, as determined by FAB-MS. 
TLC: Rf 0.66, Rf 0.72 (System A); detection: UV-fluorescence quenching, chlorine/TDM, 
sulphuric acid/methanol. 
Amino Acid Analysis: Cys 1.04 (2), Glu 4.05 (4), Phe 0.97 (1), Thr 1.61 (2), Arg 1.99 (2), 
Ser 2.54 (3), Gly 2.04 (2), Val 1.00 (int.st.), Lys 1.10 (1), Pro 1.03 (1), Туг 0.91 (1), Leu 
2.01 (2), Asp 1.05 (1). 
MS(FAB+. low resolution): m/e 4585.3 (MH,+, average for in situ reduced disulfide; 
calculated for [MH+] C^Hj^N^O^S,,: 4582.7). MS(FAB+, medium resolution): calculated 
and measured molecular isotope clusters agreed for MH3
+
. 
Deprotectkm of IIB (formation of Hi 
Acidolytic deprotection of 95 mg of crude IIB (see above; ca 20.7 pmol) was performed in 
essentially the same way as the deprotection of IB (vide supra), with the following diffe­
rences. Slight agitation was necessary to dissolve IIB in the TFA/H20/EDT cocktail and 
the resulting solution was not colourless but yellow (trityl cations). The acidic aqueous 
solution of the crude product II was treated with weakly basic ion exchanger, as described 
above, and then lyophilized to give 44 mg of a fluffy white solid (crude yield 82 %). 
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Reversed-phase HPLC (Fig. 6b) indicated a very heterogeneous product. The main product 
was isolated by reversed-phase FPLC and was homogeneous as judged by TLC, RP-
HPLC, AAA, Edman sequenching and FAB-MS. Purification of 24 mg of crude product 
gave 9 mg of pure II as a white fluffy powder (yield: 31 %), which was well soluble in 
water. At concentrations higher than ca. 3 mM, the peptide tended to aggregate and 
precipitate out of the aqueous solution. 
TLC: Rf 0.66 (System D), R, 0.33 (System E); detection: UV-fluorescence quenching, 
ninhydrine, chlorine/TDM, Sakaguchi. 
RP-HPLC: ret.time 17.71 min. (see also Fig. 6c). 
Amino acid analysis: Cys 1.02 (2), Glu 4.11 (4), Phe 0.97 (1), Thr 1.53 (2), Arg 2.12 (2), 
Ser 2.53 (3), Gly 2.03 (2), Val 1.00 (int.st.), Lys 1.06 (1), Pro 1.09 (1), Туг 0.90 (1), Leu 
2.04(2), Asp 1.04(1). 
Edman degradation: nr. of cycle (amino acid assigned): l(no signal), 2(Tyr), 3(Gln), 
4(Phe), 5(Thr), 6(Thr), 7(Arg), 8(Ser), 9(Gly), 10(Val), 11 (Ser), 12(Arg), 13(Gln), 14(Gly), 
15(Lys), 16(Pro), 17(Tyr), 18(Ser), 19(Leu), 20(Asn), 21 (Glu), 22(Gln). 
MS(FAB+, low resolution): m/e 2602.1 (MH\ average; calculated for ^ „ , Η , ^ Ν ^ Ο ^ : 
2601.9). MS(FAB+, medium resolution): calculated and measured molecular isotope 
clusters agreed for MH3
+
. 
lB NMR: cf. Fig. 9. 
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CHAPTER 3 
The conformations of [Cyt 1 7 "]-M13 GVP-(17-27)-
undecapeptide and [Cyt n 3 3]-M13 GVP-ill-33)-
tricosapeptide in aqueous solution 
ABSTRACT 
r~—'—
:
 '—I 
The cyclic disulfide peptide CGVSRQGKPYC has been prepared to obtain a constrained 
analogue of sequence 17-27 of the 'binding loop' of the gene-V encoded single-stranded 
DNA binding protein of the filamentous bacteriophage M13 (M13 GVP). The conformati­
on of the cyclized [Cyt,7'27]-M 13 GVP-(17-27)-undecapeptide, in aqueous solution, has 
been investigated using two-dimensional 'Η-nuclear magnetic resonance techniques. 
The calculated structure is: a ß-loop including a turn formed by three residues. This struc-
ture, very unusual for a cyclic disulfide peptide, is highly similar to that of the analogous 
part of the binding loop of the native protein. The constraint on the 11-residue sequence is 
essential for conformational stability, as indicated by the fact that the unconstrained native 
sequence containing Ser" and Ser27 did not adopt a detectable secondary structure in 
water. 
ι - — ' — I 
The synthetic cyclic disulfide CQFTTRSGVSRQGKPYSLNEQLC representing [Cyt lb33]-
M13 GVP-0 l-33)-tricosapeptide neither adopted any detectable ß-loop structure in water. 
INTRODUCTION 
A number of filamentous bacteriophages such as Ff(M13, fd, fl), Pf3 and Же (Model and 
Rüssel, 1988) encode a single-stranded DNA binding protein which plays a crucial role in 
the life cycle of these phages. These proteins switch the DNA synthesis from the so-called 
replicative form synthesis, in which double stranded DNA is synthesized, to the synthesis 
of the single stranded form of the viral DNA. In the latter process, the single-stranded 
viral DNA is covered with the gene-V protein. Upon passage through the host cell 
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membrane this nucleoprotein complex is converted into infectious viral particles through 
replacement of the gene-V protein by the viral coat proteins. 
Recently, the three-dimensional structure of the gene-V protein encoded by the M13 phage 
(abbreviated: M13 G VP), has been elucidated by high resolution NMR (Folkers et al., 
1994) and by X-ray diffraction (Skinner et al., 1994). 
On the basis of earlier NMR DNA-binding experiments, the DNA binding domain could 
be located in the three-dimensional structure. Part of this domain is formed by an exposed 
ß-loop encompassing residues 16-28 of the 87 residues long protein. NMR studies of the 
IKe GVP and the PO DNA binding protein have yielded secondary structures of DNA 
binding loops highly similar to the one in the M13 protein (van Duynhoven et al., 1990; 
Folmer et al., 1994) and in accordance with predictions made earlier on the basis of 
protein sequence comparison (de Jong et al., 1989); see Fig. 1. 
Furthermore, the proposed alignment of the primary sequences of the gene-V proteins of 
Ff, Ike and Pf3 with that of the related phage Pfl strongly suggests a similarly structured 
DNA-binding loop to be present in the latter protein (Plyte and Neale, 1991). 
The existence of a common structural DNA-binding motif exploited by several ssDNA 
binding proteins may raise the question to what extent the formation of this ß-loop 
conformation and its role in the binding is governed by its semi-conserved primary amino 
acid sequence. 
Synthesis and conformation analysis of peptides may provide a powerful means of gaining 
insight into the propensity of a primary sequence of specific amino acid sequences to fold 
into certain conformations (Wright et al., 1988). With this in mind, we decided to 
synthesize peptides with sequences analogous or identical to the sequence [17-27] of the 
DNA binding loop of M13 GVP, and to investigate their conformational properties in 
aqueous solution. The compounds selected for this purpose were the undecapeptide 
r~ " I 
CGVSRQGKPYC, cyclized via a disulfide bridge between the terminal cysteine residues, 
and the linear peptide SGVSRQGKPYS. 
Additionally, the cyclized tricosapeptide CQFTTRSGVSRQGKPYSLNEQLC was 
synthesized, wherein the disulfide constraint allows for a larger ring, analogous to 
sequence M13 GVP [11-33]. 
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M13GVP IKe GVP 
16 
Arg Ser Gly Val Ser Arg 
Leu Ser Туг Pro Lys Gin 
28 G ,y 
1 6
_ G i n . . . 
rg Ser Gly|Val|Serj :Lys· 
: Me|Thr(TyrjPro|Ly^ Ser 
29 ~~ [о»УІ 
Pf3 DBP 
12 
Arg Gin 
PhfrThr 
24 
Ala 
Thrjser] .Lys. Gly 
Tyr[Pro] Asn 
Fig. I. Schematic representation of fi-loop structures of the DNA binding loops of IKe 
GVP, of Ff GVP and of Pf3 GVP. The solid boxes mark conserved residues while the 
dashed boxes indicate conservative replacements, with respect to the MI3 fi-loop. Dashed 
tines indicate vacant positions, inserted in relation to the analogy of the structures. 
MATERIALS AND METHODS 
Synthesis of the cyclic peptides 
The two cyclic peptides CGVSRQGKPYC and CQFTTRSGVSRQGKPYSLNEQLC were 
prepared in our laboratory as described in chapter 2. The impurities encountered in the 
undecapeptide did not interfere with the conformation analysis. 
The tripeptide Ac-(Ala)3-OH was synthesized in this laboratory by conventional solid 
phase synthesis, also using the Fmoc strategy by a protocol described in chapter 2. The 
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SPPS started from a Wang resin (Wang 1973) and cleavage was performed with neat 
TFA. The resulting white powder was dissolved in a minimum amount of water and the 
pH of the solution was brought to 7 for NMR experiments. 
Synthesis of SGVSRQGKPYS 
The linear peptide SGVSRQGKPYS was assembled straightforwardly on a Wang resin 
(Wang, 1973) by solid phase synthesis employing the Fmoc strategy, and detached with 
TFA/ethanedithiol/water 95:2.5:2.5 (v/v/v). Work-up and analysis of the deprotected open 
peptide was performed in the same way as for the deprotected cyclic peptide. The crude 
peptide was sufficiently pure for the NMR analysis. 
Ή NMR spectroscopy 
NMR samples were prepared by dissolving the peptides in 99.8% D20 or in 90% 
H2O/10% D 2 0 to give final concentrations ranging from 2 to 3 mM. The pH of the 
samples was adjusted to 5.0 or 7.0 with 50 mM DC! or 50 mM NaOD; no buffer 
components were added. 
NMR spectra were recorded on a Bruker AM-400 spectrometer interfaced to an Aspect 
3000 computer. The data were processed on either an Aspect 3000 workstation or a SUN-
4 utilizing NMRi software. 
All two-dimensional experiments were recorded in the pure phase absorption mode by 
making use of time-proportional phase incrementation (TPPI) (Marion and Wiithrich, 
1983) with the earner at the position of the solvent resonance. A complete set of spectra 
was recorded for the peptide at 277K in both D20 and H20 at pH 5.0. Additional spectra 
were recorded at pH 7.0 to resolve ambiguities encountered in the interpretation of the 
spectra recorded at pH 5.0. 
TOCS Y spectra (Bax and Davis, 1985) were recorded with mixing times of 50 ms. The 
mixing was carried out with the MLEV 17 pulse scheme with delays before and after the 
180° pulse of the scheme to compensate for cross-relaxation peaks (Griesinger et al., 
1988). NOES Y spectra (Jeener et al., 1979) were recorded with mixing times of 300 ms. 
In experiments performed in H 20 solution, solvent suppression was achieved by using 
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semiselective pulse sequences based on the jump-return sequence (Plateau and Guéron 
1982, Bax 1989) in combination with continuous irradiation of the residual water resonan-
ce. For experiments in D20, only continuous irradiation of the residual water resonance 
was used during the recycle delay. Optimization of the receiver phase was performed to 
eliminate baseline distortions. Furthermore, additional baseline corrections were performed 
on all spectra recorded in H20 solution, after Fourier transformation in two dimensions. 
Typically, 512 increments of 2K data points were recorded. The data sets were processed 
with squared sine bell functions and zero-filling was applied to obtain spectra with a 
resolution of 8.1 Hz/point. In addition, a P-COSY (Marion and Bax, 1988) was recorded 
to aid in identifying direct correlations in the TOCSY spectra. The data manipulation for 
obtaining the actual P-COSY spectrum from the raw data was achieved with a home-
written С program. 
Restraints for structure determination of CGVSRQGKPYC 
The NOESY spectra were used for identification of resonances and for extraction of 
approximate interproton distances. A total of 91 intra- and interresidue NOEs were 
identified first and then classified into three distances ranges, 1.8-2.7, 1.8-3.3, 1.8-5.0 À, 
corresponding to strong, medium and weak NOEs. Φ backbone torsion angle restraints 
were derived from 3JH N a coupling constants measured from a one-dimensional spectrum of 
the peptide in H20. Φ angles were restrained to ranges of -160°<Φ<-80° and -90°<Φ<-40° 
on the basis of *]
та
 coupling constants of >8.0 Hz and <5.5 Hz, respectively (Kline et 
al., 1988). In addition, distance constraints were included to define the disulfide bridge be­
tween the cysteine residues. For the bridge, these were: rS(1).S(J)= 2.02 ± 0.05 Â, rCB(j).S(|) = 
2.99 ± 0.05 Â and rCWj).sm= 2.99 ± 0.05 À. 
Structure calculations for CGVSRQGKPYC 
The structure calculations were performed with the distance geometry program DIANA, 
the variable target function algorithm operating in dihedral angle space for the calculation 
of protein structures from NMR data (Giintert et al., 1991). The aforementioned restraints 
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served as an input for these calculations. Standard pseudo-atom corrections were made for 
distances involving methylprotons or non-stereo-specifically assigned methylene protons. 
The final DIANA structures were visualized using the program package QUANTA (Poly-
gen), running on Silicon Graphics workstation 4D/25. 
RESULTS 
Complete sequence-specific 'H-NMR assignments for the cyclic and for the linear 
undecapeptide in water at 277 К and at pH 5.0 were obtained using the standard two-stage 
procedure (Wüthrich, 1986). It is noted in passing that in the following the numbering of 
the amino acid residues of the peptides will be consistent with that of the native binding 
loop. The involved part of the latter will be referred to as M13 GVP [17-27]. The various 
spin systems of the cyclic undecapeptide were first identified using the TOCSY and P-
COSY data. In the amide/alpha region of the TOCSY (H20) spectrum, all of the expected 
intraresidue CaH-NH correlations were observed. Subsequently, sequential assignment of 
the cyclic peptide was almost completely possible using the dotN NOE connectivities and 
the CHa-NH couplings which are reflected in the amide/alpha region of the NOESY (Fig. 
2) and the TOCSY spectrum, respectively. The interruption caused by the presence of the 
proline residue P25 could be overcome by the observation of the sequential daN connec-
tivity between P25 and Y26 and a αα-(δ,δ') connectivity between K24 and P25. The latter 
contact, observed in the aliphatic region of the NOESY spectrum (Fig. 3) is diagnostic for 
the occurence of the normal trans conformation for P25. It is noted in passing that the 
chemical shifts are not very sensitive to temperature changes; differences between 277 К 
and 298 К do not exceed 0.1 ppm. 
The proton-resonance assignments found for the cyclic peptide are summarized in Table 1. 
The chemical shifts thus obtained for the amide and alpha protons were compared with 
those of M13 GVP [17-27]. To this end, tabulated random coil amide proton shift values 
(Wüthrich, 1986) were substracted from the amide proton shifts summarized in Table 1 for 
the peptide, and from the amide proton shift values reported previously for M13 GVP [17-
27] (van Duijnhoven et al., 1990). The resulting deviations (in ppm) were plotted versus 
residue number. The same procedure was applied to find and compare the deviations of 
the alpha proton shifts from tabulated random coil values (Wishart et al., 1992) (Fig. 4). 
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TABLE 1. Chemical shifts for the protons of the cyclic peptide CGVSRQGKPYC in H20 
at pH 5.0 and 277 K, relative to DSS. 
C17 
G18 
V19 
S20 
R21 
Q22 
G23 
K24 
P25 
Y26 
C27 
NaH 
8.53 
8,41 
8.95 
9.11 
8.12 
8.30 
7.76 
-
8.35 
8.17 
CaH 
4.47 
3.79, 4.27 
4.42 
4.66 
4.27 
4.33 
3.63,4.15 
4.82 
4.78 
4.78 
4.42 
CßH 
3.20, 3.40 
-
1.93 
4.21, 3.93 
1.87 
1.93,2.26 
-
1.71, 1.84 
1.95,2.30 
2.95, 3.06 
3.02, 3.33 
Others 
-
-
C7H 0.89 
-
C-yH 1.69, CÔH 3.18, ΝεΗ 7.23 
C-yH 2.35, 2.45 
-
Cytì 1.41, C8H 1.71, СеН 3.00 
СуН 1.95, 2.10, C8U 3.70, 4.00 
С6Н 7.03, СеН 6.68 
-
The results indicate a striking similarity between the shifts of the cyclic peptide and M13 
GVP [17-27]. A large difference between the amide proton shifts of the synthetic and the 
native molecule is only encountered for residue Glyl8, which is in the vicinity of the 
disulfide constraint in the peptide. Significant differences (both in magnitude and in sign) 
for the alpha proton shift deviations are only observed for residues 17 and 27. In the 
peptide, these residues constitute the cystine residue with the disulfide bond. Note that the 
large non-degeneracy of the alpha protons of both glycine residues G18 and G23 is similar 
to that in the Ml3 GVP. 
The one-dimensional Ή NMR spectrum (H20) of the cyclic undecapeptide at pH 5.0 and 
277 К is well resolved (Fig. 5), even to such an extent that the 3JN H a coupling constants 
can be deduced. Typically small or large couplings were found for residue R21 (J<5.5 Hz) 
and for VI9, K24, Y26 and C27 (J>8 Hz). The large values are indicative of the presence 
of extended structure (Wright et al., 1988). The rest of the 3JN H o coupling constants falls 
within the range 7-7.5 Hz, and is thus not informative about local structure. 
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connected by arrows. 
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Ρ25δ' 
P2S8 
V19a 
Ρ25α 
Κ24α 
ΡΡΜ 
Fig. 3. Aliphatic region of the 400 MHz NOESY spectrum of the cyclic peptide CGVSR 
QGKPYC (D20, pH 7.0, 277 K). Interresidue contacts are indicated by dashed lines or 
solid arrows. For clarity, the intraresidue VI9 day contact is also indicated (with a 
dotted arrow), as it is clearly seen only in the upper part of the spectrum. 
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Fig. 4. Deviations from random coil values for the amide (top) and for the alpha proton 
chemical shifts (bottom) of the cyclic peptide CGVSRQGKPYC (·) and of MI3 GVP [17-
27] (+), in ppm. 
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The amide proton shifts and the JNHot coupling constants of the linear peptide at 277 К 
fell within the ranges 8.0 - 8.5 ppm, resp. 6.0 - 8.0 Hz; this is in the range of the random 
coil values. 
NOE data and secondary structure 
For structure analysis of the cyclic undecapeptide, a total of 31 inter-residue NOEs were 
identified and classified as being strong, medium or weak (see restraints). These NOEs are 
summarized in Fig. 6 (sequential contacts) and Table 2 (long-range connectivities). 
They are also schematized in Fig. 7; it is clear that the NOE contacts are representative of 
the formation of an antiparallel ß-sheet. In particular, the strong dact(i, i+6) NOE between 
Val 19 and Pro25 (Fig. 3) in combination with the other cross strand NOEs is diagnostic of 
the formation of this structure. The observation of a cross strand dNN contact between 
Ser20 and Lys24 (Fig. 8) and cross strand daN contact between Pro25 and Ser20 (Fig. 2) 
indicates that the ß-ladder includes residues 20 and 24 and suggests the presence of a 
hydrogen bond between the amide proton of Ser20 and the Lys24. The loop region encom-
passing residues 21 through 23 is characterized by the dNN connectivities (Fig. 7 and 8). 
All these connectivities are the same as those found in the DNA binding loop in the M13 
G VP (Folkers et al., 1991) except for their relative intensities which differ in some 
instances. 
Finally, we mention that the NOESY spectra recorded both for the linear undecapeptide 
and for the cyclic tricosapeptide at 277 К did not reveal any inter-residue NOEs indicative 
of a significant population of folded structure. For example, no interresidue dace contact 
could be detected in the aliphatic part of the NOESY spectrum (Fig. 9). The gradual 
addition of Ac-(Ala)3-OH as a possible hydrophobic support did not change this situation. 
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Calculated structures of the cyclic peptide CGVSRQGKPYC 
On the basis of the available distance and torsional angle constraints, using the DIANA 
procedure, we have calculated a total of 15 structures for the peptide, having final target 
function values of less than 0.26 À. The final structures could be calculated in a straight-
forward manner using standard parameters, as the assignment of the peptide resonances 
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Fig. 5(a). One-dimensional Ή NMR (400 MHz) spectrum of the cyclic peptide: 
CGVSRQGKPYC in H20 (pH 5.0, 277 K). (b) Extended region 6.2-9.5 ppm of a second 
spectrum (same peptide, same conditions) with assignments of the amide and aromatic 
proton signals. Non-assigned signals arise from other protons (e.g., from side-chain 
ammonium functions) or from impurities. 
80 
CI7 G18 V19 S20 R21 Q22 G23 K24 P25 Y26 C27 
W M S 
W: weak 
M: medium 
S: strong 
Fig- 6. Summary of the sequential NOE connectivities observed for cyclic peptide 
l " 1 
CGVSRQGKPYC in aqueous solution. 
Interresidue contact 
j V19-P25 
V19-P25 
V19-Y26 
V19-Y26 
S20-K24 
S20-P25 
S20-Y26 
S20-Y26 
S20-Y26 
Protons involved 
CaH , CaH 
CyH , CaH 
CaH , NH 
CaH , CÔH 
NH ,NH 
NH , CaH 
CaH , CeH 
CßH , C6H 
NH , CeH 
NOE intensity 
strong 
weak 
weak 
medium 
weak 
weak 
weak 
weak 
weak 
Table 2. Summary of the long-range NOE connectivities observed for cyclic peptide 
CGVSRQGKPYC. 
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Fig. 7. Schematic representation of the backbone of cyclic peptide CGVSRQGKPYC. The 
connectivities defining its structure are indicated by arrows. 
posed no problems. There were no distance violations exceeding 0.3 Â, no van der Waals 
violations greater than 0.2 Â, and no torsional angle violations larger than 5°. 
Figs. 10 and 11 shows superpositions of these 15 calculated structures, from different 
points of view. Fig. 10 also shows the side chains. The average root-mean-square 
deviation (RMSd) of the backbone atoms is 0.90 ± 0.37 Â; the average RMSd of all non-
hydrogen atoms is 1.85 ± 0.49 À. The superposition shows that the overall backbone con-
formations are reasonably well-determined. The positions of some side chains, specially 
those of the residues in the region of the turn, are less well defined. 
A best-fit supeiposition of the calculated average structures of the synthetic 11-residue 
peptide and native M13 G VP [17-27] (Folkers et al., 1994) has been made using the 
program X-PLOR, but it is not included here. It emphasizes the common features descri-
bed; the RMSd of the fit was only 0.94 Â, which is strikingly small for a superposition of 
a synthetic and a native structure like this one. Colour slides or photographs are available 
on request. 
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Fig. 10. Stereoviews of 15 structures of the cyclic peptide CGVSRQGKPYC obtained by 
the DIANA procedure (GUntert el al., 1991), shown in superposition, from two different 
points of view (A and B). The side chains are also shown but all hydrogen atoms have 
been omitted. 
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 ( 
Fig. /ƒ. Stereoviews of 15 structures of the cyclic peptide CGVSRQGKPYC obtained by 
the DIANA procedure (Giintert et al., 1991), shown in superposition, from three different 
points of view (А, В and C). Only the backbone atoms are shown, including the amide 
protons; the disulfide moiety has been omitted. Depending on the point of view, the overall 
ß-loop structure and/or the twist of the backbone can be observed. 
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DISCUSSION 
In recent years, it has been shown by 2D NMR spectroscopy that a common structural 
motif is involved in the binding of single stranded DNA by the gene-V proteins of phages 
M13 (van Duijnhoven et al., 1990; Folkers et al., 1994), IKe (de Jong et al., 1989) and 
PO (Folmer et al., 1994). This common motif is a solvent-exposed ß-loop structure with 
highly similar amino acid sequences for the different GVPs. The great resemblance in both 
the primary and the secondary structure of these binding loops is intriguing and this has 
led us to investigate whether these sequences are 'designed' to form a ß-loop structure by 
themselves or whether they are folded this way only when they are integrated in the 
structure of the complete protein. We have tried to gain insight into this matter by the 
synthesis and conformational analysis of a cyclic, disulfide-constrained, and of a 'linear' 
analogue with a sequence identical to sequence [17-27] of the M13 GVP binding loop. 
The following reasons account for the choice for these target peptides. 
In the gene-V protein, the sequence [17-27] lacks direct interactions with other parts of the 
protein but it is maintained in its position by the connection of both of its N- and C-
terminal ends onto the hydrophobic core of the protein (Folkers et al., 1994). Furthermore, 
an interaction between the C-terminal extension of the binding loop (residues 30-32) and 
the so-called complex loop makes up a part of a triple-stranded ß-sheet (Folkers et al., 
1991). This interaction, and the anchorage onto the core, might assist in keeping the 
sequence 16-28 in its native ß-conformation. Hence, a sort of natural 'constraint' is impo-
sed on the binding loop by the protein. In the cyclic model undecapeptide, the absence of 
the natural constraint is compensated by the introduction of a disulfide bridge. 
Cyclization via disulfide bond formation is a well-known method of restricting the 
conformational flexibility of peptides (cf. chapter 1). A suitable option for this modificati-
on in the case of M13 GVP [17-27] seemed the substitution of the Serl7/Ser27 pair by a 
terminal disulfide-linked cysteine/cysteine pair (cystine residue). In the protein, these two 
serine residues are located opposite to each other within the regular ß-loop structure. Their 
side chains point in the same direction, perpendicular to the plane of the ß-structure. The 
two hydroxylic functions are relatively close in space, although not close enough for the 
possible formation of a hydrogen bridge. Exchange of the two hydroxyl groups with two 
covalently linked sulfur atoms is unlikely to introduce large changes in the overall confor-
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mation of the 11 -residue sequence [17-27]. Accordingly, congruency of this conformation 
with the solution structure of the cyclic peptide would indicate that the described ß-struc-
ture for this part of the protein indeed is energetically favorable, and governed essentially 
by its primary sequence. A similar result for the linear peptide would indicate that this 
conformation is very favorable indeed and that not even a constraint is required to reduce 
the conformational entropy expected for an open structure. 
Initially, the cyclic tricosapeptide was also chosen as a target molecule because, at that 
time, it was believed that sequence M13 [11-33] encompasses the full length of the ß-Ioop 
structure of the DNA binding loop. A similar ß-loop structure of the peptide in aqueous 
solution would again indicate a strong predetermination by the primary sequence. 
In this case, the residue pair Alai 1/Cys33 was considered to be a good candidate for the 
exchange with a (terminal) cystine residue (Fig. 2). Again, important aspects were: the 
proposed parallel orientation of the two side chains and the relatively small modifications 
expected after the construction of a disulfide bridge. 
However, during the course of this work it became clear that the regular ß-loop structure 
encompasses with certainty only residues 16-28 of M13 GVP [11-33] (Folkers et al., 
1994). The cyclized 23-residue peptide may therefore a priori not be a good model for the 
native sequence. Additionally, also the interaction of residues 30-32 with the complex loop 
was discovered only later (Folkers et al., 1991). This tertiary interaction is absent in the 
peptide, although we tried to mimic it by the addition of a hydrophobic peptide like Ac-
(Ala)j-OH. On the other hand, the sequence 16-28 is held completely in the peptide so 
formation of a complete native-resembling ß-loop should, in principle, still be possible. 
With respect to the cyclic undecapeptide, our approach turned out to be successful. The 
folding of the cyclic peptide closely resembles that determined for the corresponding DNA 
binding loop in the M13 GVP (Folkers et al., 1994). In the cyclic peptide, a ß-loop is 
formed which consists of an anti-parallel ß-Iadder involving residues 17-20 and 24-27 
connected by a turn encompassing residues 21 through 23 as in the protein molecule. Both 
in the native sequence and in the cyclic peptide the ß-loop is clearly twisted in contrast to 
the latest X-ray structure (Skinner et al., 1994). The resemblance in the conformations of 
the peptide and the DNA binding loop is stressed by the striking similarity in the chemical 
shift of the backbone protons, which is a sensitive parameter (Fig. 4). 
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At this point, it is interesting to compare the present results with some recent NMR 
studies on peptides. Scheraga and collaborators (Talluri et al., 1993) investigated frag-
ments from RNAse A, i.e. peptides [61-74] and [65-72]. In native RNAse A as well as in 
the peptide molecules a disulfide bond is formed between Cys65 and Cys72. This results 
in the formation of ß-turns in the protein as well as in the peptide fragments, but interes-
tingly there are some important differences. In the protein, a type III ß-turn is formed 
between residues 65 and 68, while in the fragments the formation of a type II ß-turn is 
induced involving residues 66-69. Thus, the local interactions defining the conformation of 
the circular peptide fragments are apparently modulated by other interactions in the native 
protein influencing the conformation of the peptide significantly. 
The present experiments suggest that similar local interactions determine the conformation 
of the DNA binding loop in the gene-V protein as well as in the circular peptide fragment. 
Thus given a restraint that joins the terminal residues in fragment [17-27], the primary 
sequence indeed determines the folding of the DNA binding loop. The requirement of a 
natural or artificial conformational constraint is reflected in the fact that the linear peptide 
SGVSRQGKPYS does not adopt a preferred structure in water but is flexible instead. 
The high cyclization yield in the synthesis of the cyclic peptide, its observed stability (see 
'Synthesis of the peptide') and IR-absorptions of dry peptide that are characteristic of high 
contents of ß-sheet and turn (chapter 5) are additional indications that the ß-loop structure 
is very favorable. To our knowledge, the described circular model 11-residue peptide is 
even the first unequivocal example of an unprotected cyclic cystine peptide that adopts a 
well-defined 'in register' ß-loop structure in aqueous solution (Srinivasan et al., 1990). 
An outstanding feature of the DNA binding loop of M13 GVP is that the Tyr26 side chain 
bends over the surface of the ß-ladder to the residue Glyl8 opposite of Tyr26 in the sheet. 
This is also seen in the cyclic peptide. It is tempting to consider the folding of the ring of 
Tyr26 over the glycine residue as an important factor in stabilizing the observed con-
formation. Tyrosine residues have been observed earlier to induce local structure by 
interaction with nearby glycine residues. For example, in a synthetic peptide corresponding 
to the 15 N-terminal residues of bovine pancreatic trypsin inhibitor, local elements of non-
random conformation were observed formed by the aromatic ring of TyrlO interacting 
with the amide group of Glyl2 (Kemmink et al., 1993). The situation in the circular 
peptide studied here is, however, somewhat different. The interaction is between a glycine 
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and a tyrosine separated by more amino acids, i.e. seven, than in the peptide studied by 
Creighton and collaborators. Moreover, the explicit interaction between the tyrosine ring 
and the amide proton of the glycine residue in the peptide studied by these authors is not 
present in the circular peptide nor in the DNA-binding loop in the protein because the 
corresponding amide proton is involved in hydrogen bonding to the opposite carbonyl. 
The fact that the much larger cyclic tricosapeptide does not adopt a detectable population 
of a ß-loop conformation in water indicates that the propensity for this type of folding 
indeed does not extend over the entire sequence M13 GVP [11-33]. Without sufficient 
support or additional constraints, the peptide probably contains too many rapidly intercon-
verting hydrophobic interactions to adopt a preferred conformation. In agreement with this, 
FT-IR indicated mainly random coil structure in the dry tricosapeptide and no content of 
α-helix or ß-sheet structure (see chapter 5). 
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CHAPTER 4 
Oligonucleotide binding studies of [Cyt1 7 2 7]-M13 GVP-
(17-27)-undecapeptide and [Cyt u 33]-M13 GVP-ЦІ-ЗЗ)-
tricosapeptide 
ABSTRACT 
Using Ή NMR spectroscopy, oligonucleotide binding studies were performed on the title 
compounds in aqueous solution by means of titration with p(dA)8, p(dT)8, poly(dA) and 
poly(dT). Upfield shifts of aromatic proton resonances indicate a (weak) oligonucleotide 
binding capacity of the peptides. 2D-trNOE experiments at 298 К indicate 
that the cyclic undecapeptide CGVSRQGKPYC, upon the binding to poly(dA) or 
poly(dT)adopts the same ß-loop conformation as preferred by the free peptide in water at 
277 K. 
INTRODUCTION 
NMR spectroscopy can be used to demonstrate and to follow the binding of peptides 
and/or proteins to DNA and/or oligonucleotides. In the case of M13 GVP, the CEH 
resonance of residue Tyr26 has been used to monitor the complexation of the protein with 
DNA fragments (Alma et al., 1982; King and Coleman, 1987). This binding is accompa-
nied by strong upfield shifts of the mentioned proton resonance, which were suggested to 
arise from ring current effects of the bound nucleotide bases. It is also known that the 
binding of a small peptide like Lys-Tyr-Lys to ssDNA can be followed by measuring the 
upfield shift of the aromatic proton resonances of the tyrosine residue (Dimicoli and Hélè-
ne, 1974). 
Following the same strategy, we intended to obtain an impression of the oligonucleotide-
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binding capacities of the synthetic cyclic peptide CGVSRQGKPYC following the chemical 
shift changes of suitable proton resonances during titration experiments. The aromatic pro­
tons of the Туг residue corresponding to Y26 in the sequence of M13 GVP seemed 
appropriate in this case (vide supra); its resonances do not overlap with others in the 
spectra. Hereafter, a gross qualitative comparison with the oligonucleotide binding 
capacities of MI3 GVP could be made. 
In the present study, the following oligonucleotides were used: p(dA)g [octa-adenylic acid 
with a 5'-terminal phosphate group], p(dT)g [octa-thymidylic acid with a 5'-terminal phosp­
hate], poly(dA) [average length 564 bases] and poly(dT) [average length 167 bases]. Also, 
experiments were carried out with the spinlabeled trinucleotide *d(A)3\ which has proven 
to be of great use in the identification of the amino acids of the DNA binding domain. 
(Folkers et al., 1993). 
In addition, some 2D transferred NOE (Campbell and Sykes, 1991) experiments were 
carried out in order to obtain more information about the binding of the cyclic 11 -residue 
peptide to poly(dA) and poly(dT). 
EXPERIMENTAL 
[Cytl7'27]-M13 GVP-(17-27)-undecapeptide and [Cyt"'"]-M13 GVP-(1 l-33)-tricosapeptide 
were synthesized as described in chapter 2. Oligonucleotides were obtained from Pharma­
cia LKB as their sodium salts. 
The spin-labeled trinucleotide designated as *d(A)3* contains three adenyl residues; to both 
ends (5' and 3') the spin-label TEMPO (4-hydroxyl-l-oxyl-2,2,6,6-tetramethyl piperidine) 
is attached via phospho-ester bonds. The spinlabeled oligonucleotide was synthesized, 
purified and characterized as described by Claesen et al. (1986). 
Titrations were performed by adding small aliquots of concentrated oligonucleotide 
solutions to a 1.0 mM peptide solution in D 20 at 298 K. Fresh solutions were prepared 
just before the start of the titration experiment; the pH was adjusted to 7.0 with dilute DC1 
or NaOD in D20. 
Binding was monitored by measuring the upfield shifts of the aromatic protons of the Tyr 
residue of the cyclic undecapeptide or the cyclic tricosapeptide. Transferred NOESY 
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experiments were performed at 298 К with mixing times of 350 or 400 msec. 
Ή NMR experiments were performed at 400 MHz on a Bruker AM 400 spectrometer. 
RESULTS 
In all titration experiments performed, small but significant upfield shifts of the tyrosyl 
aromatic proton resonances of the peptide were observed (ΥδΗ and ΥεΗ). As discussed 
above, we used the ΥεΗ resonance to monitor the binding process. The upfield shift (Δδ), 
in Hz, of this resonance (with respect to the free peptide) upon titration, was plotted 
against the N/p ratio where N is the molar amount of mononucleotides present in the 
solution and ρ is the molar amount of peptide present at the same time (Figs. 1 and 2). 
The small character 'p' is used here to distinguish the peptide concentration from the 
amount of native M13 GVP monomer, designated with a capital 'P' in similar experiments 
with the complete protein (van Duijnhoven et al., 1992). 
The following phenomena were observed during the different titrations of the cyclic 
undecapeptide with oligo- or polynucleotides. 
Titration with p(dA)H. 
A gradual upfield shift of the two resonances of the aromatic protons of the Tyr residue, 
tending towards a maximum value, was observed upon titration with the oligonucleotide 
(Fig. 1). The shape (doublets) of the resonances hardly changed, there was only a small 
increase in linewidth. 
The titration was not continued to the level of maximum upfield shift. It can be seen from 
Fig. 1, however, that this point will approach a maximum Δδ of 24 Hz (ca. 0.06 ppm). 
The signals of the aromatic protons of p(dA)8 undergo no upfield shifts or much smaller 
ones. However, the cluster of aliphatic protons of the oligonucleotide resonating around 
2.4 ppm shifts upfield by about 0.09 ppm. 
It is important to note that the aromatic proton signals of the tyrosine residue of a 
diastereomeric peptide that was present as a contamination (cf. chapter 2) hardly shifted 
upon titration with the oligonucleotides (vide infra). 
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Titration with p(dT)
s 
Also in this case, a gradua! upfield shift of both Туг aromatic proton resonances was 
observed upon titration (Fig. 1), accompanied by an only small extent of peak broadening 
(Fig. 3). The plot of Δδ versus N/p clearly tends to a maximum upfield shift of 37 Hz (ca. 
0.09 ppm) reached at a N/p value of ca. 70. 
Again, it is interesting to note from Fig. 3 that the signals of the diastereomeric peptide 
(see chapter 2) shift upfield only a few Hz upon titration. This results in a growing 
separation between corresponding signals (for both ΥδΗ and ΥεΗ) of the peptide and its 
diastereomer. It stresses the fact that the shift of the signals of the 'right' peptide is not due 
to aspecific factors as dilution or deaggregation. It also indicates that a modification in one 
of the chiral centers can largely eliminate the peptide's binding capacity. 
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Figure 1. Plots of the upfield shifts (in Hz) of the ε protons of Tyr26 of [Cyt"'27]-MI3 
GVP-(l7-27)-undecapeptide observed upon addition of p(dA)
s
 [+] or p(dT)
s
 ƒ•/. The 
titration curves are presented as functions of the mononucleotide/peptide ratio (N/p). 
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During the titration, the protons of the oligonucleotide exhibited no or only small 
(downfield) shifts (<6 Hz). 
Titration with poly(dA) 
Also during the titration with the much longer oligonucleotide poly(dA), a gradual upfield 
shift of the Tyr aromatic protons was observed (Figs. 2 and 4). No change in the signal 
shape, only little broadening was observed. We did not titrate up to the saturation level 
with maximum upfield shift and it does not seem possible to find the binding mode from 
Fig. 2. During the titration, downfield shifts were observed for some proton resonances of 
poly(dA), namely those for 2-H (-24 Hz), for 8-H (-11 Hz) and Г-Н (-20 Hz). 
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Figure 2. Plots of the upfield shift (in Hz) of the e protons of Tyr26 of [Cyt1721 J-M13 
GVP-(17-27)-undecapeptide observed upon addition of poly(dA) ['] or poly(dT) [+]. The 
titration curves are presented as functions of the mononucleotide/peptide (N/p). 
Transferred NOESY experiment. With the pcptide/poly(dA) mixture obtained at the end of 
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(he titration (N/p = 13), a transferred NOES Y experiment was performed at 298 K. In the 
spectrum obtained (not shown) not only the NOEs expected for poly(dA) were observed, 
but also most of the intraresidue NOEs for the peptide corresponding to those observed in 
, , , , , , , _ _ _ , , , , , , , , , , 1 "• P P M 
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Fig. 3. Aromatic region of the Ή NMR (400 MHz; D20, pD 7.0, 298 К) spectrum of (A) 
cyclic peptide CGVSRQGKPYC before titration; (B) after addition of p(dT)
s
 (N/p=3.4). 
the NOESY spectrum of the pure peptide at pH 7.0 and 277 К ( also cf. chapter 3). 
However, the NOEs observed for the peptide in the trNOESY spectrum of the mixture at 
277 К were weaker than those for the free peptide at 298 K. In the trNOESY spectrum, a 
ΥαΗ/ΥεΙΙ connectivity for the tyrosine residue was not even observed, while the 
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YßH/ΥδΗ contacts and the ΥαΗ/ΥδΗ contact were present. It is also possible that a 
number of intraresidue NOEs of lysine is not present but this is not certain due to possible 
overlap with other resonances. 
It could be established, however, that a relatively strong interresidue daa contact between 
Val 19 and Pro25 was present, as is the case in the NOES Y spectrum of the pure peptide 
at 277 К (cf. Chapter 3). This is a strong indication that the ß-loop conformation, 
preferred by the peptide in aqueous solution, indeed is involved in the binding process. In 
the present experiment, no intermolecular trNOEs between peptide and poly(dA) protons 
were observed. 
Titration with poly(dT) 
Also with this polynucleotide, a gradual upfield shift of the Tyr aromatic protons was 
observed (Figs. 2 and 5). The titration was continued up to a point with N/p = 8.7 and an 
upfield shift of 33 Hz. It is clear from Fig. 2 that this represents by no means the 
saturation level with maximum shift; again, the binding mode cannot be estimated from 
the curve. 
Again, during the titrations with poly(dA) and poly(dT) the Tyr aromatic resonances of the 
diastereomeric peptide shifted to a much smaller extent than those of the main peptide 
(Fig. 5). 
For the proton resonances of poly(dT), only small downfield shifts (<5 Hz) were observed. 
Transferred NOESY experiments. Transferred NOESY (298 K) spectra were taken with 
the mixtures corresponding to the last two points of the titration with poly(dT) (N/p = 3.5, 
resp. N/p = 8.7). Some interesting observations were made. 
First, as with the titration with poly(dA), most of the intraresidue NOEs for the peptide 
could be designated after comparison with the NOESY spectrum (277 K, D20) of the pure 
peptide. However, not observed were: most of the NOEs for the lysine residue (except the 
dßy contact), the dß5 and the dy6 contacts of the arginine residue and all NOEs from the 
glutamine residue. 
Secondly, the interresidue dota contact between Val 19 and Pro25 was again observed, as 
in the NOESY spectrum of the pure peptide and in the trNOESY spectrum of the 
peptide/poly(dA) titration mixture (vide supra). This again suggests that the cyclic peptide 
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adopts the ß-loop structure upon binding to poly(dT). 
Thirdly, two-dimensional spectra allow a much better monitoring of the possible shifting 
of several proton resonances during this titration. From the two trNOESY spectra taken, it 
could be deduced that the aromatic resonances of the tyrosine residue indeed shift upfield 
considerably. However, small downfield shifts were observed for the α and β proton 
resonances of Cysl7 and Ser20; these shifts cannot be observed very well in the ID NMR 
spectra due to overlap. No significant shift was observed for the proton resonances of poly 
(dT). 
Finally, but importantly, also some very small trNOEs between protons of the macromo­
lecule and of the smaller molecule were observed. They exist between the ΥεΗ resonance 
of the peptide on the one hand, and the 5'-protons and the protons of the exocyclic methyl 
group of poly(dT), on the other hand. 
Titration with 'd(A),* 
Titration with the spin-labeled oligonucleotide had virtually no effect on the proton 
resonances of the peptide; no broadening and no shift was observed, even after the 
addition of 0.25 molar equivalent of *d(A)3*. For comparison: addition of 0.05 equivalent 
of the spinlabeled molecule to a solution of M13 G VP results in a selective broadening 
causing the disappearance of several signals (among which those of Tyr26) in the Ή 
NMR spectrum (Folkers et al., 1993). 
DISCUSSION 
In recent years, binding studies of M13 G VP with spin-labeled oligonucleotides have 
provided more detailed information about the DNA binding domain and its surroundings 
(Folkers et al., 1993; see also chapter 1). The DNA binding domain is composed of two ß-
loops. The major one is the so-called DNA binding loop (residues 16-28). It was found 
that residues Arg 16, Gly 18, Ser20, Tyr26 and Leu28 were strongly affected by the spin-
label; residues Seri 7, Val 19, Arg21, Gln22, Lys24 and Ser27 were moderately affected. 
The other ß-loop involved in DNA binding is part of the so-called dyad domain (residues 
69-80) which belongs to the other monomeric unit of the protein. A part of the complex 
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Fig. 4. Ή NMR (400 MHz; D20, pD 7.0, 298 K) spectrum of cyclic peptide 
CGVSRQGKPYC before (A) and after titration with poly(dA) until N/p=l3 (B). The broad 
resonances in spectrum В that are indicated with arrows, arise from protons of poly(A). 
101 
' I ' ' ' • •' 
4 
Τ * 
3 
Ρ P M 
Fig. 5. 'Η NMR (400 MHz; D20, pD 7.0, 298 К) spectrum of cyclic peptide 
CGVSRQGKPYC before (A) and after titration with poly(dT) until N/p=8.7 (B). The 
resonances in spectrum В that are indicated with arrows arise from protons of poly(dT). 
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loop (residues 44-51), belonging to the same monomer as the DNA binding loop, runs 
contiguous to the latter and is also in close vicinity to the bound DNA. The only aromatic 
residues involved in ssDNA binding have been shown to be Tyr26 and Phe73. 
The present experiments show that the CeH resonances of residue Tyr26 in the Ή NMR 
spectrum of the cyclic 11-residue peptide gradually shift upfield during titration with 
p(dA)|j, p(dT),,, poly(dA) or poly(dT), with no substantial line broadening. These pheno­
mena are indications that the peptide is involved in a process of fast exchange between its 
free and a bound state. The trNOESY spectra taken after the titrations with poly(dA), resp. 
poly(dT) at 298 К both show, apart from intramolecular NOEs for the polynucleotide, 
NOEs that correspond to most of the intraresidue NOEs observed in the NOESY spectrum 
of the free peptide at 277 K. This indicates that the rotation correlation time of the peptide 
at 298 К decreases when the polynucleotide is added, most probably because of a binding 
process. 
In both trNOESY spectra, an interresidue dace connectivity between Val 19 and Pro25 was 
observed. As already stated, this indicates that the preferred ß-loop conformation of the 
peptide (see chapter 3) is indeed involved in the binding of the polynucleotides at 298 K. 
Transferred NOESY spectra were taken at two different points of the titration with 
poly(dT). Comparison of these spectra with each other, and with the NOESY spectrum of 
the free peptide indicates that some intraresidue NOEs arising from the peptide are not 
observed in the trNOESY spectrum and that some resonances shift significantly during 
binding. For example, intraresidue NOEs arising from the side chains of Arg21, Gln22 and 
Lys24 are either not or only weakly visible in the trNOESY spectra. They may be partially 
or completely filtered out because of the involvement of these flexible side chains in 
different, rapidly interconveiting bound states. It should be noted that residues Arg21, 
Gln22 and Lys24 are located in or near the turn of the ß-loop and that these residues are 
indeed involved in the DNA binding by the gene V protein (Folkers et al., 1993). 
In addition, the two trNOESY spectra of peptide/poly(dT) mixtures show that the side 
chain proton resonances of Cysl7, Ser20 and Tyr26 shift considerably during titration; this 
may indicate that these residues are also involved in the binding process. Indeed, residues 
Ser20 and Tyr26 of native M13 GVP are involved in the binding of ssDNA and are both 
strongly affected by spinlabeled oligonucleotides (Folkers et al., 1993). Cysteine-17 is not 
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a natural constituent of M13 G VP. However, in the peptide this residue contains the 
positively charged amino terminus which may play a role in phosphate binding and hence 
may be responsible for the observed shift. 
The residues of which the resonances change during titration of the peptide (Ser20, Arg21, 
Gln22, Lys24, Tyr26) correspond to residues in M13 GVP that constitute either one side 
of the ß-ladder or the turn. Unfortunately, the binding of the spin-labeled oligonucleotide 
*d(A)3* to the peptides was too weak to cause selective peak broadening, so extra 
information on the specificity of binding could not be obtained in this way. 
The mechanisms by which the several residues contribute to the oligonucleotide binding 
also cannot be eludicated by the NMR techniques employed here. It seems reasonable, 
however, that the positively charged side chains of Arg21 and Lys24 will interact with the 
negatively charged phosphate backbone of the oligonucleotide. For Ser20 and Gln22, 
mechanisms involving hydrogen bonding of the side chains will most probably play a role. 
The observation of small transferred NOEs between Celi of Tyr26 and CHj/S'-CHj of 
poly(dT) is important but does not clarify in which way the tyrosyl ring participates in 
binding. Stacking and/or hydrogen bonding may be involved. 
Additionally, titrations of the cyclic tricosapeptide CQFTTRSGVSRQGKPYSLNEQLC 
(corresponding to the sequence of M13 GVP [11-33], cf. chapter 2) with p(dA)g, p(dT)8 or 
'd(A)3* were carried out. For the titrations with the first two oligonucleotides, moderate 
maximum upfield shifts (0.06 resp. 0.04 ppm) of the aromatic proton resonances were 
found at N/p = 13, N/p = 72, respectively. 
These aromatic proton resonances, arising from the residues corresponding to Phel3 and 
Tyr26, of M13 GVP not only shifted but also strongly broadened upon addition of the 
oligonucleotide. This probably reflects an aggregation effect and not a binding process. As 
with the cyclic 11-residue peptide, the spinlabeled oligonucleotide gave no significant 
broadening or shift changes at all. 
In chapter 3, we have shown that the 23-residue peptide does not attain or contain a 
preferred ß-loop in water. Furthermore, Phel3 of M13 GVP is not involved in DNA 
binding, so the observed upfield shifts of the proton resonances of the corresponding 
residue in the peptide do not seem relevant in this respect. It is clear that this peptide is 
not a good model system for studying the conformation and the oligonucleotide binding 
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properties of native M13 GVP [11-33]. 
Anyway, the binding of oligonucleotides to the peptides is very weak in all cases 
investigated, as indicated by the very high maximum N/p values and the fact that the 
spinlabeied trinucleotide had no perturbing effects on peptide resonances. The high N/p 
values (in the order of tenfolds) where the maximum upfield shift of peptide proton 
resonances is reached may be qualitatively compared with the binding mode of the native 
protein, i.e. the mononucleotide/protein monomer ratio (N/P). Generally, for oligonu­
cleotides (dA)„ and (dT)„ up to about η = 30, it has been found that N/P = 3 and that there 
was little cooperativity. For polynucleotides as poly(dA) and poly(dT) it was found that 
N/P = 4, and that cooperativity of binding was high. For example, titration of M13 GVP 
with either (dA)16 (Folkers et al., 1993) or (dA)6 (van Duynhoven, 1992) both showed a 
binding mode of about N/P = 3 and gave a maximum upfield shift of ca. 0.3 ppm. The 
maximum upfield shifts we observed with the titrations of the cyclic peptides with 
oligonucleotides are smaller than 0.1 ppm, which also indicates a weaker binding as with 
the complete protein. 
It is clear that oligonucleotide binding by the peptides is much weaker than that by the 
native GVP, and probably will involve a much "looser" and less specific mechanism. This 
is not surprising considering the much smaller size and lesser complexity of the cyclic 
peptides compared to the protein. For example, cooperativity in binding seems hardly 
possible in the case of the peptide. The lack of crucial tertiary structural elements and of 
some essential residues appears to make cyclic peptide M13 GVP [17-27] not a good 
ssDNA binding model system a priori. The assistance of the complex loop and the dyad 
loop in binding (vide supra) is completely absent in the peptide. Besides, the hydrophobic 
residue Leu28 and the positively charged residue Arg 16 (which both play a role in 
binding) are also missing in the peptide. 
Nevertheless, the titration results show that the cyclic 11-residue peptide is capable of 
(weakly) binding to oligo- and polynucleotides and the trNOESY experiments show that 
indeed a ß-loop conformation is involved in the binding and that certain residues may play 
a specific role. The demonstrated congruence between the ß-loop structures of the cyclic 
11-residue peptide and M13 GVP [17-27] (cf. chapter 3) is an indication that the synthetic 
molecule is capable of at least partially reflecting the contribution of part [17-27] of gene-
V protein to polynucleotide binding. 
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CHAPTER 5 
FT-IR studies of the conformations of [Cyt17 27]-M13 
GVP-(17-27)-undecapeptide and [Cyt1133]-M13 GVP-
(ll-33)-tricosapeptide in the dehydrated state 
ABSTRACT 
The global conformations of M13 G VP and of the synthetic cyclic peptides: 
CGVSRQGKPYC and CQFTTRSGVSRQGKPYSLNEQLC in the dehydrated state have 
been analysed by FT-IR spectroscopy. The results qualitatively agree with the conforma-
tions in aqueous solution as determined by NMR spectroscopy. 
INTRODUCTION 
During recent years, Fourier Transform Infrared (FT-IR) spectroscopy has been used in an 
increasing rate as a non-invasive technique to study the conformations of proteins by band 
fitting analysis of the amide I vibrational band of the IR spectrum [1700-1620 cm'1] 
(Surewicz and Manisch, 1988; Goormaghtigh et al., 1990; Sarver and Krüger, 1991). For 
protein samples in solution, the technique may yield valuable structural information in 
combination with CD or NMR spectroscopy. For protein samples in the solid state, FT-IR 
spectroscopy may even be the only way to obtain structural information if crystals of 
sufficient quality for electron diffraction or X-ray crystallography are not available. Recent 
studies indicate that FT-IR spectroscopy is also valuable for conformational studies on 
small peptides (Manisch et al., 1993). 
As a part of an investigation into the scope and limitations of the estimation of protein 
secondary structure from the amide I and amide II vibrational bands, FT-IR analyses were 
made of a number of water-soluble proteins and peptides (Pistorius, 1995). In this study, 
the gene-V protein encoded by phage M13 (M13 GVP) was included as well as the two 
! __ !
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cyclic peptides CGVSRQGKPYC and CQFTTRSGVSRQGKPYSLNEQLC that represent 
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constrained analogues of parts 17-27 and 11-33, respectively, of the ssDNA binding loop 
of M13 GVP. The NMR analyses of the solution structures of these peptides are described 
in chapter 4. The solution structure of M13 GVP has also been studied extensively by 
NMR spectroscopy and was found to consist almost entirely of ß-strands and turns 
(Folkers, 1994; see also chapter 3). 
Analysis of secondary derivative or deconvoluted IR spectra of the protein or peptide 
gives information on the various types of secondary structural elements present. These 
results form the initial parameter sets necessary for curve fitting. This procedure ultimately 
yields the relative amounts of the structural elements, provided that the molar extinction 
coefficient of the corresponding absorption bands are approximately the same. The 
quantitative results can be given as percentages of the total area of the amide I band. 
EXPERIMENTAL 
Sample preparation 
The cyclic peptides were prepared as described in chapter 2. Wild-type MI3 GVP was 
prepared and isolated as described previously (van Duynhoven et al., 1990). 
For analysis, 0.5 mg of lyophilized peptide or protein samples were taken up in 0.6 ml 
water and deposited as a film on IR-transparent AgCl windows, using the iso-potential 
spin drying method (Clark et al., 1980). This procedure, originally developed for the 
preparation of membrane films, proves also very useful for measuring water-soluble 
protein samples in the solid state. 
FT-IR measurements 
FT-1R spectra were recorded on a Mattson Cygnus 100 single beam spectrometer 
(Madison, WI), equipped with a liquid nitrogen cooled, narrow band MCT detector and 
interfaced to a microcomputer. The optical bench was continuously purged with dry 
nitrogen gas at a flow rate of 20 1/min. 
Acquisition parameters: resolutions, 2 cm'; number of co-added interferograms, 512; 
moving mirror speed, 2.53 cm/s; wavenumber range, 4000-750 cm'; apodization function, 
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triangle. The time needed for acquisition and processing of such a spectrum was 9 
minutes. Signal to noise ratios between 2200 and 2000 cm"1 were better than 4xl03. 
Data treatment 
Data acquisition and analysis were performed with the Mattson EXPERT-IR analytical 
software. Baseline correction was applied where necessary, in order to correct for the 
absorption by the AgCl windows; the latter may vary in quality. 
Fourier self-deconvolution (Kaupinnen et al., 1981) parameters: bandwidth, up to 20 cm'; 
K-factor, up to 2.0; apodization function, sin2(x)/x2; lineshape function, Lorentz. Second 
derivative spectra were smoothed (Savitsky and Golay, 1964) over 13 datapoints. 
The amide I and II band parameters were derived with the aid of a curve fitting analysis 
of the absorbance spectra between 1800 and 1490 cm"1, using deconvoluted or second 
derivative spectra for the determination of the number and position of the bands (Surewicz 
et al., 1993). The quality of the fitted spectrum was judged by the residual integrated 
intensity and by deconvoluting the generated spectrum with the same parameters as the 
measured spectrum. 
RESULTS AND DISCUSSION 
Fig. 1 shows the IR absorbance spectra of wild-type M13 GVP and of [Cyt""27]-M13 
GVP-(17-27)-undecapeptide for the range 4000 and 800 cm'; Fig. 2 shows an amplifica-
tion of the region 1800-1450 cm"' (wherein the amide I and amide II absorptions are 
located) of the two molecules and of [Cyt""33]-M13 GVP-(1 l-33)-tricosapeptide. Fig. 3 
shows the second derivatives of these spectra of the three molecules. By making use of the 
latter and of the deconvoluted spectra the amide I and amide II components were 
identified. The results for the amide I components are resumed in Tables 1, 2 and 3. 
Tentative assignments of the amide I and amide II bands of wt M13 GVP and of the two 
synthetic peptides were made according to Bandekar (1992). 
The IR spectra of M13 GVP indicate the presence of a high content of ß-structure in this 
molecule. This is represented by a strong band at 1644 cm"' (64 %), and two weaker 
bands at 1625 and 1690 cm"1 (5 and 11 %, respectively; see table 1). It might be argued 
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Fig. I. Originell IR absorbance spectra (800-4000 cm') of dehydrated samples of M13 
GVP m (A) and ICyt"11 Ì-M13 GVP-(17-27)-undecapeptide (B). 
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Fig. 2. Region 1450-1800 cm' of the IR absorbance spectra of M13 GVP wt (A), of 
lCyt,7-27]-M13 GVP-(17-27)-undecapeptide (B) and of [Cyt""]-M13 GVP-(ll-33)-
tricosapeptide (C). 
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Fig. 3. Second order derivatives of the IR spectra of MÌ3 GVP wt (A), of [Cyt'727}-MI3 
GVP-( l7-27)-undecapeptide (B) and of [Cyt"iJ]-M13 GVP-(1 l-33)-tricosapeptide (C). 
Unfortunately, spectrum A is distorded by fringes, resulting from interference in the AgCl 
window. 
У 
1613±2 
1625±1 
1644±1 
1663±1 
1675±1 
1689±2 
2 
7±1 
35±1 
21±1 
1G±1 
12±2 
11±1 
Area 
1±1 
5±2 
64±2 
8±1 
12±3 
11±4 
(%) residues 
4 
56 
7 
10 
10 
Table 1. IR amide I band parameters ofM13-GVP wt, as derived by band fitting analysis. 
Peak positions and bandwidths in cm'. "Residues" denotes the approximate number of 
residues, giving rise to the corresponding band. All values: mean ± rounded S.D. (three 
spectra were analysed). 
I l l 
fl 
161б±2 
1627±1 
1649±1 
1659±1 
1674±1 
1694±1 
Δ
* 1 
28±2 
35±1 
22±1 
14±1 
19±2 
17±1 
Area 
5±1 
37±1 
19±1 
7±2 
21±1 
12±1 
(*) residues 
4 
2 
1 
2 
1 
Table 2. IR amide I band parameters of the synthetic peptide CGVSRQGKPYC. Peak 
positions and bandwidths in cm'. "Residues" denotes the approximate number of residues, 
giving rise to the corresponding band. All values: mean ± rounded S.D. (two spectra were 
analysed). 
V 
1599±5 
1622±X 
1647±1 
1675±1 
1705±1 
Δ1, 
2 
16±3 
21±3 
27±2 
26±1 
21±2 
Area 
3±1 
9±4 
16±1 
57±1 
10±3 
(%) 
Table 3. ¡R amide I band parameters of the synthetic peptide CQFTTRSGVSRQGKPYSL 
NEQLC. Peak positions and bandwidths in cm'. All values: mean ± rounded S.D. (two 
spectra were analysed}. 
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that the band at 1644 cm' is more in agreement with a random structure, since the 
strongest ß-type structural contribution to the amide I band is normally found below 1640 
cm'1. However, such high frequencies for ß-type structures have been observed before, e.g. 
in the case of gramicidine S (Naik et al., 1984). Secondly, absorptions at 1644 cm"1 
representing random structure are only observed in deuteriated media. The presence of ß-
turns is represented by bands at 1663 and 1675 cm"1 (8 and 12 %), that together account 
for about 10 + 7 = 17 residues, which roughly corresponds to the number of residues (18) 
involved in the turns of the M13 GVP structure, as determined by NMR spectroscopy 
(Folkers, 1994). 
As can be concluded from table 2, a relatively high content of ß-sheet is also present in 
ι ' ' I 
the synthetic peptide CGVSRQGKPYC in the dehydrated state. It is represented by the 
amide 1 bands at 1627 cm'1 (37 %) and 1694 cm1 (12 %), that together account for about 
5 residues. This roughly corresponds with the number of residues (six) that constitute the 
ß-sheet in the peptide in solution, as determined by NMR spectroscopy (chapter 3). 
In contrast, the synthetic 23-residue peptide CQFTTRSGVSRQGKPYSLNEQLC does not 
seem to contain any ß-type structure in the dehydrated state. This is indicated (table 3) by 
the absence of an amide I band at around 1690 cm' and the presence of a rather weak 
band at 1622 cm"1 (only 9 %). The strong contributions at 1647 cm"' (16 %) and 1675 cm'1 
(57 %) are probably attributable to random coil and/or ß„-turn structural elements, 
respectively. These results are not contradictory with those of the conformational analysis 
of the peptide in solution by NMR spectroscopy (chapter 3). 
Analysis of the amide II bands of the three molecules did not yield unambiguous results, 
as the separate contributions of the aromatic ring of tyrosine, of ß-sheet structure and of ß-
turn structure could not always be distinguished (data not shown). 
However, it can be concluded that band fitting analysis of the amide I band of M13 GVP 
and of the two peptides in the dehydrated state indicates the presence of structural 
elements in general agreement with the solution structures determined by the more precise 
NMR analyses. In particular, the evidence for ß-sheet formation of the cyclic 11-residue 
peptide in the dry state stresses its preference for adoption of the ß-loop conformation 
(chapter 3). 
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CHAPTER 6 
Synthesis of protected peptide disulfides by oxidative 
detachment from a trityl support 
ABSTRACT 
A new efficient method is described for the preparation of protected cyclized or symme­
trical dimeric peptide disulfides. The method employs the immobilization of a cysteine 
derivative on a solid phase by protection of its thiol function with a resin-linked trityl 
group. After conventional peptide assembly using the Fmoc strategy, detachment is 
performed by oxidation with iodine in a suitable organic solvent. When the solvent 
is Ν,Ν-dimethylformamide (DMF) and the N-terminal residue is Fmoc-Cys(Acm) or Boc-
Cys(Acm), the fully protected cyclic peptide disulfide will be obtained as the main product 
in high yield and purity. A practical work-up procedure for its isolation, without the 
interference of inorganic chemicals, is described. In some other solvents, e.g. dioxane and 
chloroform/methanol 1:1 (v/v), the iodine-mediated oxidation gave, apart from the cyclic 
product, also substantial amounts of the open symmetrical dimeric peptide disulfides with 
the N-terminal Boc- or Fmoc-Cys(Acm) residues left intact. 
INTRODUCTION 
One of the continuing challenges in peptide synthesis is the incorporation into solid phase 
methodology of a practical procedure for disulfide bond formation at any desired strategic 
moment (Biillesbach, 1992). 
Until now, most syntheses of peptides containing the disulfide moiety made use of the 
conventional peptide chain assembly in solution or on a solid phase, followed by disulfide 
bond formation in solution. Formation of cyclic disulfides on a solid support offers a 
numbers of advantages, since the pseudodilution principle (Barany and Merrifield, 1980) 
cancels some drawbacks of the synthesis in solution. However, most cyclizations of 
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cysteinyl peptides have been performed after (not before or whilst) detachment from the 
solid support and in dilute solution, which allows chromatographic monitoring. In spite of 
the reports of some promising attempts (Eritja et al., 1987; Garcia-Echeverria et al., 1989; 
Albericio et al., 1991), there should still be a considerable potential for cyclizations 
directly on a solid support. 
The commonly used convential method for the formation of the disulfide bond is the air 
oxidation of cysteinyl peptides in aqueous solution (Fujii et al., 1988; Lee et al., 1990). 
This method suffers from several drawbacks. First, the reaction requires a high dilution of 
the peptide to minimize intermolecular disulfide bond formation. Even then, polymerizati­
on is often encountered and yields are considerably lowered or even absent (Fujii et al., 
1988). 
Secondly, a long reaction time, sometimes of several days, is required to complete the 
(thermodynamica!ly-controlled) reaction, which is under thermodynamic control. Thirdly, 
the reaction is conducted at alkaline or neutral pH which may cause aggregation and 
precipitation of basic and hydrophobic peptides. Improvement of this situation is possible 
by the use of a mixed disulfide (Hantgan et al., 1974) or, probably even more, DMSO as 
the oxidant (Tarn et al., 1991). However, also the use of DMSO does not eliminate the 
drawbacks of high dilution and even not always the pH dependence of the reaction rate. 
A more facile but kinetically-controlled method employs the iodine-mediated oxidation of 
thiol groups that are either free or blocked with suitable protecting groups. With respect to 
the latter, the efficiency of the acetamidomethyl (Acm) and the trityl (Trt) group as 
disulfide moiety precursors has been explored extensively by Kamber and co-workers 
(Kamber et al., 1980; see also chapter 1 and 2). They showed by model experiments that 
the reaction rates for the formation of the intermediate reactive sulfenyl iodides depended 
strongly on the solvent. 
In one group of polar solvents ('Group Γ which includes acetic acid, dioxane and metha­
nol) the conversion of the tritylthio-function with iodine was much faster than that of the 
acetamidomethylthio-function. When both protective groups were present, the subsequent 
attack of the generated sulphenyl iodide on an S-Acm group gave the corresponding 
disulfide. In this case, there is 'partial selectivity' in the sense that an S-Acm and an S-Trt 
function are preferentially combined to the disulfide. 
In a second group of solvents ('Group 2'), including the less polar solvents chloroform and 
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dichloromethane, the rate of conversion for the tritylthio-function is so large that two S-Trt 
functions can be oxidatively linked even in presence of a S-Acm group. In DMF (belon­
ging to 'Group 3'), the S-Acm group is attacked much faster by iodine than the S-Trt 
group. 
These findings have been taken advantage of in the efficient preparation of a number of 
peptides of different nature. Kamber et al. (1980) founded their synthesis of insulin, 
somatostatine, Oxytocine and analogues, on these reactions. In most cases, however, only 
one disulfide bond in a peptide is formed by the oxidation with iodine. 
We now report an efficient method for disulfide formation in peptides that combines the 
advantages of: 
I ) Pseudo-dilution on the solid phase, with respect to cyclization; 
2) The remarkable solvent-dependence of the course of disulfide formation by Kamber's 
iodine-mediated oxidation; 
3) The novel application of an immobilized trityl group both as a protection for the thiol 
group and as an iodine-labile linker to the solid phase. 
Use of a trityl derivative as an acid-sensitive linker to a solid phase has been applied by 
Barios for the terminal-carboxyl protection of a peptide in a conventional solid phase 
assembly (Barios et al., 1991). A disadvantage of the preparation of Barios' resin is that 
the trityl function is introduced starting with a Friedel-Craft's reaction directly on a 
polystyrene matrix. This heterogeneous reaction makes it difficult to control and reproduce 
the effective loading with trityl groups. For this reason, we decided to synthesize our 
desired trityl linker independently in solution and then link it to a commercially available 
aminomethyl polystyrene via formation of an amide bond. In this way, the polystyrene 
matrix itself is not invaded and at least the maximum amount of loading can be controlled. 
The synthesis of our α-hydroxy-trityloxy-type linker I and related linkers, as well as the 
attachment of I to the aminomethyl polystyrene resin (to give II) will be described else­
where. The tritylalcohol-moiety present in II can be converted to a tritylthio-function by 
reaction with a thiol compound in acidic medium (Photaki et al., 1970). In this way, such 
compounds can be immobilized on the solid phase through their sulfur atom. Our first 
experiments were with cysteamine which was linked to II by reaction in TFA and 
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subsequent evaporation, thus obtaining III. 
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Product III possesses an ammonium function that, after deprotonation, can be acylated and 
thus makes these derivatized resins directly applicable for conventional solid phase peptide 
synthesis employing the 9-fluorenylmethyloxycarbonyl group ('Fmoc SPPS'). After 
completion of a peptide assembly, the fully blocked peptide chain can be detached simply 
by oxidation of the immobilized trityl-sulfur bond with iodine, in accordance with the 
findings of Kamber. When no other protected thiols or other sulfenyl iodide susceptible 
moieties are present in the peptide chain, its corresponding dimeric disulfide will be 
formed. The symmetrical disulfide can be formed either from the attack of the intermedi­
ary sulfenyl iodide on a similar molecule or on another tritylthioether. 
When another iodine-sensitive protected thiol function, e.g. that of Cys(Acm), is present, 
the outcome of the reaction will depend strongly on the nature of the solvent used, as 
discussed above and resumed in Scheme 1. 
S-Acm S-Trt 4 
VVVVV^ΛлΛлΛ/WVWVVVVV^Λ/VVVVVVWVVVVVVVVWVVV^ΛfVI/VVW* 
Iodine Compound V 
CHClj/MeOH/ \ DMF 
S-Acm S-I S-I S-Trt 
^ЛЛ^ ^ЛЛЛ/ У ^ И VNAA^VWWVNWVVVWVWVWVWVVVVVW 
1 l v 1 
VI vii VI 
Scheme I. The course of the iodolytic oxidation reaction depends on the nature of the 
solvent as predicted by Kamber et al. (1980). 
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We have studied such solvent-controlled results of the 'iodolytic' cleavage from the 
immobilized thiol protection by applying it to the synthesis of a number of peptides of 
short to moderate length. Two of these chosen target molecules were the cyclic disulfides 
Via and VIb. 
Boc But But Pmc Trt 
Ι Ι Ι Ι Ι ι > 
X-Cys-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr-NH-CH2-CH2-S 
Via, X=Fmoc 
Vlb, X=Boc 
Via and VIb are the protected precursors of a cyclized analogue of the so-called 'ss DNA 
binding loop' of the gene-V protein encoded by phage M13 (Folkers et al., 1994; see also 
chapter 1 and 2). In chapter 2, we showed that IVa and IVb (cyclic cystine analogues of 
Via and VIb) are well accessible by applying Kamber's iodine-mediated oxidation in 
solution to the open chain peptide bearing a Cys(Acm) and a Cys(Trt) residue at the 
respective termini. Also for this reason, the open-chain and resin-bound peptidyl chain of 
V was considered to be a good potential precursor of VI. 
But Pmc Trt But Boc 
ι ι I 
X-Cys-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr-Cys-OH 
IVa and IVb 
Acm But Pmc Trt Boc But 
1 I I I I I 
Cys-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr-NH-CH,-CH,-S-C 4CH2)4-C-CH2 •©H 
VaandVb 
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When the peptidyl resin V is treated with a solution of iodine, the nature of the released 
peptide will be governed by the solvent used. For example, in DMF the S-Acm group of 
V can be expected to be attacked by iodine giving the sulfenyl iodide. Pseudo-dilution will 
prevent subsequent attack on the S-Acm function of a second peptide chain. More likely, 
the sulfenyl iodide will attack the tritylthio-linkage at the other terminus and the cyclized 
disulfide VI will indeed be formed. The situation will be different with the solvents in 
which a S-Trt function is attacked by iodine faster than the S-Acm function. In this case, 
the sulfur-trityl linkage in V will be cleaved preferentially and the released sulfenyl iodide 
may diffuse into the solution phase. Once this occurs, the effect of pseudo-dilution is lost. 
Cyclization to VI (in this case by the attack of the intermediate S-I function on the N-
terminal S-Acm) may however still occur. But, in contrast to the situation in DMF, 
dimerization to the symmetrical disulfide VII is now also possible. 
Acm But Pmc Tit Boc But 
I I I I I I 
X-Cys-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr—NH 
(CH 2 ) 2 —S 
Лет But Pmc Trt Boc But (GH 2 ) 2 —S 
I I I I I > I 
X-Cys-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr-NH 
VII 
As a representative example of our method we describe in detail the synthesis of V 
starling from our trityl-resin and the results obtained by oxidative detachment with iodine 
in various solvents. 
RESULTS AND DISCUSSION 
Loading of the 'trityl resin' with cysteamine was performed satisfactorily by bringing the 
two components together in neat TFA and evaporating the latter. Determination of loading 
was performed by treatment of a weighed sample of the loaded resin with a large excess 
of neat TFA in order to detach the thiol compound completely. The quantity of thiol 
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groups released was determined by means of the Ellman's test (Ellman, 1959). The thiol 
loading estimated by this method agreed well with values obtained by combustion analyses 
and was convenient for efficient peptide synthesis (0.5 mmol cysteamine / g resin). 
Solid phase peptide synthesis on the resin was performed using the protocol routinely used 
for Fmoc SPPS in this laboratory. Deprotection occurred with 20% piperidine in DMF; the 
same reagent served to liberate the amino group of the cysteamine-moiety which was 
protonated by TFA at the beginning of the SPPS. Fmoc amino acids were coupled using 
TBTU, HOBt and NMM. Following completion of the SPPS of peptidyl resin V, yields 
were estimated by the weight increase and/or spectrophometric determination of the Fmoc 
content. They were 76% for Va and 85% for Vb, respectively. Amino acid analysis 
confirmed that the correct peptide had been assembled. This also indicates that the trityl-
thio linkage is stable under the conditions used for Fmoc SPPS. 
Iodine-mediated cleavage experiments and analysis of the products. Cleavage of the 
peptide from the resin was performed by addition of the peptidyl resin V to a stirred or 
shaken solution of an excess of iodine. After ten minutes of reaction time the excess 
iodine was reduced with solid ascorbic acid or aqueous thiosulphate. The protected peptide 
was isolated by extraction and/or evaporation. Yields of crude peptide were high and the 
composition of the product obtained indeed reflected a solvent dependency. 
Identity and purity of products were assessed using Amino Acid Analysis (AAA), Thin 
Layer Chromatography (TLC), Fast Atom Bombardment Mass Spectrometry (FAB-MS) 
and Edman degradation. Results obtained with DMF as the reaction medium follow the 
expectations described in the introduction. The cyclized disulfide-peptides Via and VIb 
were formed in high yield and with high degree of purity so further purification was not 
even necessary. Although the peptides appeared to be homogeneous by TLC and AAA, 
FAB-MS (Fig. 1) indicated the presence of a trace of a compound with the expected 
molecular mass of the bis-disulfide dimer VIII or its antiparallel isomer. The formation of 
a small amount of (one of) these compounds could still agree with Kamber's observations. 
However, it is also well possible that noncovalent dimerizations could have occurred 
during FAB-MS measurements. This phenomenon is encountered more often in the MS of 
cystine peptides. 
Fig. 1 shows that the calculated and the measured m/z values for both Via and VIb agree 
excellently; this also holds for the molecular clusters measured at medium resolution. 
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But Pmc Trt Boc But 
I I I I I 
X-Cys-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr-NH 
(CH2)2—S 
But Pmc Trt Boc But (ÇH2)2—S 
I I I I I I 
X-Cys-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr-NH 
Vili 
In one experiment, in which the oxidation of the Fmoc-peptidyl resin Va was performed in 
chloroform/methanol 1:1 (v/v) with mild stirring, the crude product was obtained in a 92 
% yield. TLC and FAB-MS indicated that it was heterogeneous and comprised both the 
cyclized monomer Via and the symmetrical dimer Vila as the major components. These 
products could be separated by chromatography on silica gel. FAB-MS again served as an 
accurate means for establishing the formation and isolation of both VI and VII (Fig. 2). 
Additionally, the cyclic Via and the dimeric Vila could be distinguished by performing 
one cycle of the manual Edman degradation (Edman, 1970) on both peptides after removal 
of the N-terminal Fmoc groups. As expected, Vila gave the phenylthiohydantoine-derivati-
ve of Cys(Acm) upon this treatment, while Via did not release a phenylthiohydantoine, in 
agreement with the cyclic disulfide structure (Neher et al., 1968). 
The formation of a relatively large quantity of dimer Vila indicates that the tritylthio 
linkage of Va is indeed the initial site of attack by iodine, rather than the Cys(Acm) 
residue. The formed sulfenyl iodide molecule (see Scheme 1) may attack a variety of other 
functions, viz. another identical sulfenyl iodide (yielding Vila), another resin-linked 
tritylthio-function (yielding Vila), or, intramolecularly, the Cys(Acm) function (yielding 
Via). 
Experiments on the oxidation of peptidyl resins Va and Vb in chloroform/methanol 1:1 
(v/v) with vigorous shaking yielded the cyclized monomers Via and VIb as the preponde-
rant products with Vila, resp. Vllb as substantial by-products, together with some 
unidentified minor contaminants. It is conceivable that stronger agitation favors the 
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Fig. I. FAB mass spectra (measured at low resolution) of the products obtained by the 
iodolylic detachment from peptidyl resins Va (top) and Vb (bottom) in DMF. Inserted, the 
molecular clusters corresponding with the compositions of Via (top) and Vlb (bottom), 
measured at medium resolution. 
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Fig. 2. FAB mass spectra (measured at low resolution) of the crude products obtained by 
the iodolytic detachment from peptidyl resins Va (top) and Vb (bottom) in chloroform/me­
thanol 1:1 (v/v). Inserted, the molecular clusters corresponding with the compositions of 
Via and Vila (top), and VIb and VHb (bottom), measured at medium resolution. 
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formation of the cyclized peptides. This may be the effect of a more efficient transport of 
iodine into the polymeric matrix. 
Detachment from the resin with Scm-Cl. The reaction of tritylthioethers with methoxycar-
bonylsulfenylchloride (Scm-Cl) has been applied by Kamber (1973) in the synthesis of 
asymmetric cystine peptides: 
R-S-Trt + CH30C(0)S-C1 - > CH3OC(0)S-S-R + Trt-Cl 
This reaction yields S-activated disulfides that can be reacted with free thiols to give 
asymmetric disulfides. Thus, Scm-Cl should be a reagent able to simultaneously detach 
and activate a thiol compound immobilized on a trityl resin. We confirmed this by 
reacting Scm-Cl with HI (P = Polystyrene matrix): 
CH30-C(0)-S-a + H2N-CH2-CH2-S-Trt-OP — — > CH30-C(0)-S-S-CH2-CH2-NH2 
III X 
+ СГ +Trt-0-P 
In a preliminary experiment, treatment of III with Scm-Cl in chloroform/methanol 2:1 
(v/v) released the compound X which could be isolated in a 46% yield, simply by filtra­
tion and evaporation of the filtrate. The demonstrated reactivity of the tritylthio linkage 
with Scm-Cl should enable the detachment of assembled protected peptides in the same 
way. 
Loading of the trityl resin with other thiol compounds. Experiments proved that also other 
thiols than cysteamine can be coupled to trityl-resin II via their sulfur atoms. We showed 
this for cysteine and N-Fmoc-cysteine amide. The method used for cysteamine was also 
used here; satisfactory loadings were again achieved (about 0,5 mmol/g) as determined by 
element analysis, spectro-photometric Fmoc determination and Ellman assay. Solid phase 
peptide disulfide synthesis using the immobilized Fmoc-cysteine amide and cysteine will 
be reported in the future. 
Scope and prospects. We are currently investigating whether the method described above 
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for the synthesis of disulfides has its limitation with respect to chain length. Preliminary 
results indicate that also short sequences of 2-4 residues can be detached with either 
cyclization or dimerization dependent on the solvent used for the oxidation with iodine. 
It is also feasible to obtain free peptide thiols by treating peptidyl resins as V with TFA. 
The products are promising intermediates for the synthesis of artificial antigens. Addi-
tionally, we are exploring the synthesis and applicability of other bifunctional trityl linkers. 
CONCLUSIONS 
A new general method for the solid phase synthesis of protected disulfide peptides has 
been realized. It employs the protection of a thiol function by an immobilized trityl linker, 
in combination with the solvent dependency of the iodine-mediated oxidation of S-Acm 
and S-Trt functions. After normal peptide assembly on the resin by the Fmoc strategy, 
detachment from the trityl linker with iodine affords disulfide peptides in high yield. 
When a Cys(Acm) residue is present in the chain either the cyclized disulfide or the 
homo-dimeric disulfide can be obtained from the same peptidyl resin simply by using a 
different solvent for the oxidation. We found that DMF is the solvent of choice for 
cyclization, while with the medium chloroform/methanol 1:1 (v/v) also the homo-dimer is 
obtained in acceptable yield if agitation is kept mild. These findings are largely in 
accordance with the observations by Kamber et al. (1980). 
The method described is very efficient because detachment and disulfide formation are 
effected in one step and under very mild conditions. The protecting groups on the peptide 
are maintained completely. Acidolytic deprotection can be performed afterwards in dilute 
solution, which is advantageous for suppressing undesired side reactions. 
To our knowledge, this is the first SPPS method that employs immobilization of a thiol 
function with the possibility of detachment from the resin by mild oxidation with iodine 
and concomitant formation of a disulfide bond. The short reaction time required (ten 
minutes) largely eliminates undesired side reactions with iodine. The solvent dependency 
of the reaction course allows the preparation of either the symmetrical open dimer or the 
cyclized monomer, simply by choosing the right medium for oxidation. We believe that 
this method will provide a powerful contribution to the tools available for the synthesis of 
peptides with regiospecific disulfide bonds. 
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EXPERIMENTAL 
Materials and methods. Aminopolystyrene and amino acid dervatives were purchased from 
Bachern (Bubendorf, Switzerland), solid phase syntheses were performed using the 
semiautomatic synthesizer SP 650 Labortec (Bubendorf, Switzerland), using the Fmoc 
Spps protocol described in chapter 2. Vigorous agitation of suspensions was performed 
with a flask shaker (Griffin & George Ltd.) operating at the highest attainable speed. 
Gentle agitation was performed by mild magnetic stirring or by axial rotation in a tilted 
position. Thin-layer chromatography was performed on precoated silica gel plates 60F254 
(Merck) in the following solvent systems (v/v/v): (A) chloroform/methanol/acetic acid 
(95:20:3), (B) chloroform/methanol (7:1), (С) chloroform/formic acid (20:1), (D) chloro-
form/methanol/formic acid (70:20:2), (E) chloroform/isopropyl alcohol/formic acid (70:8-
:2). Detection was by UV-fluorescence quenching, by chlorine/TDM (Von Arx et al., 
1976), by Barton's reagent [spray-reagent for reducing compounds consisting of equal 
volumes of aqueous solution of FeCl3, 30% and K3Fe(CN)6, 1%] and/or by spraying with 
methanol/sulfuric acid 1:1 (v/v); the latter reagent revealed the presence of trityl groups 
through formation of the characteristic yellow colour of trityl-cations. Melting points were 
determined using a Tottoli apparatus and are uncorrected. 
Mass spectra were recorded on a JEOL HX110 mass spectrometer, equipped with the 
DA5000 data system, after ionization/desorption with Fast Atom Bombardment (FAB) 
using xenon, and nitrobenzyl alcohol as matrix. When the isotopie peaks were resolved 
with isotopie peaks were resolved with 10 % valley definition, the assigned m/z values are 
referred to as "monoisotopic" (medium resolution). When the isotopie peaks were not 
resolved, the assigned values are referred to as "average" (low resolution). 
Immobilization of 5-[4'-(diphenylhydroxymethyl)phenoxylpentanoic acid; preparation of II. 
A roundbottomed flask was charged with aminomethylpolystyrene (8.9 g, 0.9 mmol N/g) 
and dichloromethane (150 ml). To the suspension were added sequentially: TBTU (3.9 g, 
12 mmol), HOBt (1.9 g, 12 mmol), compound I (4.5 g, 12 mmol, 50% excess), and NMM 
(2.0 ml, 18 mmol). The contents of the flask were gently agitated by rotation of the flask 
for 20 h at room temperature. The modified resin was removed by filtration and washed 
with dichloromethane and with isopropanol. Residual amino functions were capped by 
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acylation with acetic anhydride (2.5 ml) and diisopropylethylamine (5 ml) in DMF. Then 
the resin was washed with DMF, isopropanol and methanol to decompose any O-acetyla-
ted trityl groups. Resin adducts (compounds II) prepared in this way are yellowish and 
usually contain ca. 0.61 mmol trityl groups/g. 
Coupling of thiols to II (exemplified in the synthesis of III). Compound II (1.05 g, 0.64 
mmol) was suspended into TFA (25 ml) and the solid became red. Cysteamine hydro-
chloride (1.0 g, 8.8 mmol) was then added and the suspension was agitated gently for 30 
min at room temperature. TFA was evaporated in vacuo, shifting the equilibrium in the 
direction of the thioether. The residue was washed with ether, DMF, DCM and again with 
ether, to give after drying, 1.15 g of colourless compound III, which gave a strongly 
positive ninhydrin reaction (Kaiser et al., 1970); the IR spectrum showed a new, broad 
absorption band absorption at 1600-1700 cm'1, indicating the incorporation of cysteami-
ne.TFA. 
For the determination of the thiol content, samples of compound III were treated with 
TFA under equilibrium conditions by charging small glass filters with 10-20 mg quantities 
of III followed by the introduction, dropwise, of neat TFA (6 mí). The filtrates were 
evaporated and subjected to the Ellman assay (Ellman, 1959). In the pertinent experiment 
0.51 ± 0.02 mmol/g adduct was found in triplicate determinations. Elemental analyses (S 
and N) and were found to agree with the result of the Ellman test (1.68% S, equalling 
0.53 ± 0.01 mmol S/g adduct; Ν, increasing from 1.13 to 1.71%, equalling 0.49 ± 0.02 
mmol N/g adduct). The weight increment corresponded with the observed incorporations. 
Solid-phase synthesis using III: preparation of the peptidyl adducts Va and Vb. The 
syntheses were each performed with 502 mg of resin adduct III using the Fmoc strategy. 
Side chains were protected with the same functions as employed for the semipermanent 
protection of compound IV, but the N-terminal aminoacyl residue was chosen as Fmoc-
Cys(Acm) in Va or Boc-Cys(Acm) in Vb. The adapted protocol is specified in chapter 2 
(Fig. 4 therein). Although the Kaiser tests (Kaiser et al., 1970) indicated that no free 
amino functions remained, the capping step of the protocol was always performed. 
After completion of the synthesis, the peptidyl resins were washed with DMF, DCM, 
isopropanol and ether, and then dried in vacuo. The dried adduct Va (892 mg), correspon­
ded to a load of ca. 390 mg crude protected peptide or 0.20 mmol (76% yield with respect 
to the starting material III). Similarly, adduct Vb weighed 910 mg, corresponding to a 
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crude yield of 85% and a load of 0.22 mmol protected peptide. 
Iodolytic detachment of cyclic disulfides from the resins Va and Vb; synthesis of Via and 
Vlb, using DMF as the reaction medium. In a stoppered flask, containing a solution of 
iodine (47 mg, 0.185 mmol, 4 equiv. with respect to the tritylthio link) in DMF (80 ml), 
one of the peptidyl resins (200 mg, 0.045 mmol Va or 0.048 mmol Vb) was added in one 
portion. The suspension was vigorously shaken for exactly 10 min. The mixture was 
filtered, and solid ascorbic acid (250 mg, 1.4 mmol) was added. The resulting colourless 
solution was neutralized with neat triethylamine (ca. 200 ml) and the mixture was 
concentrated in vacuo below 40°C. The resulting syrupy residue was diluted with water to 
precipitate the peptide derivative. Since the pH tends to go down upon dissolution, a few 
drops of pyridine were added to maintain neutrality. The crude product solidified upon 
rubbing and the resulting white solid was collected by filtration or centrifugation. Yield 
Via, 68 mg (73%) and Vlb, 53 mg (56%). TLC (Via), homogeneous, R,=0.70 (system A); 
0.61 (system B); TLC (Vlb), homogeneous, R¡=0.68 (system A); 0.58 (system B). Amino 
acid analysis of Via: Arg 0.92 (1), Glu 0.94 (1), Gly 2.09 (2), Lys 1.00 (1), Pro 1.11 (1), 
Ser 0.80 (1), Туг 0.96 (1), Val 1.00 (internal standard). Amino acid analysis of Vlb: Arg 
0.94 (1), Glu 1.02 (1), Gly 2.11 (2), Lys 0.97 (1), Pro 1.07 (1), Ser 0.80 (1), Туг 0.83 (1), 
Val 1.00 (int.st.); Cys was not determined. 
FAB-MS (low resolution). Via, (C109H144Nl6O20S3) m/z = 2095.1 (ME*, average) and Vlb, 
(C99H,42N16O20S3) m/z = 1973.1 (MH*, average); accompanying Via: the cyclic dimer 
VIIIA, (C21sH288N32O40S6) m/z = 4189.2 (МП* average, relative abundance about 5%); 
accompanying Vlb: the cyclic dimer VIHb (С
т
Н
гк
1
Ы
п
О
А
^6), m/z = 3954.3 (МП*, avera­
ge, relative abundance about 5%). 
FAB-MS (medium resolution). Measured molecular isotope clusters for МП* of the main 
product are shown as insertions in Fig. 1. 
Iodolytic detachment of cyclic and dimeric disulfides from the adducts Va and Vb; 
synthesis of Via and Vlb, and Vila and VHb, using chloroform/methanol as the reaction 
medium. In a well-stoppered flask, containing a solution of iodine (47 mg, 0.185 mmol, 4 
equiv. respect to the tritylthio link) in a mixture of chloroform and methanol (80 ml, 1:1 
v/v), one of the peptidyl resins (200 mg) was added in one portion. The mixture was 
either shaken vigorously (which optimizes ring-closure) or gently mixed (which furthers 
dimerization), for exactly 10 min. The resin was removed by filtration and the brown 
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filtrate was decolourized by the addition of 0.01 M aqueous sodium thiosulphate solution 
(40 ml). The organic layer was separated and the aqueous phase re-extracted with 
chloroform (2x 20 ml). The combined chloroform layers were washed with water (2x), 
dried with Na2S04 and concentrated in vacuo. Ether was then added to the residue to 
precipitate the protected peptide material, which was collected by filtration (or centrifuga-
tion) and then dried in vacuo. Yields of yellowish-white crude detached peptide were: 92% 
from Va and 84% from Vb. FAB-MS and TLC indicated that both Via and Vila (VIb 
and VHb, respectively) were the major components of the crude products. The effects of 
the vigour of agitation was demonstrated here: Via and VIb were preponderant with 
strong agitation (ratio VI/VII = 4:1), whilst more of Vila and VHb were formed using 
mild agitation (ratio VI/VII « 1:1). 
Purification of Vila and VHb. Batches (30 mg) of crude products were subjected to 
medium-pressure chromatography on silica (Merck, Lobar 60B). Elution was with chloro­
form/methanol (7:1, v/v). Flow rate: 0.2 ml/min; detection: UV absorption at 280 nm or 
TLC; fractions of 6 ml were collected. The appropriate fractions were combined and 
evaporated in vacuo, yielding homogeneous Via and Vila, (VIb and VHb, respectively). 
The compounds Via and VIb obtained in this way were identified as the cyclic peptides 
obtained in the experiment using DMF as the reaction medium. The yields of compounds 
Vila and Vllb were 53 and 49 %, respectively. TLC (Vila), R,=0.68 (system A); 0.55 
(system B) and TLC (Vllb), RpO.65 (system A); 0.55 (system B). Amino acid analysis of 
Vila: Arg 1.03 (1), Glu 1.00 (1), Gly 1.82 (2), Lys 0.94 (1), Pro 1.10 (1), Ser 0.70 (1), 
Туг 1.00 (I), Val 1.00 (internal standard). Amino acid analysis of Vllb: Arg 1.10 (1), Glu 
1.09 (1), Gly 2.02 (2), Lys 1.05 (1), Pro 1.08 (1), Ser 0.78 (1), Туг 1.11 (1), Val 1.00 (int, 
st.); Cys was not determined. 
FAB-MS (hw resolution): Vila, ( C ^ H ^ ^ O ^ S , ; ) т/г = 4334.7 (MH+, average; Fig. 2) 
and VHb, (C204H296N34O42S6) m/z = 4090.3 (ΛίΗ+, average; Fig. 2). 
FAB-MS (medium resolution). Measured molecular isotope clusters for MW* of Vila and 
VHb are shown as insertions in Fig. 2. 
Edman degradation. S-Acetamidomethylcysteine was converted into 4-(acetamidomethyl-
thiomethyl)-l-phenyl-2-thiohydantoin using the prescription of Edman (1970). The 
compound was recrystallized from ethanol. M.p. 151-162°C. Anal, caled, for С, 3 Н 1 5 ^0 2 8 2 
(309.414): С 50.46, Η 4.89, Ν 13.58, S 20.72 %. Found: С 50.38, H 4.73, Ν 13.33, S 
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20.70 %. Compounds Via, VIb, Vila and Vllb were subjected to one cycle of manual 
Edman degradation. Chromatograms of the thiohydantoin of Cys(Acm) showed coinci­
dence with the product of the single Edman cycles on Vila and Vllb using the three 
solvent systems by Neher et al. (1968); TLC: Rt=0.05 (system С); 0.76 (system D) and 
0.32 (system E); Via and VIb gave no free thiohydantoin at all, as expected for an N-
terminal half-cystine. 
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CHAPTER 7 
A facile and general preparation of S-(alkylsulfenyl) 
cysteines 
ABSTRACT 
A general method for the facile preparation of S-(alkyisulfenyl)cysteines is described. It 
employs S-(methoxycarbonylsulfenyl) cysteine [H-Cys(Scm)-OH.HCl] as a parent thiol-
activated cysteine derivative; this compound was cleanly prepared by reacting cysteine 
with methoxycarbonylsulfenylchloride (Scm-CI). Subsequent reaction of the S-activated 
cysteine with the appropriate alkyl thiolates afforded the compounds H-Cys(SEt)-OH, H-
Cys(S/Bu)-OH, and the new H-Cys(STrt)-OH directly and rapidly in their zwitterionic 
form. This route to mixed disulfides of cysteine is more efficient and versatile than 
methods reported previously. 
INTRODUCTION 
During the history of peptide synthesis several protecting groups were developed for the 
strongly nucleophilic and oxidizable thiol function of the side chain of cysteine (Biilles-
bach, 1992). An important type of thiol protections for this aim is formed by aryl- and 
alkylsulfenyl groups. Of the several ones reported thus far, only the ethylsulfenyl, the 
isopropylsulfenyl and the reri-butyl-sulfenyl function appear to be applicable in peptide 
synthesis (Wünsch, 1974; Hiskey, 1981). Of these three, the i-butylsulfenyl function 
(SiBu) has found general application as exemplified by the synthesis of several cysteinyl-
peptides (van Rietschoten et al., 1975; Moroder et al., 1981; Eritja et al., 1987; Atherton et 
al., 1985). The majority of the S-(alkylsulfenyl)cysteines, including the ethyl and the 
isopropyl derivatives, has been prepared by the reaction of cysteine with the appropriate 
alkyl thiosulfinates (Wünsch, 1974; Weber and Hartter, 1970). The desired compounds 
were obtained in high yield after a reaction time of 1 hour, except the useful /-butyl 
derivative which was obtained in only 30 % yield after a reaction time of 12 h. The steric 
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hindrance of the bulky /-butyl group, the probable cause of the poor result, was elegantly 
put to advantage by Wünsch and Spangenberg (1971; see also Wünsch, 1974). Reaction of 
cystine with excess /-butyl mercaptane in alkaline solution and in presence of air gave a 
85 % yield of H-Cys(S/Bu)-OH. This result could be achieved because formation of di-
(/er/-butyl)-disulfide is unfavourable and the equilibrium is thus shifted towards formation 
of the mixed disulfide. However, the reaction time required was long (5-7 days) and the 
method suffers the disadvantage of long exposure to the disagreeable scent of /-butyl 
mercaptane. 
In an improved procedure (Wünsch et al., 1982), the /-butylmercaptane was activated with 
azodicarboxylate derivatives and subsequent reaction with cysteine gave H-Cys(SiBu)-OH 
in good yield. The reaction time as well as the exposure to thiol odour could be reduced 
strongly in this way. 
A drawback of the mentioned methods is that they are either not applicable for all 
alkylsulfenyl groups or require a separate activation step (including a purification) for each 
different protecting thiol. We now report an efficient general method for the synthesis of 
S-(alkylsulfenyl)cysteines. It makes use of S-(methoxycarbonylsulfenyl)cysteine hydro-
chloride [H-Cys(Scm)-OH.HCl] as the parent S-activated cysteine intermediate. 
This compound is readily obtained by the reaction of cysteine hydrochloride with 
methoxycarbonylsulfenylchloride ("Scm-Cl"; Zumach and Kühle, 1970). The latter reagent 
has proven to be of great value in the synthesis of asymmetric disulfides (Brois et al., 
1970). Elegant applications on cysteine derivatives (Fotouhi et al., 1989; Hiskey et al., 
1975) and cysteinyl peptides (Kamber, J973; Kemp and Carey, 1989) have been described. 
However, to our knowledge the reaction product of Scm-Cl with free cysteine (eq.l) has 
not been described as a useful intermediate for the subsequent reaction with thiols (eq.2). 
The latter has only been noted by Hiskey (1981) as an example of an irreversible reaction 
yielding disulfides of cysteine (Scheme 1). 
We will describe the conditions under which this set of reactions yields S-(alkylsulfe-
nyl)cysteines (R = ethyl, /er/-butyl or trityl) in a straightforward and efficient way with an 
exposure of only about 10 minutes to disagreeable odours. The tritylsulfenyl group has 
previously been described as an amino protection (Zervas et al., 1963) but was also inclu-
ded in this study; it is herewith introduced as a new thiol protection. 
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RESULTS AND DISCUSSION 
Synthesis of S-(methoxycarbonylsulfenyI)cysteine Hydrochloride. The key compound 
H-Cys(Scm)-OH.HCl was prepared as a crystalline compound with semi-quantitative yield 
by reacting cysteine hydrochloride with an excess of one equivalent Scm-Cl in methanol. 
The presence of an excess of HCl prevented the reaction of Scm-Cl with the amino 
function of cysteine. Without the presence of an excess of HCl, ca. 15 % of Scm-Cys(Sc-
m)-OH was formed as a by-product as indicated by NMR and TLC {cf. experimental 
section). This compound, following treatment with a thiol, affords the same end product as 
obtained from H-Cys(Scm)-OH.HCl. When a smaller excess of Scm-Cl was used, TLC 
indicated the formation of cystine as a by-product. Cystine arises through attack of the 
thiol group of unreacted cysteine on the S-Scm function of already activated cysteine. 
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Attempts for purification of impure product samples by crystallisation, counter current 
distribution or silica chromatography led to partial decomposition, because of the sensi-
tivity of the activated function towards heat and/or nucleophiles. However, when stored as 
the dry HCl-salt in the cold, crude H-Cys(Scm)-OH, obtained as indicated above, is stable 
and can be kept for longer periods. At room temperature and/or in solution, it slowly 
decomposes. 
Synthesis of S-(alkylsulfenyl)cysteines. We found that H-Cys(Scm)-OH.HCl could be 
converted directly, rapidly and cleanly to any desired S-(alkylsulfenyl)cysteine [H-
Cys(SR)-OH]. The most convenient method was to add the dissolved activated cysteine to 
a solution of an excess of the thiol RSH and one eq. of triethylamine. The preferred 
solvent is methanol but in the case of R = Tit, addition of chloroform was necessary to 
dissolve trityl mercaptane. In the absence of base, the reaction proceeds too slow for 
efficient conversion, in agreement with the findings of Brois et al. (1970). Addition of 
base following the addition of the S-activated cysteine is unsuitable because of the risk of 
premature decomposition and/or precipitation of H-Cys(Scm)-OH. With our optimized 
method, an initial excess of strongly nucleophilic thiolate anions obviously drives the 
desired reaction rapidly to completion. The net acid/base neutralisation after completed 
addition affords the products directly in their zwitterionic form. Depending on the nature 
of R, they will crystallize isoelectrically from the reaction mixture. If R = Trt, the product 
remains dissolved in the solvent chloroform/methanol because of the lipophilicity of the 
trityl group. 
Using this method we synthesized H-Cys(SEt)-OH, H-Cys(S/Bu)-OH and H-Cys(STrt)-OH 
in excellent yields. The good results with respect to the latter two compounds indicate that 
the reaction is not retarded by bulky R groups. 
S-(Tritylsulfenyl)cysteine has not been reported previously. Investigations into the qualities 
and application of the tritylthio-group as a novel thiol protection for cysteine are described 
in chapter 8 (see also Rietman et al., 1994). 
In conclusion, we expect to have elaborated a new and convenient method for the syn-
thesis of S-(alkylsulfenyl)cysteines that combines speed and general applicability by 
efficient use of an activation of the side chain of free cysteine with an alkoxycarbonylsul-
fenylchloride. 
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EXPERIMENTAL 
Materials and methods. Melting points were determined on a Toltoli capillary melting 
point apparatus from Buchi and are uncorrected. Optical rotations were measured in a 
Perkin-Elmer Polarimeter, model 241. Elemental analyses were performed in the analytical 
laboratory of the department using the Carlo Erba elemental analyser 1108. 
Thin-layer chromatography (TLC) was carried out on Merck 60F254 silica gel plates. The 
solvent system 'A' refers to 1-butanol/acetic acid/water 4:1:1 (v/v/v). The spots were 
visualized by UV light, by chlorine/TDM (4,4'-tetramethyldiaminodiphenyl methane), by 
spraying with ninhydrine reagent or with sulphuric acid/methanol 1:1 (v/v). The latter 
reagent reveals the presence of trityl compounds by a yellow colour. 
NMR spectra were recorded on a 400 MHz FT Bruker AM 400 apparatus. MS spectra 
were obtained by the use of a double focussing VG 7070E mass spectrometer. 
Methoxycarbonylsulfenylchloride, ethyl mercaptane, and f-butyl mercaptane were obtained 
from Aldrich. Trityl mercaptane was prepared by the method of Balfe et al. (1950) and 
was recrystallized from ethanol before use. 
S-(Methoxycarbonylsulfenyl)cysteine hydrochloride [H-Cys(Scm)-OH.HCl]. A solution of 
4.46 g (28.5 mmol) cysteine hydrochloride in 38 ml methanol was shortly bubbled through 
with hydrogen chloride*. Then it was added dropwise to an ice-cold and magnetically 
stirred solution of 5.0 ml (55.0 mmol) Scm-Cl in 40 ml methanol. The clear solution was 
stirred for another hour at 0°C. Then the methanol was evaporated in vacuo (t<30°C) and a 
white crystalline residue was obtained. This was repeatedly triturated with ether to afford a 
weakly odourous, colourless crystalline solid. The product was dried in vacuo over NaOH 
and stored at -20°C. Yield 7.01 g (99%). M.p. 168°C (dec). TLC (System A): Rf 0.47. 
[a]2 5 D +28.5° (c=l, in HOAc). Ή NMR (D20) Ö(ppm): 3.28 (IH, dd, J=8.7 and 15.3 Hz; 
ß'-CH2), 3.44 (IH, dd, J=4.1 and 15.3 Hz; ß2-CH.2), 3.89 (3H, s; С Щ , 4.20 (IH, dd, J=4.1 
and 8.7 Hz; α-CH.)· MS(FAB) m/e (fragment, %) 212 (MH+, 100%). Elemental analysis 
caled.: С 24.24, H 4.07, Ν 5.65, S 25.89; found: С 24.09, H 4.03, Ν 5.53, S 26.47 %. 
'Remark: an insufficient excess of HCl may result in the formation of an amount 
(<15%) of the by-product Scm-Cys(Scm)-OH, which is easily detected by TLC and 
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NMR. TLC (System A): Rf 0.49; visible signals in Ή NMR (D20) spectrum: 
Ô(ppm): 3.82 (3H, s; CH3 of N-Scm), 4.42 (IH, dd; α-CH) [other signals are 
obscured by those of main product]. 
S-(Ethylsulfenyl)cysteine [H-Cys(SEt)-OH]. To a solution of 3.6 ml (48.5 mmol) ethyl 
mercaptane and 1.77 ml (11.3 mmol) triethylamine in 12 ml methanol, a solution of 3.10 g 
(12.5 mmol) H-Cys(Scm)-OH.HCl in 10 ml methanol was added dropwise with stirring at 
room temperature. During the addition, the product crystallized spontaneously. The colour­
less crystalline precipitate was filtered off. It was washed well with methanol and ether, 
and dried in vacuo. Yield: 2.13 g (94%). M.p. >199°C (dec.) [Lit. Weber and Hartter, 
1970: 199-200"C (dec.)]. TLC (System A): Rf 0.48. [a]2 5 D -149.3° (c=0.3, in 1 N HCl) 
[Lit. Inukai et al., 1967: [a] l 5 D -148.3° (c=0.3, in 1 N HCl); Lit. Weber and Hartter, 1970: 
[a]22D-138° (c=l. in 0.3 N HCl)]. Ή NMR (D20) ô(ppm): 1.25 (3H, t, J=7.8 Hz; CHj). 
2.74 (2H, q, J=7.8 Hz; ethyl СЦ2), 3.14 (IH, dd, J=7.8 and 14.0 Hz; ß-СЩ, 3.26 (IH, dd, 
J=4.4 and 14.0 Hz; ß-CH2), 4.22 (IH, dd, J=4.4 and 7.8 Hz; α-CH). MS(FAB) m/e 
(fragment, %): 204 (MNa+, 5), 182 (MH+, 6), 165 (MH+-NH3, 15), 154 (MH+-C2H4, 20), 
136 (MH+-C2H4-H20, 22), 102 (100). 
S-(tert-Butylsulfenyl)cysteine [H-Cys(SiBu)-OH]. То a solution of 2.76 ml (24.3 mmol) 
íerr-butyl mercaptane and 1.71 ml (10.9 mmol) triethylamine in 14 ml methanol, a soluti-
on of 3.0 g (12.2 mmol) H-Cys(Scm)-OH.HCl in 9 ml methanol was added dropwise with 
stirring at room temperature. A gel formed. It was triturated with ether to give a white 
solid that was filtered off, washed well with methanol and ether, and dried in vacuo. 
Yield: 2.29 g (90%). M.p. >159°C (dec.) [Lit. Weber and Hartter, 1970: 179-182°C (dec.)]. 
TLC (System A): R,=0.48. [a]25D-86.4° (c=l, in 1 N HCl) [Lit. Wünsch, 1974: [a]25D -84° 
(c=l, in 1 N HCl); Lit. Weber and Hartter, 1970: [a]22D -87° (c=l, in 0.3 N HO)]. Ή 
NMR (D20) ô(ppm): 1.30 (9H, s, С(СЫ3)3 ), 3.17 (IH, dd, J=7.9 and 14.9 Hz; ß'-CH.2), 
3.30 (IH, dd, J=4.1 and 14.9 Hz; ß2-CH2), 4.26 (IH, dd, J=4.1 and 7.9 Hz; α-CH.). 
MS(FAB) m/e (fragment, %): 210 (MH+, 100), 153 (MH+-C4H„ 12), 102 (34). Element 
analysis caled, for C7H15N02S2.l/2 H20 : С 38.51, H 7.39, Ν 6.42, S 29.37; found С 
38.62, H 7.33, Ν 6.50, S 28.58 %. 
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S-(Tritylsulfenyl)cysteine [H-Cys(STrt)-OH]. To a solution of 8.0 g (28.9 mmol) trityl 
mercaptane and 2.28 ml (14.5 mmol) triethylamine in 90 ml chloroform/methanol 1:1 
(v/v), a solution of 4.0 g (16.1 mmol) H-Cys(Scm)-OH.HCl in 12 ml methanol was added 
with stirring at room temperature. The clear solution was concentrated in vacuo. A white 
precipitate was formed. It was collected by filtration, washed with ether and dried in 
vacuo. Yield: 6.22 g (97%). M.p. >128°C (dec). TLC (System A): R,=0.61. [ct]25D -162.0° 
(c=l, in chloroform). Ή NMR (DMSO-d6) Ô(ppm): 2.24 (IH, dd, J=8.5 and 13.7 Hz; ß'-
СЩ, 2.41 (IH, dd, J=4.3 and J=13.7 Hz; ß2-CH2), 3.09 (IH, dd, J=4.3 and 8.5 Hz; cc-
CH), 7.2-7.4 (15H, m, ArH)· MS(FAB) m/e (fragment, %): 418 (MNa\ 4), 396 (MH*, 20), 
307 ( (C6H5)3CS2+, 5), 275 ( (C6H5)3CS+, 40), 243 ( (C6H5)3C+, 100). 
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CHAPTER 8 
On the stability of S-(aIkylsulfenyl)cysteine derivatives 
during solid phase synthesis 
ABSTRACT 
N-acetyl-S-(alkyIsulfenyl)cysteine benzyl esters were synthesized as models for N-acylated 
S-(alkylsulfenyl)cysteine residues linked via an ester bond to a solid phase. The involved 
alkylthio type S-protections were: the ethylthio, the well-established i-butylthio and the 
newly developed tritylthio group. We investigated the chemical behaviour of the disulfides 
with reagents commonly applied in solid phase peptide synthesis using the Fmoc strategy 
(Fmoc SPPS). It was found that the tritylsulfenyl group as a thiol protection is comparable 
with the i-butylsulfenyl group in these respects. It is stable in TFA and it is rapidly 
reduced by thiols and phosphines. For all three cysteine esters very rapid racemization was 
observed in piperidine (25 %) in DMF, amides being chirally stable. The demonstrated 
chiral instability of cysteine esters has severe consequences for the Fmoc SPPS of peptides 
with a C-terminal cysteine residue. Accordingly, we found the use of alkylthio type 
protections for the side chain of cysteine to be inconvenient in an attempted Fmoc SPPS 
of an oligonucleotide-binding cyclic 11-residue disulfide peptide with cysteine units as 
terminal residues. 
INTRODUCTION 
Since 1970, alkylsulfenyl groups (Weber and Hartter, 1970; Wünsch and Spangenberg, 
1971) have been used currently as protection for the thiol group of cysteine during the 
synthesis of cysteinyl and cystinyl peptides (Inukat et al., 1967; Moroder et al., 1981; 
Atherton et al., 1985; Eritja et al., 1987). This type of thiol protection can be introduced 
directly into cysteine using alkoxycarbonylsulfenyl activation (Rietman et al., 1994). Using 
this method, we have synthesized S-(ethylsulfenyl)-, S-(i-butylsulfenyl)-, and the novel S-
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(tritylsulfenyl)cysteine (cf. chapter 7). 
The N-(9-fluorenylmethyloxycarbonyl) derivative of S-(t-butylsulfenyl)cysteine [Fmoc-
Cys(SrBu)-OH] has been used widely in solid phase synthesis employing the Fmoc 
strategy [Fmoc SPPS] (Moroder et al., 1981; Atherton et al., 1985; Eritja et al., 1987). 
This compound is well suited for the purpose because it largely fulfills the demands of 
orthogonal protection of the cysteine side chain. The S/Bu function is reported to be stable 
to TFA (Atherton et al., 1985) and amines (Weber and Hartter, 1970) and it is removed by 
reduction with phosphines (Atherton et al., 1985) or thiols (Eritja et al., 1987). 
However, some specific problems associated with protected cysteine residues linked to a 
solid phase via a C-terminal ester bond have largely been overlooked. Eritja et al. (1987) 
repeatingly found the formation of an undesired product comprising an unidentified 
modification of the C-terminal cysteine residue in Fmoc SPPS starting from resin-linked 
Fmoc-Cys(SrBu)-OH. In addition, Atherton et al. (1991) showed that Boc-Cys(S/Bu)-OH 
esterified to a resin had been converted for 36% into the D-isomer after a 4 hours' 
treatment with piperidine 20% in DMF. In the performance of a solid phase synthesis the 
situation will probably be worse since the cysteinyl residue is even more prone to 
racemization after removal of the urethane-type protecting group and subsequent acylation, 
Enolization of a carbonyl function has been observed in esters and active esters (Young, 
1967; Kemp, 1979). 
Hence, we consider N-acetyl-S-(alkylsulfenyl)cysteine benzyl esters to be suitable mimics 
of C-terminal Cys(SR) residues esterified to a p-alkoxybenzyl alcohol resin (Wang, 1973) 
[R = Ethyl, /eri-Butyl or Trityl]. We synthesized the three benzyl esters as well as the 
protected dipeptides X-Cys(STrt)-Gly-OBzl (X = Boc, Ac). Then we investigated the 
stability of these compounds with respect to reagents commonly applied in Fmoc SPPS. 
Some properties of the S-tritylsulfenyl function were established simultaneously and 
compared with those of the two longer reputed protecting groups. 
In addition, we evaluated the use of the three alkylsulfenyl-type protections in the 
attempted Fmoc SPPS of a cyclized 11-residue peptide starting from Fmoc-Cys(SR)-OH 
esterified to a resin, and applying the reaction sequence described by Eritja et al. (1987). 
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RESULTS AND DISCUSSION 
Synthesis of derivatives of H-Cys(SR)-OH. 
The stability of the three disulfides was investigated following their conversion into N-
acetyl benzyl esters Ac-Cys(SR)-OBzl (R = Et, /Bu, Trt) by mild and non-racemizing 
standard methods. Acetylation of each cysteine S-sulfide was performed with acetic acid 
anhydride at pH 6.0 or with AcONSu in water at pH 8.5 - 9.0 till the ninhydrine reaction 
was negative. The obtained acids were converted to benzyl esters by reacting them with 
benzyl bromide and an organic base according to Nefkens and Nivard (1964). 
The synthesis of Boc-Cys(STrt)-OH was effected satisfactorily by reaction of H-Cys(STrt)-
OH with di-(/e/7-butyl) dicarbonate (Boc-O-Boc) using a standard method (Moroder et al., 
1976). A Boc-ylation attempt using Boc-azide and a pH-stat (Schnabel, 1967) required for 
completeness a fourfold excess of Boc-azide and a reaction time of ca. 100 h at pH 9.6 in 
dioxane/aqueous NaOH. The long reaction time is inconvenient and does not exclude 
racemization under the circumstances, so the Boc-O-Boc method is preferred by far in this 
case. 
The protected dipeptide Boc-Cys(STrt)-Gly-OBzl was synthesized by activation of Boc-
Cys(STrt)-OH with DCC and N-hydroxysuccinimide (HONSu) and subsequent aminolysis 
with glycine benzyl ester in DMF. Good yields were obtained after a reaction time of only 
10 minutes. A part of the product was converted to compound Ac-Cys(Trt)-Gly-OBzl by 
removal of the Boc group with pure TFA followed by acetylation with acetic acid 
anhydride in pyridine. The obtained derivatives X-Cys(STrt)-Gly-OBzl (X = Boc, Ac) 
were used as reference compounds in racemization studies. 
The ease of the described conversions of H-Cys(STrt)-OH and derivatives contributes to 
the suitability of the novel thiol protection for peptide synthesis. 
Stability tests 
The three model compounds Ac-Cys(SR)-OBzl were subjected to the conditions applied 
during solid phase synthesis starting with an N-acylated cysteine S-sulfide insolubilized by 
esterification with an alkoxybenzyl alcohol resin (Wang, 1973). They were examined by 
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TLC and pofarimelry. 
Each of ihe cysteine derivatives was soluble in the relevant organic solvents ensuring 
optimal exposure to the reagents specified below. 
1) Acidolysis using trifluoroacetic acid (TFA) 
Cleavage of the anchoring bond of a peptide to an alkoxybenzyl alcohol resin and 
acidolytic deprotection of side chain functions is commonly performed with trifluoroacetic 
acid (Fields and Noble, 1990). We confirm the reported stability of the disulfide-type side 
chain protection during mild acidolysis (Atherton et al, 1985; Eritja et al., 1987) since the 
acetylated compounds underwent no significant decomposition when kept in pure TFA for 
at least 5 hours, at room temperature. Standing for longer periods caused the appearance 
of small amounts of Ac-Cys(H)-OBzl on TLC. Simultaneously, the appearance could be 
visualized of traces of a trityl-like compound, obviously detached from Ac-Cys(STrt)-
OBzl. 
The same experiment was carried out with TFA containing some often used scavengers 
against alkylating and sulfonating cations. In the cocktail TFA/ethanedithiol/water 
95:2.5:2.5 (v/v/v) the thiol deprotection of the cysteine derivatives was slightly larger than 
in neat TFA, but still insignificant within periods shorter than 4 hours. This observation is 
in agreement with the finding that thiol-type scavengers do not attack disulfide bonds in 
peptides during deprotection in TFA (Seidel et al., 1991). Furthermore, a stability against 
TFA of at least 4 hours is compatible with the maximal acidolysis time required for full 
deprotection of Ser(/Bu) and Arg(Pmc) residues (Riniker and Hartmann, 1990). 
2) Reduction with thiols or phosphines 
Thiols [e.g. mercaptoethanol or dithiothreitol] (Eritja et al., 1987) and phosphines [trialkyl-
or triarylphosphines] (Atherton et al., 1985) were found to be effective for mild reductive 
removal of the f-butylsulfenyl protection of the cysteine sulfur. 
We confirm that treatment of the three derivatives Ac-Cys(SR)-OBzl with excessive 
mercaptoethanol or dithiothreitol in DMF, or with tri(n-butyl)phosphine in appropriate 
media gives quantitative conversion to the thiol Ac-Cys(H)-OBzl within less than 10 
minutes. TLC did not indicate any difference in reaction rate or in the nature of the 
cysteine derivative formed. Again, the chromatographic and spectrophotometric detectabi-
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lity of the trityl products proved to be an analytical advantage. 
Since it has been demonstrated that reduction of disulfide bonds with thiols is insignificant 
in TFA (vide supra), but quantitative in neutral media, the compatibility of the alkyl-
sulfenyl type protection for the thiol group is supported. 
3) Stability to piperidine in DMF 
Piperidine in DMF is widely applied as the reagent for removal of the Fmoc group in 
SPPS (Fields and Noble, 1990), but the concomitant racemization of C-terminal cysteine 
esters is a serious problem. 
We studied this problem by following the change in observed rotation of 1% (10 mg/1 ml) 
solutions of each of the three derivatives Ac-Cys(SR)-OBzl in piperidine/DMF 1:3 (v/v) at 
room temperature. The absolute value of the rotation was found to fall to zero quite 
rapidly. Plotting the course of this parameter against time gave the graphics of Figure 1. 
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Fig. I. The course of the absolute values of the observed rotations (at 25"C and at the 
sodium D line) of the substrates Ac-Cys(SR)-OBzl (+ R=tBu, • R=Trt, • R=Et; initial 
concentrations c=1.0), Boc-Cys(STrt)-Gly-OBzl (" ; c=0.37) and Ac-Cys(STrt)-Gly-OBzl 
(x ; c=0.32) in piperidine/DMF 1:3 (v/v), versus time. 
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Noteworthy is the intense green colour developed by the solutions during the racemization 
experiments, by itself indicative of a chemical change. We did not analyse extensively the 
composition of the mixture obtained after the experiment. However, TLC after the reaction 
of Ac-Cys(STrt)-OBzl with piperidine indicated that part of the starting compound was 
unchanged (chemically, not optically) and part had been converted into other compounds, 
among which fast-running products stemming from detachment of the trityl moiety. 
The protected dipeptides Ac-Cys(STrt)-Gly-OBzl and Boc-Cys(STrt)-Gly-OBzl both did 
not show any significant decrease in optical rotation after dissolution to a known concen­
tration in the piperidine reagent. Nor did the solutions attain a colour. 
A plausible mechanism (Kovacs et al., 1970) for the observed loss of optical activity of 
the benzyl esters might be: base-induced formation of the carbanion at the chiral centre, 
causing complete racemization and the subsequent elimination of a part of the alkyl 
disulfide moiety. Addition of nucleophiles (piperidine, disulfide anion) to the formed 
dehydroalanine derivative will result in the formation of new but also racemic products. 
This mechanism is similar to that proposed for the observed racemization and partial 
conversion of C-terminally esterified Cys(Acm) residues in growing peptide chains during 
Fmoc SPPS (cf. chapter 2). 
The measurements with the dipeptides suggest that amides of N-acyl and N-alkoxycarbo-
nyl cysteine S-sulfides are chemically and optically stable under these conditions. These 
findings are in accordance with the well-known fact that enolate-stabilized carbanions are 
readily formed by α-proton abstraction from esters but not from amides. The occurrence of 
'anomalous' products found by Eritja et al. (1987) may be explained by elimination of t-
butyldisulfide anion and subsequent addition of piperidine during the Fmoc deprotection. 
In any case, it is clear that rapid racemization and/or decomposition occurs when N-acyl 
S-(alkylsulfenyl) cysteine esters are subjected to a 25 % piperidine solution. This tendency 
must be taken into account when one intends to synthesize (even small) peptides with a C-
lerminal cysteine residue by the Fmoc strategy. The danger is nonexistent when the 
cysteinyl residue is linked to the next residue (or solid phase linker) via a normal peptide 
(amide) bond. It is possible that the use of a different base or a lower base concentration 
for deprotection, may reduce the rate of racemization, as has already been shown with 
respect to a C-terminally esterified Cys(Trt) residue (Wade et al., 1991). 
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Solid phase synthesis using Cys(SR) derivatives 
The three alkylsulfenyl type protecting groups were used in the attempted "Fmoc SPPS" of 
f 1 
the cyclic peptide CGVSRQGKPYC (designated as "peptide I" in chapter 1) that has been 
shown to be capable of binding oligonucleotides and to adopt in water a preferred ß-loop 
conformation which highly resembles that of the native M13 GVP sequence [17-27] (cf. 
chapter 3). The syntheses started by attaching derivatives Fmoc-Cys(SR)-OH (R = Et or t-
Bu) to a Wang resin (Wang, 1973). Then followed assembly of the protected peptidyl 
chain in the convential way employing a DCC/HOBt protocol for Fmoc SPPS. Deprotec-
tion of the thiol groups, cyclization, and deblocking of the acid-labile side chain protecti-
ons were performed following essentially the strategy employed by Eritja et al. (1987). 
This strategy with respect to the mentioned cyclic 11-residue peptide is depicted in Fig. 2. 
After execution of this scheme, the identity and purity of the crude end products (designa-
ted A, B, and C) were investigated using amino acid analysis (AAA), RP-HPLC, NMR 
and FAB-MS. The AAA results indicated that А, В and С all had the expected amino acid 
composition. The HPLC and NMR (Fig. 3) results indicated that in all three cases the 
same main peptide product had been obtained; however, it was not the desired cyclic 
peptide I and it was contaminated with varying amounts of by-products. The FAB-MS 
results indicated that the desired peptide (with M = 1194.5) was either not present or in 
only small amounts. Instead, a large main peak with m/e 1031 (MH+) was observed in all 
three FAB-MS spectra. This value probably corresponds with the main product formed, 
but we were not able to find a satisfactory explanation for the formation of a product (or 
fragment) with a mass of 1030. A possibility is the mass of the desired peptide minus that 
of a tyrosine residue (1194 - 163 = 1031) but we did not observe a similar peak in spectra 
of the pure cyclic peptide obtained via other strategies (cf. chapter 2). Furthermore, a 
tyrosine residue was present in А, В and С according to the AAA results and it was not 
obvious that a rearrangement reaction would take place during MS measurements resulting 
in the loss of a Tyr residue from the peptide. 
Apart from several small peaks, probably arising from by-products, another substantial 
peak at m/e 1248 was detected in the FAB-MS spectrum of A and C. This value might 
correspond with the open 11-residue peptide in which the N-terminal cysteine residue has 
been normally deprotected and the C-terminal cysteine residue has the protected sulfur ex-
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changed with a piperidine moiety [cf. chapter 2 for Ala(Pip]: 
H-Cys(H)-Gly-Val-Ser-Arg-Gln-Gly-Lys-Pro-Tyr-Ala(Pipj-OH. 
In the FAB-MS spectrum of В no peak at m/e 1248 was observed, but instead a large 
peak at m/e 1337.6 was present. This may correspond to a similar compound in which the 
i-butylthio protection is still present on the N-terminal cysteine. In agreement with this, 
there was a sharp singlet at 1.30 ppm present in the Ή NMR spectrum of В (not A or C) 
which may arise from the corresponding /er/-butyl group (Fig. 3). 
Formation of (by-)products of this kind would agree well with the 'anomalous' results 
obtained by Eritja et al. (1987) and with the findings presented above for the reactivity of 
C-terminally esterified cysteine residues with piperidine. It emphasizes the fact that thiol 
protections of the alkylsulfenyl type are not suitable for Fmoc SPPS involving C-terminal­
ly esterified cysteine residues. It should be noted that the problem can be circumvented by 
the use of other thiol protections that give rise to much less racemization. Eritja et al. 
(1987) used successfully the f-butyl group for the C-terminal cysteine thiol protection, 
while we were able to obtain cyclic peptide I satisfactorily using the Trt and the Acm 
protection for resp. the N-terminal and the C-terminal thiol protection (chapter 3). 
EXPERIMENTAL 
Materials and methods 
Melting points were determined on a Totolli capillary melting point apparatus from Buechi 
and are uncorrected. Optical rotations were measured in a Perkin-Elmer Polarimeter, model 
241. Elemental analyses were performed in the analytical laboratory of the department 
using the Carlo Erba elemental analyser 1108. Thin layer chromatography (TLC) was 
carried out on Merck 60F254 silica coated glass plates. The spots were visualized by one or 
more of the following methods: (1) UV-fluorescence quenching 254 nm, (2) chlorine/TDM 
(Von Arx et al., 1976) (3) ninhydrine, (4) sodium nitroprusside in water, (5) concentrated 
sulphuric acid/methanol 1:1 (v/v). Spraying with reagent (4) reveals the presence of free 
thiols, e.g. Ac-Cys(H)-OBzl, by a red colour. Spraying with reagent (5), eventually 
followed by heating, reveals the presence of trityl-containing compounds by a yellow 
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Fmoc—Cys(SR)-0—Resin 
(X-Fmoc, R-R'-Et for A4 X-Fmoc, R-R'-tBu for B; 
X-Boc, R-tBu, R'-Trt for C) 
PmocSPPS 
X—CysCSRO-Gly— Val—Ser(tBuhArg(I>mo)—Gln—Gly—Lys(Boc)—Pro—Tyr(tBu)—Cys(SR)—O—Resin 
Meroptoethmol / DMF 
X—Cys(H)-Gly—Val·—Ser(tBu)-Arg(Pmc)—Gin—Gly—Lys(Boc)—Pro—TyrftBu)—Cys(H)—0—Resin 
K3Fe(CNls 
X—Cys-Gly—Val·—Ser(tBu)-Arg(Pmc)—Gin—Gly—Lys(Boc)—Pro—Tyr(tBu)—Cys—O—Resin 
1) piperidine 
2) TFA фгАааЛВ) 
I) TFA (forC) 
-I H-Cys-Gly— Val—Ser(H)-Aig(H)-Gln-Gly—Lys(H>-Pro— Tyr(H)-Cys—OH 
Desired cyclic undecapeptìde 
Fig. 2. Scheme for the attempted synthesis of cyclic peptide I according to the strategy of 
Eritja et al. (1987). 
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Fig. 5. Ή NMR (400 MHz, D20, pH 5.0) spectra of crude peptides А, В and C, obtained 
by the routes of synthesis depicted in Fig. 2. For the spectrum of the desired cyclic ¡¡-re-
sidue peptide ¡: see chapter 2. 
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colour. 
Solid phase peptide syntheses were performed with a Labortec SP640 semi-automatic 
peptide synthesizer. NMR spectra were recorded on a 100 MHz FT Bruker AC 100 and a 
400 MHz FT Bruker AM400 apparatus. For obtaining mass spectra a double focussing VG 
7070E mass spectrometer was used. 
HPLC analyses were performed on an Advanced Chromatography Systems apparatus using 
a Techsil 5 C18 reversed phase column (250 χ 4.6 mm, HPLC technology, Chesire, UK). 
A 30 min linear gradient of 10% (v/v) acetonitrile and 0.1% (v/v) TFA in water to 90% 
(v/v) acetonitrile and 0.08% (v/v) TFA in water was used. The flow rate was 1 ml/min 
and the peaks were detected by their UV absorption at 280 nm or 215 nm. 
Amino acid analyses were performed on a Varian 9095 amino acid analyzer using the 
Fmoc protocol. Peptide samples were hydrolyzed in 5.7 N HCl (Merck Suprapur) for 24 
hours at 120UC. 
All reagents and solvents were of the highest purity available. Wang resin (Wang, 1973) 
and Fmoc amino acids, except the cysteine derivatives, were obtained from Bachern AG 
(Bubendorf, Switzerland). Derivatives Fmoc-Cys(SR)-OH (R=Et, f-Bu) were obtained by 
Fmoc-ylation (Ten Kortenaer et al., 1986) of compounds H-Cys(SR)-OH which had been 
synthesized by our own method (Rietman et al., 1994; see also chapter 7); Fmoc-Cys(SE-
0-OH was purified by washing with water and dichloromethane, respectively. Fmoc-ONSu 
and Ac-ONSu were obtained from Sigma, Boc-O-Boc from Fluka, and tri(/i-butyl)phosp-
hine from Aldrich. 
Synthesis 
N-Acetyl-S-(ethylsulfenyl)cysteine (Ac-Cys(SEt)-OH). To an ice-cold solution of 700 mg 
(3.86 mmol) H-Cys(SEt)-OH in 8 ml water was added 0.40 ml (4.24 mmol) acetic acid 
anhydride. The pH was kept at 6.0 by the addition of 2 N NaOH. When the pH remained 
constant, completion of the reaction was checked by the ninhydrine test. If necessary, 
another 0.40 ml of acetic acid anhydride was added till the ninhydrine test was negative. 
The solution was then washed three times with 5 ml of ether to remove the excess of 
acetic acid anhydride. The water was removed by azeotropic distillation with toluene. The 
resulting yellowish oil was dried in vacuo to give a white sticky gum, that became solid 
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after trituration with ether. The product was taken up into 0.1 N HCl and the solution was 
extracted three times with ethyl acetate. The ethyl acetate layers were combined, dried on 
sodium sulfate, and evaporated. The resulting oil was taken into hexane. The hexane was 
slowly removed at 20 mm Hg and room temperature. In this way, the product was 
obtained as a colourless crystalline solid. Yield: 802 mg (98%). Mpt: 98°C. [a]2 5 D -132.4° 
(c=1.0, 1.5 N HCl). TLC: Rf 0.39 (СНСуМеОШНОАс 95/20/3). Ή NMR(D20) ö(ppm): 
1.05 (3H, t, J=7.3 Hz; ethyl CH3), 1.82 (3H, s; acetyl СЩ, 2.51 (2H, q, J=7.3 Hz; ethyl 
Сиг), 2.77 (IH, dd, J=8.9 and 14.2 Hz; ß'-CH.2), 3.06 (IH, dd, J=4.5 and 14.2 Hz; ß2-
СЩ, 4.46 (IH, dd, J=4.5 and 8.9 Hz; ct-CH). MS(EI) m/e (fragment, %): 223 (M+, 30), 
178 (M+-CH02, 24), 149 (M+-CH02-C2H5, 100). 
N-Acetyl-S-(etliylsulfenyl)cysteine benzyl ester (Ac-Cys(SEt)-OBzl). A solution of 274 mg 
(1.11 mmol) Ac-Cys(SEt)-OH and 0.22 mi (1.11 mmol) dicyclohexylamine (DCA) in 3 mi 
DMF was heated to 60"C. Then 0.15 ml (1.26 mmol) benzylbromide was added with stir­
ring. After completed precipitation of DCA.HBr, the salt was removed by filtration. Water 
(30 ml) was added to the filtrate and the solution was extracted three times with ethyl 
acetate. The combined organic layers were washed with water, dried over sodium sulfate, 
and evaporated in vacuo. The product was obtained as a yellowish oil, homogeneous by 
TLC and NMR. Yield: 219 mg (63%). [a] 2 5 D +57.6° (c=1.14, chloroform); [a]2 5 D -50.6° 
(c=1.0, DMF). TLC: Rf 0.72 (CHCI3/MeOH/HOAc 95/20/3); see also table 1. Ή 
NMR(CDC13) δ(ρρπι): 1.28 (3H, t, J=7.3 Hz; ethyl С Щ , 2.05 (3H, s; acetyl С Щ , 2.65 
(2H, q, J=7.3 Hz; ethyl СЩ, 3.20 (2H, d, J=5.0 Hz; ß-CH2), 4.93 (IH, d t, J=5.0 and 7.6 
Hz; ct-CH), 5.20 (2H, s; benzyl С Щ , 6.40 (2H, br d; NH), 7.2-7.4 (5H, m; ArHJ. MS(EI) 
m/e (fragment, %): 313 (M+, 10), 91 (C6H5CH/, 100). 
N-Acetyl-S-(tert-butyl)cy steine (Ac-Cys(SrBu)-OH). 1.0 g (4.78 mmol) H-Cys(S/Bu)-OH 
and 0.66 ml (4.75 mmol) triethylamine were dissolved in 16 ml water. With stirring, 751 
mg (4.78 mmol) Ac-ONSu, dissolved in acetonitrile, was added. The pH was kept between 
8.5 and 9.0 by the addition of triethylamine until it remained constant. The reaction 
mixture was concentrated in vacuo and poured into 50 ml of 1.5 N HCl. A part of the 
product precipitated as a white crystalline solid that was collected by filtration, washed 
with water and dried in vacuo. TLC indicated that a substantial amount of product had 
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remained in solution. It was isolated by acidification to pH 4, removal of water ¿и vacuo 
(t<40°C), and extraction of the white residue with acetone. Filtration and evaporation of 
the extract gave the remaining product as a white solid that also was dried in vacuo and 
was homogeneous by TLC and NMR. Yield: 1.07 g (89%). Colourless crystals, mpt. 168-
171°C (dec). [cc]25D +33.1° (c=1.0, methanol). TLC: Rf 0.48 (CHCl3/MeOH/HOAc 
95/20/3). Ή NMR(CD3OD) 6(ppm): 1.33 (9H, s; (CH3)3C), 2.06 (3H, s; acetyl CH3), 3.20 
(2H, d, J=5.3 Hz; ß-CHJ, 4.78 (IH, t, J=5.3 Hz; a-Cffi· MS(EI) m/e (fragment, %): 252 
(M+, 17), 209 (M+-C2H30, 6), 195 (M+-C4H9, 37), 57 (C4H9+, 100), 43 (C2H30+, 72). 
Elemental analysis caled,: С 43.00, Η 6.82, Ν 5.57, S 25.51; found: С 42.89, H 6.71, Ν 
5.57, S 25.94%. 
N-Acetyl-S-(tert-butytmlfenyl)cysteine benzyl ester (Ac-Cys(SíBu)-OBzl). A solution of 
500 mg Ac-Cys(S/Bu)-OH (1.99 mmol) and 0.40 ml (1.99 mmol) dicyclohexylamine 
(DCA) in 40 ml DMF was heated to 65°C. With stirring, 0.26 ml (2.19 mmol) benzyl 
bromide was added. The solution was heated at 65°C for 3 hours and then cooled down to 
room temperature. Following the addition of 400 ml of water, the mixture was extracted 
three times with ethyl acetate. The combined organic fractions were washed with water, 
dried over sodium sulfate and evaporated in vacuo. The yellow oily residue was diluted 
with pet-ether (40-65) and the solution was filtered. The filtrate was evaporated in vacuo 
at room temperature, yielding the product as a white amorphous solid, homogeneous by 
NMR and TLC. Yield: 350 mg (52 %). [a]25D -78.8° (c=1.0, DMF). TLC: Rf 0.75 
(CHCIj/MeOH/HOAc 95/20/3); see also table 1. Ή NMR(CDC13) 5<ppm): 1.30 (9H, s; 
C(CH3)3), 2.05 (3H, s; acetyl СЫ3), 3.21 (2H, d, J=4.8 Hz; ß-СЩ, 4.92 (IH, d t, J=7.6 
and 4.8 Hz; a-CH), 5.20 (2H, s; benzyl CH2), 6.42 (IH, br d; NH), 7.2-7.4 (5H, m; benzyl 
ArH). MS(EI) m/e (fragment, %): 341 (M+, 19), 285 (M+-C4H9, 23), 91 (C6H5CH2+, 100), 
57 (C4H,+, 39), 43 (C2H30\ 29). Elemental analysis caled.: С 56.28, H 6.79, Ν 3.62; 
found С 56.69, Η 6.93, Ν 4.10%. 
N-Acetyl-S-(tritylsulfenyl)cysteine (Ac-Cys(STrt)-OH). A solution of 400 mg (1.01 mmol) 
H-Cys(STrt)-OH in 10 ml chloroform was cooled on an ice bath. Then a solution of 96 μ 1 
(1.01 mmol) acetic acid anhydride in 5 ml chloroform was added dropwise under vigorous 
stirring. The pH was kept at 6.0 by the addition of 0.5 M aqueous NaOH. The stirring was 
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continued until the ninhydrine test became negative. Following completion of reaction, the 
solution was passed over a column of Dowex H* and evaporated twice with toluene. This 
afforded the product as a white powder, homogeneous by TLC and NMR. Yield: 360 mg 
(81%). Mpt. 84°C. [a]2 5 D +4.4° (c=1.0, chloroform). TLC: Rf 0.52 (СНСЦ/МеОН/НОАс 
95/20/3). Ή NMR(CDCI3) Ô(ppm): 1.97 (3H, s; CH3), 2.13 (2H, d, J=5.0 Hz; ß-СЩ, 
4.45 (IH, d t, J=7.5 and 5.0 Hz; oc-CH), 6.22 (IH, d, J=7.5 Hz; NH), 7.2-7.4 (15H, m; 
ArH). MS(FAB) m/e (fragment, %): 460 (MNa*. 4), 243 ((C6H5)3C\ 100). 
N-Acetyt-S-(tritylsulfenyl)-cysteine benzyl ester (Ac-Cys(STrt)-OBzl). A solution of 1.0 g 
(2.29 mmol) Ac-Cys(STrl)-OH and 0.45 ml (2.40 mmol) DCA in 30 ml DMF was heated 
to 70"C. With stirring, 0.30 ml (2.52 mmol) benzyl bromide was added. After 5 hours of 
stirring the precipitation of DCA.HBr ceased. Following cooling of the reaction mixture to 
room temperature, the salt was removed by filtration. Ethyl acetate (300 ml) was added 
and the diluted solution was washed with water, dried over sodium sulfate, and evapora­
ted. The resulting oil was purified by low pressure chromatography on silica using the 
eluent chloroform/methanol 99:1 (v/v). After evaporation of the product-containing fracti­
ons, an oil was obtained that was triturated with pentane affording a white semi-solid, 
homogeneous by TLC and NMR. Yield: 640 mg (53%). [ct]25D -62.3° (c=1.0, DMF). TLC: 
Rt 0.80 (CHClj/MeOH/HOAc 95/20/3 v/v/v); see also table 1. Ή NMR(CDC13) 5(ppm): 
1.98 (3H, s; С Щ , 2.09 (2H, d, J=4.5 Hz; ß-CH2), 4.58 (IH, d t, J=7.5 and 4.5 Hz; a-CH), 
5.07 (2H, s; benzyl СЫ2), 6.15 (IH, d, J=7.5 Hz; NH), 7.2-7.5 (20H, m; АгШ- MS(FAB) 
m/e (fragment, %): 243 ((C6H5)3C+, 55), 91 (C6H5CH2+, 100); molecular ion not observed. 
N-(tert-Butyloxycarbonyl)-S-(tritylsulfenyl)cysteine (Boc-Cys(STrt)-OH). 200 mg (0.5 
mmol) H-Cys(STrt)-OH was dissolved in 5 ml DMF with stirring at room temperature. 
Triethylamine (70 μΙ, 0.5 mmol) was added. Following the addition of 110 mg Boc-O-Boc 
(0.5 mmol), stirring was continued for 30 minutes. The ninhydrine test showed that the 
reaction was completed by then. The mixture was concentrated in vacuo at t<40°C. The 
residue was partitioned between 2 N KHS04 and ether under ice cooling. The aqueous 
phase (pH 2) was extracted two times with ether. The combined ether layers were dried 
over sodium sulfate and evaporated. The oily residue was taken up in di/'sopropylether and 
insoluble contaminants were filtered off. The product was precipitated and triturated with 
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petroleum-ether to afford Boc-Cys(STrt)-OH as a white amorphous powder. Yield: 62%. 
[cc]25D -38.4" (c=0.37, chloroform). TLC: R, 0.74 (CHCI3/MeOH/HOAc 95/20/3 [v/v/v]); Rf 
0.37 (CHClj/MeOH 7:t ν/ν). Ή NMR(CDCl3) 5(ppm): 1.40 (9H, s; C(CH3)3), 2.10 (2H, 
d, J=4.8 Hz; CH2). 4.24 (IH, d t, J=7.3 and 4.8 Hz; oc-CH). 5.10 (2H, d, J=7.3 Hz; NH), 
7.2-7.4 (15H, m; ArH)· MS(FAB) m/e (fragment, %): 518 (MNa+, 8.5), 307 ((C6H5)3CS2+, 
3), 275 ((C6H5)3CS\ 12), 243 ((C6H5)3C+, 100). 
A part of the batch was converted to the DCA-salt (Klieger et al., 1961) for additional 
characterization. 
Dicyclohexylammonium salt of N-(tert-butyloxycarbonyl)-S-(tritylsulfenyl)cysteine (Boc-
Cys(STrt)-OH.DCA). Boc-Cys(STrt)-OH (200 mg, 0.4 mmol) was dissolved in 10 ml 
diisopropylether/pet-ether 1:1 (v/v) and 200 μΐ dicyclohexylamine (1.0 mmol) was added. 
After gentle mixing, the clear solution was left standing at 4°C overnight. During this 
period, the salt crystallized in colourless aggregates. Following décantation of the mother 
liquor, the crystals were washed with pet-ether and dried in vacuo. Mpt.>167°C (dec). 
[a]25„ -10.4° (c=1.0, chloroform). MS(FAB) m/e (fragment, %): 677 (MH\ 7), 243 
((C„H5)3C\ 100), 182 ((C6H12)2NH2+, 100). Elemental analysis caled: С 69.19, H 7.74, Ν 
4.14, S 9.47; found: С 68.61, H 7.82, Ν 4.32, S 8.95%. 
[N-(tert-butyloxycarbonyl)-S-(tritylsulfenyl)Jcysteinyl glycine benzyl ester (Boc-Cys(STrt)-
Gly-OBzl). A solution of 70 mg (0.61 mmol) HONSu and 125 mg (0.64 mmol) DCC in 
5.0 ml acetonitrile was cooled to 0°C on an ice bath. With stirring, a solution of 300 mg 
(0.61 mmol) Boc-Cys(STrt)-OH in 60 ml acetonitrile was added. The solution was left at 
0°C for one hour and then at room temperature for 2 hours. The precipitated dicyclo-
hexylurea was removed by filtration and the filtrate was evaporated in vacuo. The 
resulting yellow oil was taken in diisopropylether leaving a small residue that was filtered. 
The clear filtrate was evaporated in vacuo which afforded a white semi-solid. Yield of 
crude Boc-Cys(STrt)-ONSu: 296 mg (82%). TLC(CHCl3/MeOH/HOAc 95/20/3 v/v/v): Rf 
0.78; some minor contaminants were present. 
A portion of the crude active ester was directly reacted with H-Gly-OH.HOTos. Thus, 147 
mg (0.44 mmol) of the latter and 258 mg (0.44 mmol) of the Boc-Cys(STrt)-ONSu were 
dissolved in 10 ml DMF. The apparent pH was raised to 7 by the addition of DIPEA and 
the solution was left standing for 10 minutes at room temperature. Water (50 ml) was 
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added after which an emulsion formed. The mixture was extracted with chloroform until 
the aqueous layer remained clear. The combined chloroform extracts were dried over 
sodium sulfate and evaporated in vacuo. The product was purified by column chromato­
graphy on silica using the eluent chloroform/methanol 19:1 (v/v). Yield: 201 mg (72%) of 
an amorphous white solid, homogeneous as judged by TLC and NMR. [a]2 5 D -57.5° 
(c=1.0, DMF). TLC: Rf 0.90 (CHClj/MeOH 19:1 ν/ν). Ή NMR(CDC13) 6(ppm): 1.41 (9H, 
s; С(СН3)з ), 2.00 (2H, d, J=6.6 Hz; ß-CH2 of Cys), 4.01 (2H, d, J=5.2 Hz; a-CH2 of 
Gly), 5.00 (Ш, d, J=8.1 Hz; urethane NH), 5.16 (2H, s; benzyl С Щ , 6.66 (IH, t, J=5.2 
Hz; amide NH), 7.2-7.5 (20H, m; benzyl + trityl ArH); α-CH signal of Cys largely 
obscured by ct-CH2 signal of Gly. MS(FAB) m/e (fragment, %): 665 (MNa\ 10), 643 
(MH+, 15), 275 ((C6H5)3CS\ 55), 243 ((C4H5)3C+, 100), 91 ((C6H5CH2+, 45). 
lN-(Acetyl)-S-(tritylsulfenyl)]cysteinyl glycine benzyl ester (Ac-Cys(STrt)-Gly-OBzl). Boc-
Cys(STrt)-Gly-OBzl (50 mg, 0.076 mmol) was dissolved in 2 ml TFA at room temperatu­
re. The yellow solution was left standing for ten minutes to remove the Boc group. Then 
the TFA was evaporated in vacuo to leave a yellow syrup, which was dissolved in 5 ml 
DMF. The acidic solution was neutralized with DIPEA to apparent pH 5. Next, 0.5 ml 
Ac20 and I ml pyridine were added and the solution was left standing at room tempera­
ture overnight for complete acetylation. The mixture was partitioned between ethyl acetate 
and water. The aqueous phase was extracted twice with ethyl acetate. The organic layers 
were combined, washed with water, dried over sodium sulfate, and evaporated in vacuo. 
The oily residue was triturated with ether and dried in vacuo affording a yellowish glass, 
homogeneous by TLC and NMR. Yield: 90 %. TLC: Rf 0.80 (CHCl3/MeOH 7:1 v/v). 
[ct]"D -44,4° (c=0.32, DMF). Ή NMR(CDC13) Ô(ppm): 1.87 (3H, s; С Щ , 1.90 (2H, d, 
J=6.0 Hz; ß-CH2 of Cys), 3.92 (2H, d, J=5.5 Hz; ct-CH2 of Gly), 4.33 (Ш, d t, J=7.5 and 
6.0 Hz; ос-СЫ of Cys), 5.08 (2H, s; benzyl СЩ, 5.97 (IH, d, J=7.5 Hz; amide NH), 6.64 
(IH, t, J=5.4 Hz; urethane NH), 7.2-7.5 (20H, m; ArH). 
Stability towards trifluoroacetic acid (TFA) 
Solutions were prepared of each of the benzyl esters Ac-Cys(SR)-OBzl (10 mg/1 ml) in 
neat TFA. The trityl derivative (R = Trt) gave a yellow colour upon dissolution, probably 
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caused by the formation of a small amount of trityl cations. The three clear solutions were 
left standing at room temperature. With intervals of 30 minutes, aliquots of 2 μΙ were 
spotted on TLC plates and chromatographed using the eluent chloroform/methanol 38:1 
(v/v). 
During 5 hours of standing, no decomposition was observed. After this period, gradual 
decomposition of the substrate was indicated by the appearance of new spots on TLC. The 
Rf values of starting compounds and identified decomposition products are given in table 
1. 
The stability experiment was repeated with the cocktail TFA/EDT/H20 95:2.5:2.5 (v/v/v). 
In this case, beginning decomposition was observed after 4 h of standing. 
TABLE 1. Rf values of compounds Ac-Cys(SR)-OBzl and decomposition products on TLC, 
Compound 
Ac-Cys(SEt)-OBzl 
Ac-Cys(SiBu)-OBzl 
Ac-Cys(STrt)-OBzl 
Ac-Cys(H)-OBzl 
Trt-OH 
Trt-SH 
Rf value (CHCl3/MeOH 38:1 v/v) 
0.43 
0.49 
0.51 
0.32 
0.82 
0.88 
Reduction by thiols and phosphines 
The following three reducing reagents were prepared : 
1) mercaptoethanol/DMF 1:10 (v/v); 
2) 0.17 ml tri(n-butyl)phosphine in a mixture of trifluoroethanol (1 ml) and water (0.02 
ml); 
J) 3.4 ml tri(/j-butyl)phosphine in 20 ml acetic acid/water 4:1 (v/v) containing 0.87 g 
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ammonium acetate. 
Of each of the three derivatives Ac-Cys(SR)-OBzl, solutions (10 mg/ml) were prepared in 
each of the three reducing solutions. TLC after 10 minutes of standing at room temperatu-
re indicated quantitative deprotection of the thiol function, invariably yielding the 
derivative Ac-Cys(H)-OBzl (Table 1). 
Stability towards piperidine in DMF 
Polarimetrie experiments on the behaviour of the L-cysteine derivatives in piperidine 
(25%) in DMF were performed as described under 'Results and discussion'. The results are 
depicted in Fig. 1. 
Attempted solid phase synthesis of peptide I (cf. Fig. 2.) 
a) Coupling of Fmoc-Cys(SR)-OH (R-Et or t-Bu) to the Wang resin (Grandas et al., 
1989). A suspension of 1.5 mmol of the Fmoc amino acid and 173 mg (1.13 mmol) HOBt 
in 3 ml DMF was cooled in an ice bath. Following the addition of 310 mg (1.5 mmol) 
DCC in 0.5 ml DMF, the mixture was agitated for 10 minutes. After addition of 500 mg 
Wang resin (load with benzylalcoholic hydroxy groups: 1.01 mmol/g), the suspension was 
rotated at room temperature for 17 h. Hereafter, the resin was filtered, washed with DMF, 
dichloromethane and methanol, and dried in vacuo. Resulting amino acyl loadings 
(determined by gravimetry and elemental analysis): Fmoc-Cys(SEt)-OH: 0.29 mmol/g 
resin; Fmoc-Cys(S/Bu)-OH: 0.34 mmol/g resin. 
b) Solid phase synthesis of the peptidyl resins. The protected peptidyl chains were 
assembled starting from the Fmoc amino acyl resins prepared as described above. The 
used Fmoc SPPS protocol is described in chapter 2. The only modification was the 
coupling procedure, which used DCC rather than TBTU as the coupling agent. With 
respect to the theoretical amount of amino groups, per coupling were added: 3 eqs of 
Fmoc amino acid, 3.6 eqs of HOBt, and 3.3 eqs. of DCC, together dissolved in 5 ml 
DMF. Then the suspension was shaken for 30 min. 
The SPPS leading to A started with the deprotection of the Fmoc-Cys(SEt)-0-Resin and 
ended with the N-terminal coupling of Fmoc-Cys(SEt)-OH and subsequent capping and 
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washings. 
For the syntheses leading to В and C, a single SPPS, starting from the Fmoc-Cys(SiBu)-
O-Resin, was performed up to and including the coupling of the last but one protected 
amino acid (Fmoc-Gly-OH). Hereafter, the peptidyl resin was divided in two equal 
portions by weight. One portion was used for a final coupling with Fmoc-Cys(S/Bu)-OH 
(for B) and the other for a final coupling with Boc-Cys(STrt)-OH (for C). 
c) Deprotection of the cysteine thiol groups. The peptidyl resin was suspended in 5 ml 2-
mercaptoethanol/DMF 1:1 (v/v). The mixture was rotated for 5 hours at room temperature. 
Then the resin was filtered and washed three times with resp. DMF, DCM, DMF, ethanol 
and DMF. 
d) Disulfide cyclization on the resin. Directly after deprotection of the thiol functions as 
described above, the resin was suspended in a mixture of 10 ml of DMF and 1 ml of 1M 
aqueous solution of potassium ferricyanide. The resulting suspension was rotated overnight 
at room temperature. After this treatment, the resin was washed with resp. DMF/water 
(1:1), water, DMF, DCM, DMF, and ethanol until it was colourless. 
e) Deprotection of the N-terminal Fmoc group. For the syntheses leading to A and B, the 
N-terminal Fmoc group of the peptidyl chain was removed directly after the cyclization. 
The same deprotection method as in the SPPS protocol was followed. Thus, the resin was 
swollen in DMF, shaken for 6 min. with 20% piperidine in DMF and washed with resp. 
DMF, DCM, and ethanol. This procedure was repeated two times. 
f) Acidolytic detachment and deprotection. The peptidyl resin was suspended in 10 ml of 
TFA/EDT/H20 95:2.5:2.5 (v/v/v). The suspension was rotated for 3.5 hours at room 
temperature. Following filtration of the resin, the solution was added dropwise to 30 ml 
ether cooled to -20°C. The precipitated peptide material was spun down in a centrifuge 
tube and washed 5 times with ether, followed by centrifugation. The three crude peptides 
(А, В and C) were dried at the air and obtained as white powders that were stored at 
- 20ÜC. 
Overall yields of crude peptides: 
A: 40 mg (22%) 
В: 23 mg (11%) 
С: 22 mg (10%) 
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g) Analysis af crude peptides А, В and С : 
Amino acid analysis (all values ± 0.2; expected values for cyclic peptide I in parentheses): 
Cys 0.8 (2), Gly 2.1 (2), Val 1 (int. st.), Ser 0.9 (I), Arg l.l (1), Glu 1.0 (1), Lys 1.1 (1), 
Pro 1.0(1), Туг 1.0(1). 
HPLC: retention times: main product at 13.0 min; small and varying amounts of by­
products between 7.5-10.0 min. 
FAB-MS (m/e; prominent peaks underlined): 
A: 902.5. 1031.5. 1195.4, 1214.5. 1248.5. 1280.5, 1324.5, 1350.4, 1367.5 
B: 1031.5. 1337.6. 1470.5 
C: 1031.5. 1248.5. 1381.5, 2116.8, 2188.8 
'11 NMR (400 MHz; D20, pH 5.0, 298 K): spectra of products А, В and С are shown in 
Fig. 3. 
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Summary 
Interactions between nucleic acids and proteins play an essential role in the living cell, 
particularly in the regulation of the so-called gene-expression in the process of protein 
synthesis. During the last decennium, considerable progess has been made with respect to 
the insight in the structure-function relations of double-stranded DNA with their binding 
proteins on a (sub-)molecular level. Considerably less knowledge, however, is available of 
the single-stranded DNA binding proteins and their complexes with ssDNA. Probably the 
best studied protein in this respect is the single-standed DNA binding protein encoded by 
gene-V of the bacteriophage M13 (M13 GVP). In 1994, both its crystal structure and its 
solution structure were reported. It has also been deduced which protein subunits and 
which amino acid residues actually interact with the ssDNA during binding. 
An important part of the DNA binding domain of M13 GVP is formed by the so-called 
DNA binding loop, which comprises residues 16-28 of the 87 residues long protein. This 
loop is folded as a solvent-exposed, flexible, twisted, antiparallel ß-loop, with the side 
chain of residue Tyr26 bent over to residue Glyl8 which is located in the opposite strand 
of the ß-structure. Accumulating evidence suggests the existence of similar loops in the 
DNA binding proteins of related phages. The question has been raised whether the specific 
conformation and DNA binding properties of these loops are determined entirely by their 
primary sequences. To investigate this problem, we synthesized peptides with sequences 
analogous to parts of the M13 GVP DNA binding loop, and studied their conformations in 
aqueous solution, to obtain insight into the ß-loop folding independent of the protein 
matrix. 
Chapter 1 explains our choice of sequence-specific peptides in relation to the biophysical 
knowledge on M13 GVP. Subsequently, in chapter 2 the synthesis is described of two 
target peptides that both are constrained by a disulfide bridge. 
Chapter 3 describes the results of a NMR study of the conformations of the synthetic 
peptides in aqueous solution. Most important was the outcome of NMR data analysis and 
subsequent structure calculations for the cyclic disulfide-constrained [Cyt1727]-M13 GVP-
(l7-27)-undecapeptide. It was established that this cyclic undecapeptide adopts in water at 
277 К a preferred conformation highly resembling that of the corresponding sequence in 
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native M13 GVP. The resemblance includes the backbone twist and the specific confor-
mation of Tyr26. The conformational similarity is stressed by a striking agreement of the 
chemical shifts of the backbone protons. The NMR-derived results described in chapter 2 
are qualitatively supported by conformational analysis of the dry peptides by means of FT-
IR spectroscopy, which is described in chapter 5. Obviously, the choice of the mentioned 
cyclic undecapeptide as a conformational model peptide for sequence 17-27 of M13 GVP 
was appropriate. It has thus been shown that the preference for the characteristic ß-Ioop is 
indeed governed by the (constrained) primary sequence alone. 
DNA binding experiments with the model peptides gave somewhat less impressive results, 
as described in chapter 4. NMR-monitored titrations of the cyclic undecapeptide with 
oligonucleotides indicated a binding capacity but it is much less than that of the intact 
protein. Nevertheless, TrNOESY experiments performed at 298 К after titrations with 
longer oligonucleotides indicate that the peptide adopts the characteristic ß-loop confor-
mation upon binding. 
The sulfur chemistry involved in the synthesis of the disulfide peptides (chapter 2) 
inspired us to develope efficient new methods for the solid phase synthesis of such com-
pounds (described in chapter 6) and for the side chain protection of cysteine (described in 
chapter 7). Additionally, the solid phase syntheses described in chapter 2 indicated a side 
reaction takes place inducing racemisation of esterified cysteine residues during exposure 
to piperidine. Chapter 8 describes how this side-reaction was studied in more detail. N-
acetylated, S-protected cysteine esters were synthesized as soluble model compounds and 
their chemical behaviour in reagents commonly applied in solid phase peptide synthesis 
employing the Fmoc strategy, was studied. It was established that the cysteine esters 
racemize rapidly in piperidine. This phenomenon has serious consequences for the 
synthesis of peptides with a C-terminal cysteine residue, like our model undecapeptide. 
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Samenvatting 
Interakties tussen nucleïnezuren en eiwitten spelen een essentiële rol in de levende cel, 
niet name in de z.g. genexpressie. Dit betreft processen die het tot uitdrukking komen van 
een gen in de synthese van een eiwit reguleren. Gedurende het laatste decennium is er 
imposante vooruitgang geboekt met betrekking tot het inzicht in de struktuur-funktie 
relaties van dubbelstrengs (ds) DNA bindende eiwitten op een (sub)moleculair niveau. 
Daarentegen is er aanzienlijk minder bekend over de enkelstrengs (ss) DNA eiwitten en 
hun complexen met ssDNA. Waarschijnlijk de best bestudeerde van deze eiwitten is het 
ssDNA bindende eiwit dat wordt gecodeerd door het gen V van bakteriofaag M3 (M13 
G VP). In 1994 werden zowel een kristalstruktuur als een oplossingstruktuur van dit 
molekuul beschreven. Ook heeft men weten af te leiden welke secundaire struktuureiemen-
ten en welke aminozuurresiduen van het eiwit daadwerkelijk interaktie hebben met het 
gebonden ssDNA. 
Een belangrijk deel van het DN A-bindingsdomein van het Ml 3 GVP wordt gevormd door 
de zogenaamde DNA bindingslus die de residuen 16-28 omvat van het 87 residuen lange 
eiwit. Deze (in oplossing aan het milieu blootgestelde) lus is gevouwen als een flexibele, 
karakteristiek gedraaide, antiparallele ß-lus, waarin de zijketen van residu Tyr26 naar het 
residu Glyl8 van de andere streng is toegebogen. Steeds meer gegevens duiden op het 
bestaan van soortgelijke ß-lussen in de DNA-bindende eiwitten van verwante fagen. Mede 
daarom rees de vraag of de karakteristieke ß-conformatie en de rol in DNA-binding van 
deze lussen al of niet volledig zijn bepaald door hun primaire sequenties. Om dit probleem 
op te lossen m.b.t. M13 GVP werd de organische peptidesynthese te hulp geroepen. Wij 
besloten derhalve peptiden te synthetiseren met aminozuursequenties analoog aan delen 
van de DNA bindingslus en hun (van de overige delen van het protein onafhankelijke) 
conformaties in waterig milieu te onderzoeken. 
In hoofdstuk 1 wordt onze keuze van te synthetiseren sequentie-specifieke peptiden toege-
licht in het kader van de biofysische kennis van het M13 GVP. Vervolgens wordt in 
hoofdstuk 2 gedetailleerd de synthese beschreven van die twee doelpeptiden die m.b.v. een 
disulfide-bnig in hun conformationele vrijheid beperkt zijn. 
Hoofdstuk 3 beschrijft de resultaten van een NMR studie van de conformaties van de 
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van de analyse van de NMR-gegevens en de opvolgende struktuurberekening voor het 
[Cytl7'27]-M13 GVP-(17-27)-undecapeptide. Vastgesteld werd dat dit cyclische disulfide 
peptide in water bij 277 К een voorkeursconformatie aanneemt die sterk overeenkomt met 
die van het analoge deel in het natieve gen V protein. De overeenkomst geldt ook voor de 
"twist" in de ruggegraat en voor de specifieke conformatie van de zijketen van residu 
Tyr26. De gelijkenis wordt nog eens benadrukt door de opvallende overeenkomst in de 
chemische verschuiving van de analoge protonen aan de twee backbones. De uit de NMR-
metingen verkregen resultaten werden kwalitatief ondersteund door conformatie-analyse 
van de peptiden in droge toestand m.b.v. FT-IR Spektroskopie, zoals beschreven in 
hoofdstuk 5. Het blijkt dus dat het genoemde cyclische undecapeptide als conformationeel 
modelmolekuul voor sequentie 17-27 of M13 GVP goed gekozen is. Daarmee is aange­
toond dat de (energetische) voorkeur voor de karakteristieke conformatie van de DNA-
bindingslus inderdaad uitsluitend wordt bepaald door zijn eigen primaire sequentie. 
Wat minder indrukwekkend waren de resultaten van DNA-bindingsexperimenten met de 
modelpeptiden; deze zijn beschreven in hoofdstuk 4. Met behulp van met NMR gevolgde 
titraties van het cyclische undecapeptide met oligonucleotides wezen op een zekere 
bindingscapaciteit, die echter veel kleiner is dan die van het intakte proteïne. Niettemin 
gaven TrNOESY experimenten, verricht na titraties met langere oligonucleotides, aan dat 
het peptide wel degelijk de karakteristieke ß-lus conformatie aanneemt tijdens het 
bindingsproces. 
De zwavelchemie die is gebruikt bij de synthese van de disulfide-peptiden (hoofdstuk 2) 
zette ons aan om nog efficiëntere methoden te ontwikkelen voor de vaste drager synthese 
van dit type verbindingen; de resultaten zijn beschreven in hoofdstuk 6. Een nieuwe en 
snelle methode voor de zijketenbescherming van cysteine, het aminozuur dat direkt 
betrokken is bij de vorming van de disulfide binding, is beschreven in hoofdstuk 7. 
Hoofdstuk 8 behandelt onder meer een nader onderzoek naar nevenreakties van cysteine 
esters gedurende de behandeling met piperidine die gebruikelijk is bij de vaste drager 
peptide synthese m.b.v. de Fmoc strategie. Deze nevenreakties bleken aanleiding te geven 
tot racemisatie en daarmee tot de vorming van soms moeilijk te verwijderen bijprodukten 
tijdens de syntheses beschreven in hoofdstuk 2. 
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